






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































with	 the	 PV	 (arrow)	 and	 the	 parasite’s	 plasma	 membrane	 and	 rhoptries	 (arrowhead).	B.	Fluorescence	
microscopy	of	Nc-Liv-infected	HFF	labeled	with	Nile	Red.	HFF	were	infected	with	Nc-Liv	for	24	h,	fixed	and	
stained	with	Nile	Red	for	lipid	bodies	(arrowhead).	C.	Live	fluorescence	microscopy	of	Nc-Liv-infected	HFF	
incubated	 with	 exogenous	 fluorescent	 cholesterol.	 HFF	 infected	 with	 Nc-Liv	 for	 24	 h	 (arrows)	 were	
incubated	 with	 NBD-cholesterol	 incorporated	 into	 lipoproteins	 ([NBD-C]-LP)	 for	 5	 to	 20	 min	 prior	 to	
observation	by	live	fluorescence	microscopy,	showing	cholesterol	on	the	plasma	membrane,	and	then	in	
lipid	 bodies	 (arrowheads).	D.	Influence	 of	 exogenous	lipoproteins	 on	 Nc-Liv	 proliferation.	 Uracil	
incorporation	 by	Nc-Liv	24	 h	 or	 36	 h	 p.i.	 in	 either	 CHO	 cels	 grown	 in	 medium	 containing:	 a)	 10%	 FBS	



























































































































A.	Fluorescence	 microscopy	 of	 Nc-Liv-infected	 HFF	 expressing	 GFP-Rab14,	-Rab43	 or	-Rab30.	 HFF	
expressing	the	GFP-Rab	constructs	(green)	were	infected	for	24	h	or	30	h	with	Nc-Liv,	fixed	and	stained	
with	 DAPI	 (blue,	 nucleus)	 and	 antibodies	 against	 NcPIS	 (red,	parasite).	 The	 distribution	 of	 GFP-Rab-
positive	 vesicles	 around	 individual	 PV,	 in	 mono-	or	 multi-infected	 cels	 are	 shown	 in	 extended	 focus	
images.	B.	HFF	 expressing	 GFP-Rab14	 (green),	 either	 uninfected	 or	 infected	 with	 Nc-Liv	 for	 24	 h,	 were	
incubated	 in	the	 presence	 of	 BODIPY	 TR	 C5-ceramide	 (red)	 at	 the	 indicated	 times.	 An	 optical	 z-slice	 is	
shown	 for	 the	 merged,	 BODIPY	 TR	 C5-ceramide	 and	 GFP-Rab14	 channels	 plus	 the	 positive	 PDM.	 The	
white	and	blue	boxes	contain	Rab14-GFP	vesicles	inside	the	PV	and	along	the	PV	membrane,	respectively.	








































































































































































































































































































































































































































































































































































































































































































































Phospholipids	 Yes	(PC,	PE,	PS)	 Yes	 Sampels	et	al,	2012;	
Charron	and	Sibley,	2002.	
Triacylglycerols	 Yes	 Unknown	 Quittnat	et	al,	2004.	
Steryl	esters	 Yes	 Unknown	 Nishiwaka	et	al,	2005;	
Charron	and	Sibley,	2002;	
Lige	et	al,	2013.	
	
Table	3.1.	Summary	of	the	synthesis	or	scavenging	potential	of	lipids	by	Toxoplasma	gondi.	
Table	showing	whether	the	parasite	Toxoplasma	gondi	can	synthesize	or	scavenge	various	lipids	from	the	
host	cel.	It	is	unknown	whether	the	parasite	can	scavenge	triacylglycerols	or	sterol	esters	from	the	host	
cel,	both	lipids	found	predominantly	in	lipid	droplets.	
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One	potential	mechanism	used	by	the	parasite	to	scavenge	lipids	from	the	host	cel	
would	be	by	attracting	host	organeles	that	produce	and/or	store	lipids.	Shortly	after	invasion,	
the	host	mitochondria	and	ER	associate	closely	with	the	PVM	(Sinai	and	Joiner,	2001).	A	
Toxoplasma-secreted	protein,	TgMAF1,	was	recently	recognized	as	mediating	the	interaction	
between	host	mitochondria	and	the	PVM,	at	least	partialy	(Pernas	et	al,	2014).	It	is	
hypothesized	that	this	close	apposition	between	the	PV	and	host	organeles	could	facilitate	lipid	
transfer	to	the	PV.	It	is	unknown	why	an	increase	in	host	LD	and	association	to	the	PV	could	
occur	in	Toxoplasma-infected	cels.	It	is	also	unknown	whether	this	could	be	beneficial	for	the	
parasite.	In	any	case,	host	LD	could	represent	a	proficient	source	of	lipid,	and	due	to	the	
parasite’s	gluttonous	nature,	may	potentialy	be	scavenged	to	the	PV.		
3.2.11.	Chapter	goals	
In	this	chapter,	we	have	addressed	the	folowing	questions:	
- Does	Toxoplasma	induce	LD	formation	in	the	host	cel?	
- Do	host	LD	associate	with	the	PV?	
- Does	an	increase	in	host	LD	alter	Toxoplasma‘s	neutral	lipid	content?	
- Can	the	parasite	scavenge	neutral	lipids	from	the	host	cel	or	from	LD?	
- Can	the	parasite	sequester	LD	into	the	PV?	
- What	are	potential	mechanisms	by	which	host	LD	could	be	scavenged	by	Toxoplasma?	
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3.3.	MATERIALS	AND	METHODS	
3.3.1.	Reagents	and	antibodies	
Al	chemicals	were	obtained	from	Sigma	(St	Louis,	MO)	or	Fisher	(Waltham,	MA)	unless	
otherwise	stated.	[3H]Oleic	acid	was	purchased	Moravek	(Brea,	CA).	5-Butyl-4,4-Difluoro-4-Bora-
3a,4a-Diaza-s-Indacene-3-Nonanoic	Acid	(C4-BODIPY-C9)	was	purchased	from	ThermoFisher	
Scientific	(Waltham,	MA)	and	4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacene	
(BODIPY	493/503)	from	Life	Technologies	(Carlsbad,	CA).	The	primary	antibody	rabbit	polyclonal	
anti-GRA7	antibodies	was	used	(Coppens	et	al.,	2006).	Secondary	antibodies	used	for	
immunofluorescence	were	conjugated	to	Alexa594	or	Alexa350	(Invitrogen,	Carlsbad,	CA).	For	oleic	
acid	(OA)	preparations,	sodium	oleate	was	dissolved	in	H2O	at	a	concentration	of	100	mM,	then	
thoroughly	mixed	by	vortexing	(3	minutes)	with	5%	Fatty	Acid	Free	BSA	for	a	final	concentration	
of	10	mM	to	ensure	BSA-OA	complexes	formation	and	stored	in	the	dark	at	4°C.	In	our	hands,	
our	HFF	could	tolerate	OA	up	to	a	concentration	of	0.7	mM.	Many	studies	use	0.5	mM	and	there	
are	reports	of	no	cytotoxicity	up	to	1.2	mM	OA	in	human	erythrocytes	(Dwight	et	al,	1992;	Mei	
et	al,	2011;	Thörn	and	Bergsten,	2010).	For	palmitic	acid	(PA)	preparations,	sodium	palmitate	
was	dissolved	in	50%	ethanol	at	a	concentration	of	100	mM	and	prepared	subsequently	
identicaly	as	OA.	Cels	were	incubated	in	medium	with	various	final	OA	or	PA	concentrations.	
	
3.3.2.	Cel	lines	and	culture	conditions	
Human	foreskin	fibroblasts	(HFF)	were	obtained	from	the	American	Type	Culture	Colection	
(Manassas,	VA).	GFP-ADRP	HeLa	cels	were	kindly	provided	by	Raphael	Valdivia	(Duke	University,	
North	Carolina,	USA;	originaly	made	by	P.	Targett-Adams	and	J.	McLauchlan	at	the	Medical	
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Research	Council	Virology	Unit,	Institute	of	Virology,	Glasgow,	UK;	Targett-Adams	et	al,	2003).	
Al	cel	lines	were	grown	as	monolayers	and	cultivated	in	α-minimum	essential	medium	(MEM)	
supplemented	with	10%	fetal	bovine	serum	(FBS),	2	mM	glutamine	and	penicilin/streptomycin	
(100	units/ml	per	100	µg/ml),	and	maintained	at	37oC	in	5%	CO2.	
	
3.3.3.	Parasite	cultivation	
The	tachyzoites	from	the	RH	strain	(type	I	lineage)	were	used	throughout	this	study.	Toxoplasma	
stably	expressing	RFP	was	kindly	provided	by	Florence	Dzierszinski	(McGil	University,	Montreal,	
Canada).	The	parasites	were	propagated	in	vitro	by	serial	passage	in	monolayers	of	HFF	(Roos	et	
al.,	1994).	
	
3.3.4.	Real-Time	PCR	
Confluent	HFF	were	infected	with	Toxoplasma	RH	for	30	minutes,	folowed	by	PBS	washes	to	
remove	extracelular	parasites	then	incubated	with	0.2	mM	OA	for	various	times.	The	RNA	was	
extracted	using	RNeasy	Minikit	(Qiagen,	Valencia,	CA,	USA)	according	to	the	manufacturer’s	
protocol.	The	concentration	was	determined	on	a	NanoDrop	1000	Spectrophotometer	(Thermo	
Scientific,	Waltham,	MA).	Amplified	cDNA	of	the	RNA	samples	was	made	using	SuperScript	II	
First	Strand	kit	(Invitrogen).	100	ng	of	cDNA	per	sample	was	incubated	with	2.25	µl	each	of	
forward	and	reverse	appropriate	primer	and	17.5	µl	of	PowerUp	SyBr	Green	Master	Mix	
(Applied	Biosystems)	and	run	on	StepOne	Plus	Real-Time	PCR	Systems	(Applied	Biosystems).	The	
data	of	TgACAT1,	TgACAT2	and	TgDGAT	was	normalized	to	the	TgGT1	housekeeping	gene	
whereas	the	data	of	HsACAT,	HsDGAT,	HsADRP	and	HsATGL	was	normalized	to	HsGAPDH.	ΔΔCCs	
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were	calculated	using	as	controls	RNA	from	uninfected	HFF	to	assess	transcripts	levels	of	
HsACAT,	HsDGAT,	HsADRP	and	HsATGL	in	mammalian	cels.	In	Toxoplasma	transcript	level	
quantification,	ΔΔCCs	were	calculated	using	RNA	from	infected	HFF	without	OA	as	controls.	The	
folowing	primers	were	used:	TgACAT1:	(F)	CGA	CAT	CCT	CAT	TTT	CTA	CAT	TCT	C	and	(R)	GTG	
ACT	CCA	CTT	GTA	TCT	TTG	CTG;	TgACAT2:	(F)	ATG	CAT	TTT	TGT	ATT	CTA	GGT	GCA	and	(R)	GGA	
GAA	GGA	GAA	GAG	TTG	CAA	A;	TgDGAT:	(F)	GGA	AGT	GTG	CTA	TCC	CTT	ACA	C	and	(R)	CTC	CCT	
TAC	CAA	AGC	CGA	TAA	T;	TgGT1:	(F)	GGC	TAT	TTT	GGC	ACC	TTT	CA	and	(R)	AAC	GGG	AAG	ACA	
AAC	CAC	AG	;	HsADRP:	(F)	CAG	TAG	TCG	TCA	CAG	CAT	CTT	and	(R)	GAT	TGA	GGA	GAG	ACT	GCC	
TAT	TC	;	HsACAT:	(F)	CGG	GCT	AAC	TGA	TGT	CTA	CAA	T	and	(R)	GCA	TAA	GCG	TCC	TGT	TCA	TTT	C	
;	HsDGAT1:	(F)	CTGCAG	GAT	TCT	TTA	TTC	AGC	TC	and	(R)	CAT	TGC	TCA	AGA	TCA	GCA	TCA	C	;	
HsGAPDH:	(F)	GGT	GTG	AAC	CAT	GAG	AAG	TAT	GA	and	(R)	GAG	TCC	TTC	CAC	GAT	ACC	AAA	G	;	
HsATGL:	(F)	TGT	CTG	CAG	CGG	TT	CAT	and	(R)	CTC	ATA	GCG	TGG	CAG	GTT	GTC.	
	
3.3.5.	Mammalian	cel	transfection	with	Rab	constructs	
The	GFP-Rab7	was	kindly	provided	by	Craig	Roy	(Yale	University,	School	of	Medicine,	New	
Haven,	CT).	The	EGFP-Rab18	construct	was	a	gift	from	Marci	Scidmore	(Addgene	plasmid	#	
49550)	(Huang	et	al,	2010).	The	mCherry-Rab7	constructs	were	generated	in	the	laboratory.	
Rab7A	was	amplified	by	PCR	using	the	forward	primer	(5’	CTGGTGGACAGCAAATGG	3’)	and	
reverse	primer	(5’	CCTTCACAAAGATCCCAAGC	3’)	from	pEGFP-Rab7A,	generously	provided	by	
Craig	Roy	(Yale	University	School	of	Medicine,	New	Haven,	CT).	The	PCR	product	was	cloned	into	
pmCherry-C1	(Clontech,	Mountain	View,	CA)	using	XhoI	and	HindII.	The	plasmid	DNA	was	
confirmed	by	sequencing.	Only	HFF	were	used	for	transfections	using	the	Amaxa	nucleofector	
kit	V	according	to	the	manufacturer’s	protocol	(Lonza,	Basel,	Switzerland).	Cels	were	
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transfected	with	2.5	μg	of	plasmid	DNA	and	left	to	recover	overnight	prior	to	infections	with	
Toxoplasma	for	30	minutes	at	37°C,	cascade-washed	with	PBS	to	remove	extracelular	parasites,	
and	incubated	for	24	h	at	37°C.		
	
3.3.6.	[3H]Oleic	acid	uptake	
[3H]Oleic	acid	was	mixed	with	100	mM	of	OA	in	ethanol,	evaporated	by	N2	and	resuspended	in	
100	µl	DMSO,	mixed	with	900	µl	of	7%	fatty	acid	free	BSA	for	a	final	concentration	of	10	mM	
[3H]OA.	HFF	cels	were	seeded	in	24	wel	plates	and	incubated	with	0.1	or	0.4	mM	of	[3H]OA	to	
induce	the	formation	of	lipid	droplets	(LD)	containing	radioactive	OA.	Excess	[3H]OA	was	
thoroughly	washed	from	the	medium	and	the	cels	were	infected	with	Toxoplasma	for	24	or	36	
h.	The	calcium	ionophore	A23187	(20	µM)	was	added	to	the	cels	in	order	to	induce	Toxoplasma	
egress.	The	parasites	were	subsequently	purified	from	the	medium	by	3	rounds	of	washes.	The	
radioactivity	specificaly	associated	with	the	parasite	faction	was	determined	by	scintilation	
counting	(Multipurpose	Scintilation	Counter,	Beckman,	Brea,	CA)	and	cpm	values	were	
normalized	to	the	protein	concentration	of	the	sample	using	a	Biorad	Protein	Assay	(Biorad,	
Hercules,	CA).	These	assays	were	graphed	according	to	the	means	of	means	of	radioactivity	per	
mg	in	Excel	(Microsoft).	
	
3.3.7.	Fluorescence	microscopy	
For	staining	with	BODIPY	dyes,	infected	HFF	pretreated	with	0.4	mM	OA	or	not,	were	incubated	
with	either	10	mM	of	C4-BODIPY-C9	or	BODIPY	493/503	for	24	h,	thoroughly	washed	with	PBS	
then	incubated	for	2	h	with	α-MEM	medium.	These	pre-loaded	BODIPY-stained	hLD	cels	were	
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infected	with	Toxoplasma	(RH	or	RFP-RH)	for	the	indicated	times	prior	to	fixation,	staining	or	
image	acquisition.	During	infection	with	Toxoplasma,	0.2	mM	of	OA	was	added	to	the	medium	
to	ensure	that	hLD	would	remain	as	such	and	would	not	undergo	lipophagy	by	the	host	cel.	
	 	 Immunofluorescence	assays	(IFA)	on	fixed	cels	using	4%	formaldehyde	(Polysciences,	
Warrington,	PA)	plus	0.02%	glutaraldehyde	in	PBS	was	performed	as	described	previously	
(Karsten	et	al.,	2004)	with	a	5	minute	permeabilization	step	with	0.3%	TritonX-100	in	PBS	if	
staining	with	antibodies.	Specific	IFA	with	BODIPY	493/503	labeling	was	performed	after	the	
secondary	incubation	step	for	30	minutes	at	1:100	dilution	in	PBS,	folowed	by	three	5	minute	
PBS	washes	prior	to	staining	with	4-,6-diamidino-2-phenylindole	(DAPI).	Coverslips	were	
mounted	using	ProLong	Diamond	Antifade	Mountant	(Life	Technologies)	to	minimize	bleaching	
during	microscopy.	Cels	were	viewed	with	a	Nikon	Eclipse	90i	equipped	with	an	oil-immersion	
plan	Apo	100x	NA	1.4	objective	and	a	Hamamatsu	GRCA-ER	camera	(Hamamatsu	Photonics,	
Hamamatsu,	Japan).	Optical	z-sections	with	0.2-µm	spacing	were	acquired	using	Volocity	
software	(PerkinElmer,	Waltham,	MA).	The	images	were	deconvolved	using	an	iterative	
restoration	algorithm	and	the	registry	was	corrected	using	Volocity	software.	The	positive	
product	of	the	diferences	of	the	mean	(PDM)	images	were	calculated	using	Volocity	software,	
which	was	also	used	to	adjust	brightness	levels,	cropping	and	resizing	of	the	images	obtained.	
	
3.3.8.	Image	analysis	
GFP-ADRP	HeLa	cels	were	infected	with	Toxoplasma	for	various	amounts	of	time	ranging	from	2	
h	to	36	h	and	viewed	by	microscopy	to	quantify	the	amassing	of	host	LD	around	the	PV	of	
Toxoplasma.	The	percentage	of	PV	surrounded	by	host	LD	was	calculated	by	observation	of	host	
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LD	around	the	PV.	If	over	70%	of	the	PV	was	surrounded	by	host	LD,	the	PV	was	marked	as	
positive	and	plotted	as	such	in	a	histogram.		
	
3.3.9.	Electron	microscopy	
For	transmission	EM,	HFF	cels	infected	with	Toxoplasma	RH	strain	for	24	h	(with	or	without	OA)	
were	fixed	in	2.5%	glutaraldehyde	(EM	grade;	Electron	Microscopy	Sciences,	Hatfield,	PA)	in	0.1	
M	sodium	cacodylate	bufer	(pH	7.4)	for	1	h	at	room	temperature,	and	processed	as	described	
(Fölsch	et	al.,	2001)	before	examination	with	a	Philips	CM120	Electron	Microscope	(Eindhoven,	
the	Netherlands)	under	80	kV.	
	
3.3.10.	Statistical	methods	
Data	were	displayed	in	box	plots	using	Kaleidagraph	software	(Synergy	Software)	or	graphed	in	
Excel	(Microsoft)	with	standard	deviations	displayed.	Whiskers	of	the	box	plots	represent	the	
upper	and	lower	values	excluding	outliers,	outliers	are	marked	as	open	circles,	and	the	line	
inside	the	box	is	the	median	value.	Means	and	standard	deviations	were	calculated	from	three	
independent	experiments	using	Excel	(Microsoft).	p	values	were	calculated	using	either	student	
t-test	or	a	Chi-squared	test	in	Excel	(Microsoft).		
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3.4.	RESULTS	
3.4.1.	Host	lipid	droplets	cluster	around	the	PV	of	Toxoplasma	
The	rapid	intracelular	multiplication	of	Apicomplexan	parasites	such	as	Toxoplasma	gondi	
requires	large	amounts	of	lipids	for	the	membrane	biogenesis	of	the	new	progenies.	Hence,	the	
study	of	lipids	is	fundamental	to	understand	the	biology	and	pathogenesis	of	this	human	
pathogen.	Toxoplasma	scavenges	many	lipids	from	mammalian	host	organeles	(Coppens	et	al,	
2006;	Romano	et	al,	2013;	Quittnat	et	al,	2004;	Charron	and	Sibley,	2002;	Sampels	et	al,	2012),	
but	its	ability	to	salvage	lipids	stored	in	host	lipid	droplets	(LD)	remains	unexplored.	LD	are	
found	in	virtualy	al	cel	types	and	serve	primarily	as	lipid	depots	for	energy	(e.g.	fatty	acids	as	
respiratory	substrates),	membrane	biogenesis	(e.g.	fatty	acids,	cholesterol)	and/or	for	the	
formation	of	specific	lipophilic	components,	(e.g.	steroid	hormones)	as	wel	as	for	the	
prevention	of	celular	lipotoxicity	(Khor	et	al,	2013;	Smirnova	et	al,	2006;	Athenstaedt	and	
Daum,	2006;	Bickel	et	al,	2010).	The	lipids	stored	in	LD	are	esterified	with	a	fatty	acid	(FA)	into	a	
neutral	lipid	(NL)	form.	The	two	main	lipids	present	in	mammalian	LD	are	cholesteryl	esters	(CE)	
and	triacylglycerols	(TAG).	
	 A	halmark	of	a	Toxoplasma	infection	is	the	interaction	of	host	organeles	with	the	
parasitophorous	vacuole	(PV)	(Coppens	et	al,	2006;	Sinai	et	al,	1997;	Walker	et	al,	2008;	Romano	
et	al,	2008;	Wang	et	al,	2010;	Romano	et	al,	2013;	Pernas	et	al,	2014)	so	we	first	investigated	
the	spatial	distribution	of	host	LD	in	Toxoplasma-infected	cels.	We	stained	infected	cels	with	
the	fluorescent	NL	dye,	BODIPY	493/503	which	specificaly	fluoresces	and	accumulates	in	LD.	
Fluorescence	microscopy	reveals	the	partial	clustering	of	host	LD	around	the	PV	of	Toxoplasma	
24	h	post-infection	(p.i.)	(Fig.	3-4.A,	panel	a).	Culture	medium	supplemented	with	10%	serum,	
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which	is	referred	to	here	as	control	medium,	contains	on	average	30	μg/ml	of	cholesterol	and	3	
μg/ml	oleic	acid.	Incubation	of	mammalian	cels	with	oleic	acid	(OA)	at	a	concentration	of	0.2	
mM,	which	corresponds	to	approximately	a	20	fold	excess	of	OA,	increased	numbers	of	LD.	We	
investigated	the	efect	of	increased	OA	concentrations	on	LD	association	with	the	PV.	In	infected	
cels	exposed	to	0.2	mM	OA,	we	observed	a	more	dramatic	perivacuolar	accumulation	of	host	
LD	as	compared	to	control	medium	(Fig.	3-4.A,	panel	b).	This	feature	was	further	examined	by	
electron	microscopy	(EM)	in	which	LD	can	be	identified	as	homogenous	electron-dense	
structures	without	bilayer	membranous	profiles.	Our	ultrastructural	observations	of	
Toxoplasma-infected	cels	confirmed	the	clustering	of	host	LD	at	the	PV,	often	organized	in	
multilayers	(Fig.	3-4.B).		
To	quantify	the	amassing	of	host	LD	around	the	PV	and	examine	the	dynamics	of	this	
process	over	time,	we	assessed	the	percent	of	PV,	from	2	to	32	h	p.i.,	that	had	greater	than	70%	
of	their	perimeter	ringed	by	host	LD	(Fig.	3-4.C).	For	better	visualization	of	this	feature,	we	used	
HeLa	cels	overexpressing	the	Adipose	Diferentiation-Related	Protein	(ADRP)	in	which	the	
biogenesis	of	LD	is	stimulated,	as	host	cels	for	the	Toxoplasma	infection	(Targett-Adams	et	al,	
2003).	Indeed,	as	compared	to	fibroblasts	and	HeLa	cels	that	produce	a	median	of	23	and	17	LD	
per	cel	respectively,	ADRP-overexpressing	HeLa	cels	contain	a	median	of	36	LD	per	cel	(Fig.	3-
4.D	and	E).	Imaging	of	fixed	samples	by	microscopy	showed	that	the	mean	diameter	of	LD	in	HFF	
or	HeLa	cels	ranged	between	1	and	3	μm,	similarly	as	reported	for	a	human	hepatocyte	cel	line,	
Huh7	(Targett-Adams	et	al,	2003).	As	the	infection	progresses	concomitant	with	the	PV	
enlargement,	a	greater	number	of	PVs	were	surrounded	by	host	LD,	with	less	than	1%	of	PV	at	2	
h	p.i.	and	up	to	~	45%	of	PV	by	32	h	p.i.	(Fig.	3-4.C).	Addition	of	0.2	mM	OA	during	infection	
amplified	this	phenomenon	with	~70%	of	PVs	surrounded	with	hLD	by	32	h	p.i.		
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Figure	3-4.	Dynamic	changes	of	host	LD	upon	Toxoplasma	infection.	
A.	Fluorescence	microscopy	of	HFF	infected	with	RFP-expressing	Toxoplasma	for	24	h	and	stained	with	
BODIPY	493/503	after	fixation	without	oleic	acid	(OA)	(a)	or	with	0.2	mM	OA	(b)	during	infection.	
Representative	images	of	host	lipid	droplets	(host	LD)	stained	with	BODIPY	493/503	(green)	surrounding	
the	PV	of	Toxoplasma	(red)	are	shown.	Scale	bars,	7	μm.	B.	Ultrastructural	EM	view	of	an	infected	HFF	
with	the	PV	of	Toxoplasma	surrounded	by	host	LD	in	the	presence	of	0.2	mM	OA.	Scale	bar,	1	μm.	C.	
Quantification	of	the	percent	of	PVs	surrounded	by	host	LD	over	time,	with	or	without	OA.	GFP-ADRP-
expressing	HeLa	cels	were	infected	with	Toxoplasma	at	the	indicated	times	and	stained	with	BODIPY	
493/503	as	shown	in	(A).	PVs	were	scored	as	LD-associated	if	over	70%	of	the	PV	was	surrounded	by	host	
LD.	Data	representative	of	2	independent	experiments.	D-E.	Enumeration	of	host	LD	numbers	after	24	h	
Toxoplasma	infection	in	HeLa	and	GFP-ADRP	expressing-HeLa	cels.	Cels	were	infected	with	Toxoplasma,	
fixed	and	stained	with	BODIPY	493/503	to	count	the	number	of	host	LD.	The	boxplot	in	(D)	shows	the	
number	of	host	LD	in	uninfected	and	infected	HeLa	cels	at	24	h	p.i.	whereas	the	boxplot	in	(E)	shows	data	
from	GFP-ADRP	expressing-HeLa	cels.	Data	acquired	from	two	independent	measurements	with	n>40.	
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3.4.2.	Host	lipid	droplet	number	fluctuates	throughout	infection	
Next,	we	examined	whether	there	is	a	fluctuation	in	the	host	LD	number	throughout	a	
Toxoplasma	infection	in	cultured	cels.	The	number	of	parasites	per	PV	is	a	recognized	indicator	
of	infection	time	since	Toxoplasma	has	a	doubling	time	of	6-8	h.	In	HFF	infected	with	
Toxoplasma,	LD	were	counted	after	staining	with	BODIPY	493/503	(Fig.	3-5).	Early	during	
infection	(1,	2	or	4	parasites	per	PV),	host	LD	numbers	steadily	increased	from	a	median	of	23	in	
uninfected	cels	to	34	(1/PV),	51	(2/PV)	and	50	(4/PV)	in	infected	cels.	However,	once	the	PV	
contained	8	parasites	which	corresponds	to	~	24	h	p.i.,	host	LD	numbers	abruptly	declined	to	
approximately	26	per	cel.	This	suggests	a	highly	dynamic	status	of	host	LD	upon	Toxoplasma	
infection,	with	a	stimulation	of	LD	production	up	to	16	h	p.i.,	and	a	slowdown	in	host	LD	
biogenesis	and/or	consumption	of	host	LD	from	24	h	p.i.	until	parasite	egress.		
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Figure	3-5.	Influence	of	Toxoplasma	on	host	LD	dynamics.	
Enumeration	of	host	LD	numbers	throughout	Toxoplasma	infection	in	HFF.	HFF	were	infected	with	
Toxoplasma,	fixed	and	stained	with	BODIPY	493/503	to	count	the	number	of	host	LD.	The	boxplot	shows	
the	number	of	host	LD	in	infected	HFF	as	infection	with	Toxoplasma	progresses.	HFF	with	PVs	of	1,	2	or	4	
parasites	have	statisticaly	more	host	LD	than	uninfected	cels,	or	HFF	with	8	or	16	parasites	per	PV.	Data	
acquired	from	two	independent	experiments,	counting	>30	PVs	per	condition	per	experiment.	
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3.4.3.	Infection	with	Toxoplasma	alters	the	cycle	of	host	neutral	lipids	
The	variability	of	host	LD	numbers	in	Toxoplasma-infected	cels	prompted	us	to	examine	
potential	changes	in	the	NL	cycle	(synthesis	and	lipolysis)	in	LD.	To	do	so,	we	monitored	the	
transcriptional	activities	of	host	Acetyl-Coenzyme	A	Acetyltransferase	(ACAT),	Diacylglycerol	O-
Acyltransferase	1	(DGAT1)	and	Adipose	Triglyceride	Lipase	(ATGL)	in	infected	fibroblasts	for	24	h	
(Fig.	3-6.A).	Infection	with	Toxoplasma	led	to	a	statisticaly	significant	(p	<	0.05)	decrease	in	
transcript	levels	for	ACAT	by	2.85	fold,	DGAT1	by	1.25	fold	and	ATGL	by	3.44	fold	as	compared	to	
uninfected	control	HFF	(Fig.	3-6.A).		
In	paralel,	we	investigated	whether	these	changes	could	also	occur	under	conditions	of	
excess	OA	in	the	medium.	It	is	known	that	exogenous	addition	of	OA	results	in	an	increase	in	LD	
formation	and	impacts	NL	content	in	mammalian	cels	(Bickel	et	al,	2010;	Rohwedder	et	al,	
2014).	In	our	system	using	HFF,	addition	of	0.2	mM	OA	to	the	medium	of	a	confluent	layer	of	
HFF	for	24	h	led	to	an	increase	of	ADRP	and	DGAT1	transcription	by	3.87	and	1.66	fold,	
respectively,	but	no	statisticaly	significant	increase	in	ACAT	nor	ATGL	gene	expression	(Fig.	3-
6.B).	Upon	excess	OA	in	Toxoplasma-infected	cels,	we	observed	the	decrease	of	ACAT,	DGAT	
and	ATGL	transcript	levels,	to	a	similar	extent	as	in	cels	without	OA	(Fig.	3-6.A).	ADRP	
expression	does	not	change	with	infection	but	increases	with	excess	OA	in	both	uninfected	and	
infected	cels,	as	previously	reported	(Ducharme	and	Bickel,	2008;	Mei	et	al,	2011).	
These	data	show	that	the	drop	in	host	LD	number	24	h	p.i.	may	be	related	to	decreased	
ACAT	and	DGAT	activity.	However,	the	reduced	ATGL	activity	would	have	led	to	a	reduced	
catalysis	of	LD	and	concomitant	increase	or	stabilization	in	LD	and	its	NL	content.	This	seems	to	
not	be	the	case,	as	we	observe	a	decline	in	LD	number	observed	upon	24	h	infection,	suggestive	
of	a	dysregulation	in	the	NL	cycle	of	the	host	cel	during	Toxoplasma	infection.	
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Figure	3-6.	Mammalian	LD-related	gene	expression	upon	OA	addition	and	Toxoplasma	infection.	
A.	Real-time	PCR	analysis	of	Acetyl-Coenzyme	A	Acetyltransferase	(ACAT),	Diacylglycerol	O-Acyltransferase	
1	(DGAT1),	Adipose	Diferentiation-Related	Protein	(ADRP)	and	Adipose	Triglyceride	Lipase	(ATGL)	gene	
expression	in	uninfected	HFF	and	HFF	infected	with	Toxoplasma	for	24	h	in	the	absence	or	presence	of	0.2	
mM	OA.	Means	±	SD	of	assay	triplicates.	*p	<0.001	indicates	statistical	diference	between	infected	
control	HFF	and	infected	HFF	with	0.2	mM	OA.B.	Real-time	PCR	analysis	of	mammalian	ACAT,	DGAT1,	
ADRP,	and	ATGL	gene	expression	in	HFF	in	the	presence	of	0.2	mM	OA	or	absence	for	24	h.	Means	±	SD	of	
assays	in	triplicates.	Indicated	statistical	diferences	are	between	control	and	0.2	mM	OA	treated	HFF.	*	
p<0.02;	**p	<0.03.	
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3.4.4.	Exogenously	added	oleic	acid	triggers	neutral	lipid	synthesis	and	storage	
in	Toxoplasma.	
Intracelular	Toxoplasma	has	the	ability	to	divert	various	FA	present	in	its	environment	and	
incorporate	them	into	major	lipids	and	proteins	(Charron	and	Sibley,	2002;	Tomavo	et	al,	1989;	
Quittnat	et	al,	2004;	Polonais	and	Soldati-Favre,	2010).	The	parasite	has	distinct	enzymes	to	
catalyze	the	esterification	of	cholesterol	and	DAG.	In	contrast	to	mammalian	cels,	Toxoplasma	
possesses	two	ACATs	(TgACAT1	and	Tg	ACAT2)	difering	in	FA	substrate	specificity	and	one	
DGAT,	TgDGAT	(Quittnat	et	al,	2004;	Nishikawa	et	al,	2005;	Lige	et	al,	2013).	The	simultaneous	
deletion	of	both	TgACAT	in	or	deletion	of	TgDGAT	is	lethal	for	Toxoplasma,	emphasizing	the	
importance	of	NL	storage	for	the	parasite	(Nishikawa	et	al,	2005;	Lige	et	al,	2013).	
We	examined	the	physiological	response	of	Toxoplasma	to	excess	OA	present	in	the	
culture	medium	and	stored	in	host	LD.	In	particular,	we	sought	to	determine	if	the	parasite	takes	
advantage	of	the	copious	source	of	exogenous	OA	by	scavenging	these	lipids,	e.g.,	to	boost	its	
replication,	and	whether	it	has	the	capacity	to	store	FA	in	its	LD	in	case	of	surplus.	To	examine	
whether	the	parasite	is	able	to	access	FA	accumulated	in	the	host	cel,	we	measured	the	
transcriptional	levels	of	TgACATs	and	TgDGAT	after	12	or	24	h	incubation	with	excess	OA	(0.2	
mM).	No	statisticaly	significant	variations	were	observed	in	al	three	transcripts	at	12	h	p.i.	as	
compared	to	no	OA	addition	(12	h	control).	At	24	h	p.i.,	a	significant	increase	in	TgACAT2	(1.71	
fold)	and	TgDGAT	(1.79	fold)	expression	was	observed	with	0.2	mM	OA	compared	to	the	
condition	without	OA	added	(24	h	control)	(Fig.	3-7.A).	In	complement	to	these	assays,	we	
stained	infected	cels	with	BODIPY	493/503	to	visualize	NL	stores	in	Toxoplasma	during	exposure	
to	excess	OA	(Fig.	3-7.B	and	3-7.C).	Under	control	conditions,	the	parasite	contains	an	average	of	
1	to	4	LD	with	a	diameter	between	0.1	and	0.5μm	(Nishikawa	et	al,	2005;	Charron	and	Sibley,	
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2002;	Fig.	3-7.B).	Prominent	LD	accumulation	was	observed	in	the	PV	folowing	incubation	with	
0.2	mM	OA	for	24	h	(Fig.	3-7.C),	consistent	with	the	increase	in	TgACAT2	and	TgDGAT	transcript	
levels.	These	results	suggest	that	Toxoplasma	may	salvage	exogenous	OA	for	storage	in	LD,	via	
conversion	of	OA	to	TAG	or	CE.	Unlike	mammalian	cels,	TgACAT	transcription	increased	upon	
excess	OA	in	the	medium.	TgACAT	transcription	also	increased	upon	excess	cholesterol	addition	
to	the	medium	(Nishikawa	et	al,	2005).	
	
3.4.5.	Very	large	excess	OA	leads	to	a	dramatic	accumulation	of	lipid	droplets	in	
Toxoplasma.	
We	were	interested	in	examining	how	intracelular	Toxoplasma	would	cope	when	exposed	to	
very	large	excess	of	OA	in	its	environment.	Upon	0.4	to	1	mM	OA	incubation,	mammalian	cels	
respond	by	regulating	the	massive	influx	of	OA	mainly	by	conjugating	OA	to	DAG	and	storing	
TAG	in	newly	formed	LD	(Fig.	3-8.A).	After	24	h	incubation	with	0.4	mM	OA,	we	detected	
extremely	large	LD	within	the	parasite	with	a	diameter	up	to	0.8	μm,	confirming	that	
Toxoplasma	is	capable	of	storing	excess	lipids	retrieved	from	their	environment	(Fig.	3-8.A).	
Most	of	the	parasites	had	a	normal	ultrastructure	except	for	large	LD	and	massive	
accumulations	of	osmiophilic	materials,	i.e.,	lipid	deposits,	amassed	in	the	residual	body,	a	
structure	leftover	from	the	mother	cel	folowing	replication.	EM	studies	revealed	that	some	
parasite	LD	were	as	large	as	host	mammalian	LD	regardless	of	the	PV	size,	and	some	LD	were	
clustered	in	the	cytosol	(Fig.	3-8,	panels	B-C).	The	vacuolar	space	was	also	characterized	by	an	
extensive	development	of	the	intravacuolar	network	(IVN),	which	is	a	membranous	tubular	
network	derived	from	vesicles	exported	by	the	parasite.	Lipidic	structures	were	also	present	in	
the	vacuolar	space,	wrapped	by	the	tubules	on	the	IVN	(Fig.	3-8.B,	inset	i).	
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We	next	wanted	to	use	fluorescent	microscopy	to	confirm	that	the	enlarged	parasite	LD	
identified	by	EM	contained	NL.	We	infected	HFF	with	RFP-Toxoplasma	for	24	h	with	0.5mM	OA,	
fixed	the	coverslips	and	stained	with	BODIPY	493/503	(Fig.	3-9).	Large	BODIPY	493/503-
containing	structures	were	observed,	whose	size	matched	that	of	the	structures	observed	at	the	
ultrastructural	level	(Fig.	3-8.B	and	C),	which	we	ascertain	are	canonical	LD.	Parasites	were	able	
to	form	up	to	5	large	LD	per	individual	parasite.		
Altogether,	these	data	revealed	that	Toxoplasma	is	capable	of	retrieving	OA	from	the	
medium	with	subsequent	storage	in	LD.	Additionaly,	the	amount	of	OA	scavenged	is	
proportional	to	the	exogenous	OA	concentration.	It	strongly	suggests	that	the	parasite	does	not	
have	the	capacity	to	regulate	FA	uptake	and	can	store	copious	amounts	of	FA	in	its	LD.	However,	
the	parasite	can	also	accumulate	lipidic	structures,	putting	it	at	risk	for	lipotoxicity.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	131	
Figure	3-7.	Neutral	lipid	synthesis	and	storage	in	Toxoplasma	with	0.2	mM	OA	for	24h.	
A.	Real-time	PCR	analysis	of	Toxoplasma	gondi	Acetyl-Coenzyme	A	Acetyltransferase	1	and	2	(TgACAT1,	
TgACAT2),	Diacylglycerol	O-Acyltransferase	1	(TgDGAT)	gene	expression	in	infected	HFF	grown	without	OA	
(control)	or	with	0.2	mM	OA	for	12	or	24	h.	Means	±	SD	of	assay	triplicates.	*	p	<0.001	indicates	statistical	
diference	between	infected	control	HFF	and	infected	HFF	with	0.2	mM	OA.B-C.	Fluorescence	microscopy	
of	Toxoplasma-infected	HFF	grown	without	OA	(B)	or	with	0.2	mM	OA	(C)	for	24	h	and	stained	with	
BODIPY	493/503.	The	green	staining	is	specific	for	host	LD	as	wel	as	neutral	lipid	depots	in	the	parasite	
and	PV.	White	arrows,	host	LD;	Red	arrows,	Toxoplasma	LD.	Scale	bars,	7	μm.	 	
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Figure	3-8.	Ultrastructural	analysis	of	Toxoplasma-infected	HFF	upon	excess	OA.	
A.	EM	showing	the	accumulation	of	LD	in	HFF	and	the	parasite	with	0.4	mM	OA	incubation	for	24	h.	Red	
arrows	point	to	Toxoplasma	LD.	Scale	bar,	3	μm.	B-C.	EM	of	the	PV	of	Toxoplasma	in	infected-HFF	for	24	h	
with	0.4	mM	OA.	Large	LD	accumulate	in	the	parasite	(B,	inset	i)	and	PV	lumen	(B,	inset	i,	red	asterisk).	LD	
in	the	parasite	are	the	same	size	and	morphology	as	LD	in	the	host	cel	(C,	red	arrow).	Scale	bar,	1	μm.	
Abbreviations:	hLD:	host	LD;	RB:	residual	body.	
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Figure	3-9.	Neutral	lipid	stores	in	Toxoplasma	upon	excess	OA.	
Three	examples	of	fluorescence	microscopy	of	HFF	infected	with	RFP-expressing	Toxoplasma	for	24	h	in	
the	presence	of	0.5mM	OA	and	stained	with	BODIPY	493/503.	Up	to	6	very	large	BODIPY-stained	
structures	can	be	observed	within	a	single	parasite.	Scale	bars,	7	μm.	
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3.4.6.	Toxoplasma	scavenges	the	free	fatty	acid	C4-BODIPY-C9	from	host	lipid	
droplets	
Previous	studies	reported	lipid	scavenging	by	Toxoplasma	from	host	cels	(Charron	and	Sibley,	
2002;	Quittnat	et	al,	2004;	Polonais	and	Soldati-Favre,	2010;	Coppens	et	al,	2006;	Romano	et	al,	
2013)	and	our	data	above	highlight	the	capability	of	the	parasite	to	scavenge	and	store	lipids	
when	infected	cels	were	incubated	in	excess	OA.	We	next	wanted	to	determine	whether	the	
parasite	retrieves	NL	directly	from	host	LD	or	from	the	host	cel	but	not	stored	in	LD.		
We	incubated	Toxoplasma-infected	cels	with	the	fluorescently-labeled	free	fatty	acid	
C4-BODIPY-C9	to	track	the	internalization	of	this	lipid	into	the	parasite.	Addition	of	FA	C4-
BODIPY-C9	and	0.4	mM	OA	to	the	medium	of	infected	cels	for	2	h	led	to	intensive	fluorescent	
labeling	of	host	LD	and	internal	membranes	of	the	parasite,	confirming	that	Toxoplasma	
scavenges	FA	(Fig.	3-10.A).	At	24	h	p.i.,	we	observed	fluorescent	signals	in	both	the	host	cel	and	
the	parasite	(Fig.	3-11.A)	
	To	specificaly	assess	whether	the	parasite	retrieves	this	lipid	from	host	LD,	we	
incubated	HFF	with	0.4	mM	OA	and	C4-BODIPY-C9	for	18	h,	washing	away	the	excess	C4-
BODIPY-C9	from	the	medium,	then	infected	with	Toxoplasma	for	2	h	or	24	h	in	the	presence	of	
0.4	mM	OA	for	sustainment	of	LD	formation	(Fig.	3-10.B,	Fig.	3-11.B).	At	2	h	p.i.,	no	fluorescent	
signal	associated	with	the	parasite	could	be	resolved	by	live	fluorescence	microscopy	(Fig.	3-
10.B).	At	24	h	p.i.	however,	we	observed	by	live	microscopy	a	dotty	intra-parasitic	staining	
resembling	LD,	as	seen	on	z-stacks	images	of	the	PV	shown	in	Fig.	3-11.B.	This	is	suggestive	of	a	
traficking	of	FA	C4-BODIBY-C9	from	host	LD	to	parasite	LD	by	24	h	p.i.,	a	phenomenon	not	
observed	(or	undetectable)	at	2	h	p.i.	
To	confirm	this	process,	we	devised	another	experimental	protocol	that	would	ensure	
that	lipids	found	in	Toxoplasma’s	LD	contain	lipids	originating	from	the	host	LD.	BODIPY	493/503	
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is	not	a	fluorescently	labeled	FA,	and	is	instead	a	lipid	dye	specific	to	NL.	Only	NL	within	LD	
fluorescence	with	this	dye	thus	enabling	the	tracking	of	NL.	Host	LD	formation	was	induced	in	
HFF	by	incubating	with	0.4	mM	OA	in	addition	to	BODIPY	493/503	for	18	h,	and	a	plethora	of	LD	
became	fluorescent	in	HFF.	After	washing,	HFF	loaded	with	BODIPY-stained	LD	were	infected	
with	RFP-expressing	Toxoplasma	for	24	h	in	the	presence	of	0.2	mM	OA	to	pressure	the	host	cel	
to	maintain	LD	(Fig.	3-12).	The	coverslips	were	then	viewed	by	live	or	fixed	microscopy	(Fig.	3-12	
and	3-13,	respectively).	Remarkably,	BODIPY	493/503	staining	was	observed	in	Toxoplasma	LD,	
and	the	signal	was	more	prominent	on	fixed	cels.	This	staining	could	only	have	occurred	if	the	
parasite	had	taken	up	fluorescent	lipids	derived	directly	from	host	LD	prior	to	storage	in	their	
own	LD.		
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Figure	3-10.	Detection	of	the	fatty	acid	C4-BODIPY-C9	in	Toxoplasma	2	h	p.i.	
A.	Immunofluorescence	microscopy	of	uninfected	(panels	a)	or	infected	HFF	(panels	b,	c)	for	2	h	in	the	
presence	of	0.4mM	OA	and	the	free	fatty	acid	C4-BODIPY-C9	(10	μM)	stained	with	anti-GRA7	antibody	for	
the	PV	of	Toxoplasma.	In	A,	BODIPY-positive	structures	are	visible	on	parasite	membranes	and	in	wel	as	
LDs	(c).	Scale	bars,	7	μm.	B.	Schema	outlining	the	experimental	protocol	for	the	induction	of	C4-BODIPY-
C9	positive	LDs	in	HFF.	Green	fluorescent	LD	formation	in	HFF	was	stimulated	by	incubating	cels	with	
0.4mM	OA	and	10	μM	of	C4-BODIPY-C9	for	18	h,	folowed	by	a	2	hour	chase	in	normal	α-MEM	medium.	
These	cels	were	then	infected	with	Toxoplasma	and	visualized	by	live	microscopy	after	2	of	infection.	
Fluorescence	microscopy	of	Toxoplasma-infected	HFF	for	2	h.	Host	LD	labeled	with	C4-BODIPY-C9	seen	in	
green,	are	visible	around	Toxoplasma	PV,	but	not	inside	the	parasites.	Scale	bars,	7	μm.	
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Figure	3-11.	Detection	of	the	fatty	acid	C4-BODIPY-C9	pre-accumulated	into	host	LD	in	Toxoplasma.	
Schema	outlining	the	experimental	protocol	for	the	induction	of	C4-BODIPY-C9	positive	LDs	in	HFF.	Green	
fluorescent	LD	formation	in	HFF	was	stimulated	by	incubating	cels	with	0.4mM	OA	and	10	μM	of	C4-
BODIPY-C9	for	18	h,	folowed	by	a	2	hour	chase	in	normal	α-MEM	medium.	These	cels	were	then	infected	
with	Toxoplasma	and	visualized	by	live	microscopy	after	24	h	of	infection.	A.	Immunofluorescence	
microscopy	of	uninfected	(panels	a)	or	infected	HFF	(panel	b)	for	24	h	in	the	presence	of	0.4mM	OA	and	
the	free	fatty	acid	C4-BODIPY-C9	(10	μM),	stained	with	anti-GRA7	antibody	for	the	PV	of	Toxoplasma.	In	
panel	b,	BODIPY-positive	LDs	are	seen	in	the	PV	of	Toxoplasma	demonstrating	scavenging	of	free	fatty	
acid	from	the	host	cel	and	incorporation	into	LD.	Scale	bars,	7	μm.	B.	Fluorescence	and	phase	microscopy	
of	Toxoplasma-infected	HFF	for	24	h.	Images	show	individual	z-stacks	demonstrating	the	presence	of	host	
LD-derived	C4-BODIPY-C9	inside	Toxoplasma	LD.	Scale	bars,	7	μm.	 	
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Figure	3-12.	Detection	of	BODIPY	493/503	pre-labeled	host	LD	in	Toxoplasma	(live	microscopy)	
Schema	outlining	the	experimental	protocol	for	the	induction	of	LD	labeled	specificaly	with	BODIPY	
493/503	in	HFF.	BODIPY-labeled	LD	in	HFF	were	induced	by	incubating	with	0.4mM	OA	and	BODIPY	
493/503	prior	to	infection	with	RFP-expressing	Toxoplasma	for	24	h.	a-b.	Fluorescence	microscopy	of	
uninfected	(a)	and	RFP-expressing	Toxoplasma-infected	HFF	(b)	containing	pre-labeled	host	LD	with	
BODIPY	493/503.	BODIPY	493/503	labeling	is	visible	inside	individual	parasites	in	z-slices	from	smal	or	
large	PV.	Scale	bars,	7	μm.	
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Figure	3-13	Detection	of	BODIPY	493/503	pre-labeled	host	LD	in	Toxoplasma	(fixed	cels).	
Fluorescence	microscopy	of	RFP-Toxoplasma	and	BODIPY	493/503	labeled	host	LD	in	HFF	at	24	h	
infection.	The	same	protocol	displayed	in	Fig.	3-8	was	used	to	pre-label	LD	in	HFF	with	BODIPY	493/503	
prior	to	infecting	with	RFP-expressing	Toxoplasma	for	24	h.	Coverslips	were	fixed	prior	to	viewing	by	
microscopy.	Smal	PV	(a)	and	large	PVs	(b,	c)	display	green	BODIPY	labeling,	indicating	the	uptake	of	
neutral	lipids	directly	from	host	LD.	Scale	bars,	7	μm.	 	
	140	
3.4.7.	Quantification	of	[3H]OA	uptake	by	the	parasite	
We	wanted	to	quantify	the	uptake	of	host	derived	NL	by	Toxoplasma	by	measuring	the	presence	
of	radiolabeled	OA	originating	from	host	LD,	into	the	parasite.	LD	were	induced	in	HFF	by	
incubating	with	either	0.1	mM	or	0.4	mM	OA	mixed	with	traces	of	[3H]OA	for	24	h.	After	
washing,	cels	were	infected	with	Toxoplasma,	and	parasite	egress	was	induced	at	24	or	36	h	p.i.	
using	the	calcium	ionophore	A23817	(Endo	et	al,	1982).	Parasites	were	colected,	purified	from	
celular	debris	and	the	radioactivity	associated	with	parasite	preparations	was	determined	(Fig.	
3-14).	Tritiated	material	was	incorporated	into	Toxoplasma	proportionaly	to	OA	concentration,	
amounts	stored	in	host	LD	and	the	infection	time	(Fig.	3-14.A).	These	data	provide	additional	
evidence	that	the	parasites	can	acquire	lipids	associated	with	host	LD,	though,	it	remains	a	
possibility	that	Toxoplasma	can	divert	radioactive	OA	from	other	cel	compartments	than	LD.	
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Figure	3-14.	Quantification	of	[
3
H]OA	association	with	the	parasite.	
Schema	outlining	the	experimental	protocol	for	the	formation	of	[
3
H]-labeled	LD	in	HFF,	infection	with	
Toxoplasma	and	measurement	of	[
3
H]OA	association	with	the	parasite.	A.	Quantification	of	[
3
H]OA	levels	
in	Toxoplasma.	HFF	were	incubated	with	0.1	mM	or	0.4	mM	[
3
H]OA	for	24	h,	thoroughly	washed	and	
infected	with	Toxoplasma	for	24	or	36	h	before	chemicaly	inducing	parasite	egress.	Parasites	were	
colected,	washed	and	purified	to	determine	the	radioactivity	and	protein	contents.	Means	±	SD	of	assay	
triplicates.	p*	<0.05;	.	p**	<0.001.	
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3.4.8.	Host	LD	protrude	into	the	PV	of	Toxoplasma	and	are	trapped	in	the	PV	
lumen	
Our	data	suggests	that	lipids	present	in	host	LD	can	be	detected	in	the	parasite.	Several	
mechanisms	could	be	involved	in	this	process	such	as	the	exportation	of	efectors	by	the	
parasite	that	could	retrieve	lipids	from	host	LD,	or	the	scavenging	of	host	LD	intact	into	the	PV,	
as	observed	for	other	host	organeles	(Coppens	et	al,	2006;	Romano	et	al,	2013).	The	gathering	
of	host	LD	around	the	PV	favors	the	second	scenario.	We	thus	conducted	ultrastructural	studies	
by	EM	due	to	its	high	resolution	in	order	to	visualize	the	distribution	of	host	LD	in	Toxoplasma-
infected	cels.	HFF	infected	with	Toxoplasma	were	incubated	with	0.2	mM	OA	and	then	
processed	for	EM.	In	many	instances,	we	observed	host	LD	in	close	proximity	to	the	PVM	of	
Toxoplasma	(Fig.	3-15.A).	Some	host	LD	were	seen	deeply	protruding	into	the	PV	(Fig.	3-15.B	
panels	a	and	b)	whilst	other	host	LD	were	found	in	the	PV	lumen	(Fig.	3-16,	panels	a	and	b).	Host	
LD	were	unmistakently	detected	within	the	PV	lumen,	as	characterized	by	identical	size,	
electron-density	and	shape	as	those	located	in	the	host	cytoplasm.	Interestingly,	intraluminal	LD	
were	surrounded	by	tubules	of	the	IVN	(Fig.	3-16,	panel	a),	a	network	hypothesized	to	be	
involved	in	nutrient	uptake	and	traficking	within	the	PV	(Coppens	et	al,	2006).	
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Figure	3-15.	Ultrastructural	evidence	of	host	LD	protrusion	to	PV.	
A-B.	EM	of	infected	HFF	with	0.2	mM	OA	showing	a	host	LD	in	close	proximity	to	the	PV	(A)	or	largely	
protruding	to	the	PV	lumen	(B)	at	various	degrees,	shalow	depth	(a)	and	deeper	in	the	PV	membrane	
(PVM)	(b).	Cyan	line	in	magnified	panel	represents	the	PVM	of	Toxoplasma.	Scale	bar,	0.2	μm.	
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Figure	3-16.	Ultrastructural	evidence	of	host	LD	inside	the	PV.	
A-B.	EM	of	infected	HFF	with	0.2	mM	OA	showing	host	LD	wrapped	by	the	intravacuolar	network	(IVN)	
within	the	Toxoplasma	PV.	Host	LD	trapped	in	the	PV	were	identified	based	on	their	electron	density	and	
similar	size	to	LD	present	in	the	mammalian	cytoplasm.	Scale	bar,	0.1	μm.	
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3.4.9.	Rab7-GTPase	associated	with	host	lipid	droplets	are	trapped	in	the	
Toxoplasma	PV	
Our	lab	previously	found	that	host	mammalian	Rab14,	Rab30	and	Rab43	vesicles	containing	
lipids	(e.g.,	ceramides,	sphingolipids)	can	be	diverted	by	intracelular	Apicomplexa	including	
Toxoplasma	and	Neospora	caninum,	and	sequestered	into	the	PV	(Romano	et	al,	2013;	Nolan	et	
al,	2015).	In	mammalian	cels,	several	Rab	vesicles	intersect	with	LD	traficking	pathways	as	
some	Rab	GTPases	proteins	have	been	detected	on	LD.	While	Rab7	is	known	to	regulate	
traficking	and	maturation	of	endosomes	it	has	also	been	implicated	as	a	principal	regulator	of	
lipophagy	and	is	found	on	10%	of	LD	(Schroeder	et	al,	2015;	Oseki	et	al,	2005).	Rab18	localizes	to	
~	50	%	of	LD,	especialy	those	located	close	to	the	ER,	and	its	presence	is	negatively	correlated	
with	ADRP	expression.	We	thus	wanted	to	investigate	whether	Rab7-	or	Rab18-associated	LD	
may	selectively	be	re-routed	to	the	PV	alowing	Toxoplasma	to	have	access	to	their	NL	cargo.		
Next,	we	wanted	to	confirm	that	Rab7	localizes,	at	least	in	part,	to	LD	in	our	system.	HFF	
were	transfected	with	a	plasmid	containing	an	mCherry-Rab7	construct,	incubated	with	0.2	mM	
OA	for	24	h	then	fixed	for	microscopy	observations	of	mCherry-Rab7-vesicles	and	host	LD,	
stained	with	BODIPY	493/503.	Fig.	3-17.A	shows	partial	colocalization	(yelow,	PDM)	between	
the	red	mCherry	and	the	green	BODIPY	signals	(PCC:	0.129),	primarily	on	the	surface	of	the	LD.,	
confirming	published	data	(Ozeki	et	al,	2005).	mCherry-Rab7-expressing	HFF	were	infected	with	
Toxoplasma	for	24	h	and	stained	for	BODIPY	493/503	and	colocalization	events	could	also	be	
observed	between	host	Rab7	vesicles	and	host	LD.	Upon	the	addition	of	OA,	the	number	of	
number	of	foci	containing	the	two	signals	increased	dramaticaly	(Fig.	3-17.B).	Quantification	of	
this	increase	was	performed	by	counting	the	number	of	green	(LD)	foci	and	yelow	(PDM)	foci	in	
both	uninfected	and	infected	cels.	On	average,	the	addition	of	0.2	mM	OA	led	to	a	3	fold	
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increase	in	yelow	foci	in	uninfected	HFF,	and	a	2	fold	increase	in	Toxoplasma-infected	HFF	(p	<	
0.005)	(data	not	shown).	
Having	confirmed	the	localization	of	Rab7	to	LD	in	uninfected	cels,	we	next	performed	
assays	to	visualize	the	potential	presence	of	Rab7	foci	within	the	PV	of	Toxoplasma.	Since	the	
mCherry-Rab7	construct	used	in	Fig.	3-17	did	not	emit	a	strong	enough	fluorescence	signal	in	
our	experimental	conditions	to	conclusively	detect	mCherry-Rab7	inside	the	PV,	we	transfected	
cels	with	a	plasmid	containing	a	GFP-Rab7	construct	showing	brighter	fluorescence	in	the	green	
channel	(Fig.	3-18).	GFP-Rab7-expressing	HFF	were	infected	with	Toxoplasma	for	24	h	with	0.2	
or	0.4	mM	OA	or	without	OA,	fixed	and	immunostained	for	GRA7	to	delineate	the	PVM.	Several	
GFP-Rab7	foci	were	observed	inside	the	PV,	as	visualized	in	the	XYZ	image,	in	al	conditions	(Fig.	
3-18.A,	panels	a-c).	Quantification	of	the	percent	of	PVs	containing	at	least	one	GFP-Rab7	foci	
showed	an	average	of	60	%	of	positively	stained	PV	without	OA,	whilst	addition	of	0.2	mM	or	0.4	
mM	OA	led	to	a	statisticaly	significant	increase	up	to	90	%	(Fig.	3-18.B).	
In	infected	GFP-Rab18-expressing	HFF	we	observed	GFP-Rab18	positive	vesicles	inside	~	
40	%	of	PV	of	Toxoplasma	(Fig.	3-19.A,	panels	a-c).	In	contrast	to	GFP-Rab7	assays,	there	was	no	
significant	increase	in	the	percent	of	PVs	containing	Rab18	in	the	presence	of	0.2	or	0.4	mM	OA	
(Fig.	3-19.B).		
The	data	show	that	host	Rab7	and	Rab18	are	present	inside	the	PV.	Based	on	these	
observations,	we	hypothesize	that	if	host	LD	are	marked	with	Rab7	and/or	Rab18	and	found	
within	the	PV,	this	may	represent	a	way	for	the	parasites	to	have	access	to	NL.	 	
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Figure	3-17.	Codistribution	of	host	Rab7	vesicles	with	BODIPY	493/503-stained	structures	in	mammalian	
cels.	
A.	Fluorescence	microscopy	of	HFF	expressing	mCherry-Rab7.	HFF	expressing	the	mCherry	Rab7	
constructs	were	fixed	and	stained	with	BODIPY	493/503.	Extended-focus	images	are	shown	for	the	
BODIPY	493/503	(green),	mCherry	Rab7	(red)	and	the	positive	PDM	(yelow,	indicating	colocalization,	
Pearson’s	Correlation	Coeficient:	0.129).	A	subset	of	host	LD	colocalize	with	mCherry-Rab7	indicating	that	
some	host	LD	possess	Rab7	at	their	surface	(white	boxes	highlighting	areas	of	colocalization,	arrows).	
Scale	bars,	7	μm.	B.	Fluorescence	microscopy	of	infected	HFF	expressing	mCherry	Rab7	grown	in	normal	
α-MEM	medium,	or	in	the	presence	of	0.2	mM	OA.	Transfected	mCherry-Rab7	HFF	were	infected	with	
Toxoplasma	and	incubated	with	0.2	mM	OA	for	24	h,	fixed	and	stained	with	BODIPY	493/503	(green)	and	
anti-GRA7	antibodies	(blue,	PV).	Two	representative	extended	focus	images	of	merged	and	PDM	(yelow)	
show	increased	colocalization	events	between	mCherry	Rab7	and	BODIPY	493/503	when	cels	were	
incubated	with	0.2	mM	OA.	Colocalization	foci	were	confirmed	by	analyzing	the	Z-slices.	Scale	bars,	7	μm.	
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Figure	3-18.	Detection	of	host	Rab7	vesicles	in	the	PV.	
A.	Fluorescence	microscopy	of	uninfected	or	Toxoplasma-infected	HFF	expressing	GFP-Rab7	grown	
without	OA	(a),	with	0.2	mM	OA	(b)	or	0.4	mM	OA	(c).	GFP-Rab7	transfected	HFF	were	infected	with	
Toxoplasma	and	incubated	for	24	h	in	the	indicated	concentrations	of	OA.	Coverslips	were	fixed	and	
stained	with	antibodies	for	GRA7	(red,	parasite	PVM	and	PV	lumen)	and	4-,6-diamidino-2-phenylindole	
(DAPI;	blue,	nucleus).	The	distribution	of	GFP-Rab7-positive	vesicles	(green)	is	shown	in	these	extended-
focus	images	in	both	uninfected	and	infected	cels.	Cropped	images	of	the	Toxoplasma	PV	is	also	shown	in	
an	optical	XYZ	slice	to	highlight	the	localization	of	host-derived	GFP-Rab7	vesicles	inside	the	PV	of	
Toxoplasma	(arrows).	Scale	bar,	7	μm	unles	specified.	B.	Quantification	of	the	percentage	of	PVs	
positively	containing	GFP-Rab7	vesicles	from	(A).	The	percent	of	PVs	containing	Rab7	foci,	determined	by	
XYZ	visualization	of	cropped	PVs	in	GFP-Rab7	transfected	HFF,	increases	when	cels	were	incubated	in	the	
presence	of	0.2	or	0.4	mM	OA.	Representative	of	duplicate	experiments,	n>20	in	each	experiment;	Chi-
squared	test,	p*	<0.05.	
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Figure	3-19.	Detection	of	host	Rab18	vesicles	in	the	PV.	
A.	Fluorescence	microscopy	of	uninfected	or	Toxoplasma-infected	HFF	expressing	GFP-Rab18	grown	
without	OA	(a),	with	0.2	mM	OA	(b),	or	0.4	mM	OA	(c).	GFP-Rab18-transfected	HFF	were	infected	with	
Toxoplasma	and	incubated	for	24	h	in	the	indicated	concentrations	of	OA.	Fixed	cels	were	stained	with	
antibodies	for	GRA7	and	4-,6-diamidino-2-phenylindole	(DAPI;	blue,	nucleus).	The	distribution	of	GFP-
Rab18-positive	vesicles	(green)	is	shown	in	these	extended-focus	images	in	both	uninfected	and	infected	
cels.	A	cropped	image	of	the	Toxoplasma	PV	at	various	OA	concentrations	is	also	shown	in	an	optical	XYZ	
slice	to	highlight	the	localization	of	host-derived	GFP-Rab18	vesicles	inside	the	PV,	arrows.	Scale	bar,	7	
μm.	B.	Quantification	of	the	percentage	of	PVs	containing	GFP-Rab18	vesicles.	XYZ	visualization	of	
cropped	PVs	was	used	to	determine	the	presence	of	GFP-Rab18	inside	the	PV,	and	plotted	in	the	
histograms.	There	is	no	statistical	diference	in	the	uptake	of	GFP-Rab18	to	Toxoplasma	PVs	when	
incubated	with	OA.	Representative	of	duplicate	experiments,	n>20;	Chi-squared	test,	non	significant.	
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3.4.10.	Upon	excess	OA	incubation,	Toxoplasma	shows	endocytic	activities	
Compeling	morphological	evidence	revealed	that	host	Rab	vesicles,	organeles	and	LD	are	
sequestered	into	the	PV	of	Toxoplasma	(Coppens	et	al,	2000;	Coppens	et	al,	2006;	Romano	et	al,	
2013).	We	hypothesize	that	this	feature	is	orchestrated	by	the	parasite	to	usurp	their	nutrient	
content.	To	acquire	nutrients	present	in	the	PV,	the	parasite	expresses	several	transporters	or	
translocators	on	its	PM	that	can	mediate	the	internalization	of	lipids,	amino	acids	or	sugars	by	
simple	difusion	or	active	transport	(reviewed	in	Robibaro	et	al.,	2001).	In	regard	to	endocytic	
mechanisms	for	the	uptake	of	macromolecules,	Toxoplasma	is	an	intriguing	organism	since	no	
internalization	gates	have	been	identified	so	far	for	this	pathogen,	and	the	question	whether	
Toxoplasma	is	able	to	incorporate	large	extracelular	material	into	an	internal	membrane	system	
is	stil	disputable	since	the	parasite	is	lacking	canonical	lysosome-like	compartments	and	
digestive	enzymes.	One	intriguing	feature	of	the	PM	of	the	parasites	is	the	presence	of	a	smal	
cup-shaped	invagination	(20	nm	in	diameter),	the	micropore,	that	is	covered	by	filamentous	
coat	material	(Nichols	et	al,	1994).	While	this	structure	brings	to	mind	endocytic-like	PM	
invaginations,	the	micropore	is	static	and	its	physiological	role	e.g.	in	nutrient	uptake,	has	not	
yet	been	demonstrated.	The	genome	of	Toxoplasma	contains	homologues	coding	for	the	AP2	
complex,	and	the	light	and	heavy	chains	of	clathrin	but	does	not	express	these	proteins	at	the	
PM	to	form	clathrin-coated	pits	(reviewed	in	Field	et	al,	2007).	No	caveolin	homologues	can	be	
retrieved	from	the	parasite	genome	data,	and	therefore	Toxoplasma	lacks	PM	domains	with	the	
characteristic	features	of	caveolae.	In	conclusion,	the	current	dogma	is	that	Toxoplasma	is	
refractory	to	endocytosis,	and	solely	relies	on	transport	activities	across	the	PM	to	have	access	
to	nutrients.	
During	our	in-depth	scrutiny	of	the	ultrastructure	of	Toxoplasma	exposed	to	0.2	mM	OA,	
we	observed	a	very	large	invagination	of	the	parasite	PM,	with	a	narrow	neck	and	a	diameter	of,	
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on	average,	250	nm.	This	open	structure	was	usualy	located	at	the	anterior	pole	of	the	mother	
parasite,	close	to	the	apex,	and	was	never	found	on	dividing	parasites	during	endodyogeny	(Fig.	
3-20,	panels	a	and	b).	This	structure	was	distinct	from	the	micropore	by	its	larger	size	and	more	
post-nuclear	localization.	Based	on	the	folowing	observations,	we	hypothesize	that	this	
structure	may	represent	an	endocytic	gate	as	opposed	to	an	exocytic	cup:	1)	the	content	of	the	
invagination	was	identical	to	that	of	the	PV	lumen	indicative	of	a	connection	between	these	
structures	and	the	PV	milieu,	and	2)	their	cytoplasmic	surface	was	often	coated	with	a	radiating	
bristle-like	structure,	reminiscent	of	the	clathrin	coat	of	mammalian	coated	pits	(Fig.	3-20,	al	
panels).	Moreover,	although	the	presence	of	these	structures	were	not	a	rare	occurrence	when	
incubated	with	excess	OA,	they	were	exclusively	detected	in	these	conditions	i.e.,	gavage	
conditions,	since	Toxoplasma	cannot	regulate	nutrient	intake.		
If	these	structures	contribute	to	the	endocytosis	of	PV	material,	we	might	expect	the	
presence	of	endocytic	structures	within	the	parasite’s	cytoplasm.	Our	EM	studies	reveal	several	
structures	intriguingly	similar	in	electron-density	and	morphology	to	those	found	in	the	close	
vicinity	of	the	parasite	in	the	PV,	like	membrane	whorls	(Fig.	3-21,	al	panels),	suggestive	of	
endocytic	vesicles.	These	data	may	represent	the	first	evidence	of	an	endocytic	event	associated	
with	an	intravesicular	system	within	the	parasite,	likely	involved	in	nutrient	uptake	and	delivery	
to	the	Toxoplasma	interior.	This	also	might	imply	that	endocytic	processes	must	be	particularly	
fast	in	this	parasite,	due	to	the	untrackability	of	these	endocytic	profiles	under	normal	
conditions.	
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Figure	3-20.	Ultrastructural	detection	of	endocytic	pits	on	the	parasite	plasma	membrane.	
EM	of	parasites	in	HFF	incubated	with	0.2	mM	OA	for	24	h.	Structures	resembling	endocytic	pits	docked	
onto	the	parasite	plasma	membrane	are	observed	at	the	apical	end	of	the	parasite.	The	double-
membraned	pits	appear	to	be	coated	with	protein	(arrow)	indicating	an	endocytic	event,	and	appear	to	be	
in	the	process	of	pinching	of	(a,	b)	or	nearly	completely	pinched	of	(c).	The	content	of	the	pits	display	a	
striking	resemblance	to	the	material	present	in	the	PV	lumen.	Scale	bars,	1	μm	(a),	0.3	μm	(b)	and	0.4	μm	
(c).	
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Figure	3-21.	Ultrastructural	detection	of	PV	lumen	material	inside	endocytic	vesicles	in	Toxoplasma.	
a-d.	EM	of	parasites	in	HFF	incubated	with	0.2	mM	OA	for	24	h	showing	intraparasitic	vesicles	containing	
lipophilic	material	similar	to	that	present	in	the	PV	lumen	(red	arrowheads).	These	structures	are	
hypothesized	to	have	originated	from	an	endocytic	process	of	PV	lumen	material.	Scale	bar,	0.3	μm.	
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3.5.	DISCUSSION	
Toxoplasma	gondi	requires	vast	amounts	of	lipids	for	the	biogenesis	of	new	membranes	for	its	
daughter	cels	during	replication,	which	occurs	every	6-8	h	in	cel	culture.	One	way	Toxoplasma	
obtains	these	needed	lipids	is	to	scavenge	lipids	species	such	as	cholesterol,	fatty	acids,	
sphingolipids	or	lipid	precursors	from	host	organeles	such	as	endolysosomes	or	the	Golgi	
(Charron	and	Sibley,	2002;	Quittnat	et	al,	2004;	Coppens	et	al,	2006;	Romano	et	al,	2013).	In	
this	study,	we	demonstrated	that	Toxoplasma	has	the	capacity	to	scavenge	NL;	e.g.,	fatty	acids	
(FA)	from	host	lipid	droplets	(LD).	These	NL,	present	in	LD,	may	not	solely	provide	the	building	
blocks	of	membranes	but	may	also	function	as	energy	sources	as	some	lipids	like	FA	are	
substrates	for	β-oxidation	in	mitochondria	and	ATP	generation.	
One	of	the	most	abundant	FA	in	humans	and	animals	is	the	monounsaturated	18:1	cis9	
fatty	acid,	oleic	acid	(OA).	OA	is	present	in	the	blood	(complexed	to	albumin),	is	highly	abundant	
in	adipose	tissue,	and	is	associated	with	membranes	in	many	cel	types	(Baylin	et	al,	2002;	
Hodson	and	Fielding	2013;	Lopez	et	al,	2014).	Human	serum	contains	around	7.5	mM	of	FA,	of	
which	OA	is	the	most	profuse	FA	species	at	38	%,	folowed	by	palmitic	acid	(25	%),	linoleate	acid	
(22	%)	and	stearic	acid	(10	%)	(Richieri	and	Kleinfeld,1995).	Adipose	tissue	is	composed	of	
adipocytes,	highly	specialized	cels	for	the	storage	of	energy	and	fat,	particularly	in	the	form	of	
TAG.	In	these	cel	types,	OA	makes	up	over	40%	of	al	fatty	acids,	predominantly	in	membranes	
and	in	a	single	enormous	LD	(Seidelin,	1995;	Baylin	et	al,	2002).	In	the	plasma	membrane	(PM)	
of	human	cells,	the	concentration	of	free	OA	is	between	1-2%,	on	average,	of	al	lipids,	a	number	
that	can	rise	nearly	two-fold	in	individuals	on	a	Mediterranean	diet,	rich	in	olive	oil.	Oleic	acid	is	
the	main	constituent	of	olive	oil,	accounting	for	up	to	83%	of	its	composition	(Vicario	et	al,	1998;	
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Funari	et	al,	2002;	Lopez	et	al,	2014).	In	human	fibroblasts,	one	of	the	major	cel	types	most	
commonly	used	in	Toxoplasma	research,	up	to	3%	of	total	lipids	is	OA	(Schroeder	et	al,	1984).	
The	molecular	structure	of	OA	afects	the	organization,	structure	and	function	of	
membranes.	The	kink	in	the	structure	of	OA	at	the	9th	carbon	helps	organize	membranes	into	
non-lamelar	phase,	induces	negative	curvature	and	therefore	helps	govern	the	fluidity	of	the	
membrane	matrix	(Khandoker	et	al,	1997;	Funari	et	al,	2003;	Lopez	et	al,	2014).	At	higher	OA	
concentrations	in	the	membrane,	membrane	fluidity	is	increased.	Other	FA	like	palmitic	or	
stearic	acid	do	not	afect	membrane	fluidity	to	the	same	extent	due	to	their	molecular	structure.	
The	saturation	of	these	FA	causes	them	to	be	tightly	packed	together	in	the	PM	(Funari	et	al,	
2003).	As	wel	as	influencing	membrane	fluidity,	OA	can	act	as	a	signaling	molecule	at	the	
plasma	or	nuclear	membrane,	afecting	various	celular	and	protein	functions	directly.	OA	can	
signal	through	G-protein-coupled	receptors	leading	to	celular	transcriptional	changes,	
activation	of	ERK1/2,	PI3K	or	Akt,	or	cause	an	increase	of	cytosolic	calcium	levels	(Funari	et	al,	
2003;	Hara	et	al,	2011).	
The	addition	of	OA	to	cel	culture	has	several	downstream	efects	including	increased	
LD-related	transcriptional	and	metabolic	activities,	increased	OA	in	membranes,	and	the	
upregulation	of	autophagy.	Adding	exogenous	OA	to	cels	leads	to	an	increase	in	LD	biogenesis	
due	to	an	accumulation	of	intracelular	TAG	levels	as	a	result	of	increased	DGAT	and	ADRP	
expression	(Listenberger	et	al,	2003;	Fujimoto	et	al,	2006;	Thörn	and	Bergsten,	2010;	Mei	et	al,	
2011;	Ahn	et	al,	2013).	Membranes	are	also	afected	by	excess	OA	which	tends	to	accumulate	
within	the	bilayer,	increasing	the	baseline	level	of	OA	in	membranes	from	18%	to	39%	of	al	FA	
in	human	macrophage	cel	lines	and	Caco-2	epithelial	cels	(Nowak	et	al,	2011;	Jackson	et	al,	
2009).	Addition	of	OA	can	also	lead	to	an	upregulation	of	autophagy	in	order	to	catabolize	free	
FA.	The	buildup	of	free	FA	such	as	OA	can	be	harmful	for	cels	and	cause	lipotoxicity.	This	results	
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in	celular	dysfunction	and	death	by	apoptosis	via	the	generation	of	reactive	oxygen	species	
(ROS)	and	nitric	oxide	(NO)	(Shimabukuro	et	al,	1997;	Ostrander	et	al,	2001;	Listenberger	et	al,	
2003;	Ricchi	et	al,	2009;	Mei	et	al,	2011).	
In	Toxoplasma-infected	cels	(HFF	or	HeLa),	host	LD	grouped	around	the	PV	of	
Toxoplasma.	This	perivacuolar	localization	became	more	obvious	upon	the	addition	of	0.2	mM	
OA	that	increases	the	numbers	of	LD	in	the	host	cel	and	LD	clustered	around	the	PV.	The	
detection	of	host	LD	around	the	PV	is	consistent	with	other	studies	reporting	such	events	
around	the	PV	in	skeletal	muscle	cels	and	macrophages	infected	with	Toxoplasma	at	2	h,	6	h,	
and	24	h	p.i.,	even	though	these	studies	did	not	use	OA	(Mota	et	al,	2014,	Gomes	et	al,	2014).	It	
seems	unlikely	that	this	process	is	triggered	by	the	host	cel	in	HFF	for	immune	protection	as	OA	
lacks	the	carbon	unsaturation	at	the	omega-6	position,	and	therefore	cannot	contribute	to	the	
synthesis	of	eicosanoids,	the	primary	immune	modulator	related	to	LD	(Barteli	et	al,	2000;	Zhou	
and	Nilsson,	2001).	Eicosanoid	production	requires	the	FA	linoleic	acid,	a	20-carbon	
polyunsaturated	FA,	the	precursor	to	arachidonic	acid.	These	findings	suggest	that	the	parasite	
may	be	mediating	the	observed	clustering	of	host	LD	around	the	PV	for	lipid	acquisition,	a	
hypothesis	supported	by	the	detection	of	host	LD	in	the	PV	lumen.		
The	number	of	LD	in	the	host	cel	is	not	constant	during	Toxoplasma	infection.	Although	
the	number	of	host	LD	initialy	doubles	during	the	first	24	h	of	infection,	the	number	of	host	LD	
then	returns	to	levels	observed	prior	to	infection.	An	increase	in	host	LD	numbers	has	been	
reported	in	Toxoplasma-infected	skeletal	cels	at	6	h,	24	h	and	48	h	p.i,	but	no	decrease	in	LD	
number	was	reported	by	48	h	p.i.	(Gomes	et	al,	2014).	In	contrast	to	HFF,	skeletal	muscle	cels	
contain	fewer	LD	at	baseline	(5	LD	per	cel)	which	may	afect	LD	dynamics	during	the	late	stages	
of	infection.	Indeed,	in	these	cel	types,	the	number	of	LD	rose	only	by	10	over	the	entire	course	
of	infection,	which	is	less	than	our	observed	increase	by	25	in	HFF	(Gomes	et	al,	2014).	
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Furthermore,	Toxoplasma	may	undergo	spontaneous	stage	conversion	to	bradyzoites	in	skeletal	
muscle	cels,	so	the	dynamics	of	the	host	cel	and	the	parasite	difers	from	our	cel	culture	
system	(Ferreira-da-Silva	et	al,	2009).	However,	these	experiments	do	suggest	that	Toxoplasma	
infection	interferes	with	the	host	cel	lipid	metabolism.	Indeed,	large	scale	microarrays	of	HFF	
gene	expression	folowing	Toxoplasma	infection	for	24	h	revealed	changes	in	host	cel	
metabolism.	An	increase	in	host	metabolic	activities,	such	as	glycolysis	and	the	melavonate	and	
squalene	biosynthesis	pathways	was	observed	(Blader	et	al,	2001).	Both	of	these	pathways	
supply	nutrients	for	the	parasite,	suggestive	of	the	parasite	boosting	their	activity.	On	the	other	
hand,	the	host	cel	may	be	upregulating	the	activity	of	these	enzymes	to	ensure	it	has	enough	
nutrients	for	itself	due	to	excessive	scavenging	by	the	parasite.	The	dynamic	variation	in	LD	
numbers	upon	in	Toxoplasma-infected	HFF	may	therefore	be	a	consequence	of	Toxoplasma	
infection	in	specific	cel	types.	The	decrease	in	LD	by	24	h	p.i.	may	be	attributed	to	the	deviation	
of	lipid	stores	to	the	Toxoplasma	PV.	As	the	parasite	replicates,	its	nutritional	needs	increase	
proportionaly,	and	must	scavenge	lipids	accordingly	from	the	host	cel.	The	progressive	decline	
in	host	LD	numbers	could	be	due	to	the	translocation	and	consumption	of	LD	by	Toxoplasma.	
Addition	of	OA	to	cel	culture	leads	to	transcriptional	changes	in	enzymes	involved	in	LD	
metabolism.	Incubation	of	MIN6	pancreatic	cels	with	0.5	mM	OA	for	6	h	leads	to	a	two-fold	
increase	in	DGAT2	expression,	and	a	2-fold	increase	in	intracelular	TAG	levels	whereas	in	
hepatocytes,	TAG	levels	rose	3-fold	(Mei	et	al,	2011;	Thörn	and	Bergsten,	2010).	Interestingly,	
0.25	mM	OA	incubation	of	pancreatic	AR42J	cels	leads	to	a	slight,	but	significant	increase	in	
DGAT2	expression	(1.2x),	similar	to	DGAT	transcription	in	HFF	with	0.2	mM	OA	(Ahn	et	al,	2013).	
An	increase	in	ADRP	expression	in	HFF	with	0.2	mM	OA	incubation	is	detected	but	no	change	in	
ACAT	expression	is	observed.	The	lack	of	ACAT	expression	is	due	to	the	preferential	
esterification	of	DAG	over	cholesterol	with	OA	in	mammalian	embryonic	fibroblasts,	
	158	
hepatocytes	and	pancreatic	cels	(Ahn	et	al,	2013;	Mei	et	al,	2011;	Listenberger	et	al,	2003).	In	
Toxoplasma-infected	cels,	the	decrease	in	transcription	of	ACAT,	DGAT	and	ATGL	is	surprising	
and	could	be	explained	by	a	dysregulation	of	the	NL	cycle	in	host	cels	upon	parasite	assault.	
Nevertheless,	the	decrease	in	ACAT	and	DGAT	upon	Toxoplasma	infection	mirrors	our	
observation	of	a	dwindling	of	host	LD	numbers	24	h	p.i.	
In	the	same	fashion	as	in	mammalian	cels,	Toxoplasma	is	responsive	to	excess	OA.	
Incubation	of	infected	HFF	with	0.2	mM	leads	to	the	increase	in	expression	of	TgDGAT,	
concomitant	with	increased	numbers	of	LD	in	the	parasite,	likely	as	means	to	store	TAG	or	free	
OA.	However,	Toxoplasma	seems	incapable	of	regulating	OA	intake	as	exposure	with	OA	up	to	
0.5	mM	forces	to	parasite	to	store	excessive	lipids,	resulting	in	a	massive	accumulation	of	
numerous	LD	that	occupy	a	large	space	in	the	cytoplasm,	and	even	protruding	out	from	the	
parasite.	Another	similar	example	of	the	unrelentless	lipid	scavenging	activities	of	Toxoplasma	is	
ilustrated	with	cholesterol	(Coppens	et	al,	2000).	In	host	cels	incubated	with	excess	LDL	(the	
source	of	cholesterol	for	the	parasite),	Toxoplasma	takes	up	cholesterol	in	quantities	that	
exceed	its	needs	and	must	store	the	excess	in	LD	that	accumulate	in	the	cytoplasm	(Coppens	et	
al,	2000;	Nishikawa	et	al,	2005;	Coppens	et	al,	2006)	This	can	be	detrimental	to	the	parasite	if	
incubated	with	ACAT	inhibitors,	which	block	cholesterol	esterification	into	CE	and	consequently,	
LD	formation	(Coppens	and	Vielemeyer,	2005).	The	free	cholesterol	becomes	toxic	as	it	
accumulates	in	the	membranes	of	Toxoplasma,	which	are	destabilized,	leading	to	the	
destruction	of	the	parasite	(Nishikawa	et	al,	2005).	Lipidomics	studies	may	prove	fruitful	to	
investigate	how	excess	OA	afects	the	total	lipid	composition	of	the	parasite	to	provide	insights	
on	lipid	homeostasis	in	Toxoplasma.	
Intact	host	LD	were	detected	inside	the	PV	of	Toxoplasma.	By	tracking	the	movement	of	
lipids	such	as	C4-BODIPY-C9,	BODIPY	493/503	or	radiolabeled	OA	stored	in	host	LD	in	
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Toxoplasma-infected	cels,	we	provide	evidence	that	Toxoplasma	can	have	access	to	these	host	
cel-derived	lipids.	The	mechanism	of	lipid	acquisition	by	Toxoplasma	was	investigated	by	EM	
which	hinted	at	the	engulfment	of	intact	host	LD	by	Toxoplasma.	Indeed,	despite	the	PVM	
providing	a	safe	haven	for	the	parasite,	it	also	creates	a	barrier	for	nutrient	uptake.	However,	
this	membrane	is	permeable	to	smal	solutes	(Schwab	et	al,	1994)	and	is	composed	of	lipids	
derived	from	the	host	PM,	and	is	therefore	very	dynamic	and	deformable.	Indeed,	the	PVM	can	
form	long	protruding	tubules	that	pervade	the	host	cytoplasm	(Coppens	et	al,	2006)	and	
invaginations	in	the	PV.	With	the	sharing	of	these	characteristics,	it	is	possible	that	the	PVM	
functions	as	a	PM	and	may	be	able	to	“phagocytose”	or	translocate	larger	structures	such	as	
vesicles,	endolysosomes,	and	potentialy	LD.	In	fact,	intact	endolysosomes	have	been	observed	
in	the	PV	and	are	surrounded	by	the	PVM,	suggestive	of	a	phagocytosis-like	process	(Coppens	et	
al,	2006).	Further	confirmation	of	the	presence	of	host	LD	in	the	PV	would	necessitate	
immunogold	staining	for	a	protein	marker	of	LD	such	as	ADRP.	We	have	previously	shown	that	
both	Toxoplasma	and	a	closely	related	protozoan,	Neospora	caninum	can	take	up	host	Rab	
vesicles	(Rab14,	Rab30,	Rab43)	containing	lipids,	possibly	also	via	a	phagocytosis-like	mechanism	
(Romano	et	al,	2013;	Nolan	et	al,	2015:	Fig.	2-9,	Chapter	2).	This	present	study	has	added	Rab7	
and	Rab18	to	the	list	of	Rab	structures	that	Toxoplasma	can	reroute	to	its	PV,	with	potentialy	
NL	as	contents	if	these	Rab	proteins	are	present	on	LD	leaflet.	Other	Rab	proteins	like	Rab5,	
Rab7	and	Rab10	are	also	associated	to	subsets	of	LD	(Ozeki	et	al,	2005).	It	could	be	interesting	to	
investigate	if	Toxoplasma	can	also	hijack	these	Rab	associated	to	the	LD	to	assess	the	selectivity	
of	this	process	of	LD	translocation.	
Host	LD	trapped	in	the	PV	lumen	are	wrapped	by	the	intravacuolar	network	(IVN),	which	
is	a	membranous	tubular	network	derived	from	vesicles	exported	by	the	parasite.	The	IVN	
contains	mainly	lipids	derived	from	the	host	cel	and	dense	granule	proteins	secreted	by	the	
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parasite	(GRA2,	GRA4,	GRA6)	(Cafaro	and	Boothroyd,	2011;	Mercier	et	al,	2002;	Labruyere	et	al,	
1999).	Analysis	of	the	IVN	by	EM	revealed	that	host	LD	in	the	PV	lumen	are	completely	
surrounded	by	membranous	tubules	of	the	IVN,	a	process	proposed	to	play	a	role	in	nutrient	
uptake	and	lipid	scavenging.	Interestingly,	a	recent	study	identified	a	phospholipase	secreted	by	
Toxoplasma,	TgLCAT,	which	is	distributed	in	the	IVN	and	PM	(Pszenny	et	al,	2015).	This	finding	
leads	to	the	possibility	that	this	enzyme	could	be	implicated	in	the	degradation	of	organeles	or	
structures	derived	from	the	host	cels	such	as	LD,	alowing	the	parasite	to	have	access	to	their	
nutrients	liberated	in	the	PV	lumen.	Interference	with	the	IVN	using	parasites	lacking	GRA2	and	
GRA6	proteins	would	be	an	interesting	direction	to	investigate	if	translocation	of	host	LD	stil	
occurs.		
The	intravacuolar	bacterium	Chlamydia	trachomatis	has	similar	post-invasion	events	as	
Toxoplasma	such	as	association	with	the	host	ER,	mitochondria,	Golgi	apparatus	and	host	
endolysosomes.	The	bacterium	also	scavenges	lipids	from	the	host	cel	such	as	cholesterol	and	
ceramide	(Romano	and	Coppens,	2013).	Moreover,	host	cytoplasmic	LD	are	translocated	into	
the	inclusion	body	of	the	bacterium,	which	adds	another	analogous	feature	shared	between	the	
two	pathogens	(Romano	and	Coppens,	2013;	Cocchiaro	et	al,	2008).	Similarly	to	the	data	shown	
here,	intact	host	LD	are	detected	within	the	replicative	niche	of	the	bacterium.	Interestedly,	in	
Chlamydia-infected	cels,	ADRP	is	cleaved	of	the	host	LD	prior	to	translocation	to	the	inclusion	
of	C.	trachomatis.	C.	trachomatis	secretes	3	bacterial	proteins	that	interact	with	ADRP	to	form	a	
complex	prior	to	LD	translocation	to	the	inclusion	body	named	LC1,	LC2	and	LC3	(Cocchiaro	et	al,	
2008).	It	would	be	interesting	to	test	to	what	extent	the	activities	of	Toxoplasma	mirrors	
Chlamydia	spp.	The	parasite	efector	on	the	PVM	that	mediates	the	recognition	and	
internalization	of	host	LD	remains	to	be	identified	by	cross-linking	assays	and	co-
immunoprecipitation	with	a	host	LD	protein.	
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The	mechanism	by	which	Toxoplasma	takes	up	lipids	internalized	to	the	PV	is	unknown.	
Toxoplasma	contains	several	protein	transporters	located	on	the	PM	for	the	active	transport	of	
lipids,	nucleotides,	amino	acids	or	hexoses	(reviewed	in	Blader	and	Saeij,	2010).	Exposure	of	
Toxoplasma	to	0.2	mM	OA	revealed	previously	unreported	large	invaginations	of	the	parasite	
PM,	containing	material	present	in	the	PV	lumen,	as	wel	as	intra-parasitic	vesicles.	This	
highlights	that	Toxoplasma	may	also	able	to	endocytose	macromolecules	and	vesicles	present	in	
the	PV.	The	identification	of	these	endocytic	structures	solely	under	conditions	of	
oversaturation	of	the	parasite	with	large	amount	of	fatty	acids	may	suggest	that	this	
hypothesized	process	of	endocytosis	occurs	much	faster	in	Toxoplasma	cultivated	under	normal	
nutritional	conditions.	Actualy,	the	process	might	occur	too	fast	to	have	ever	been	captured	
before.	Alternatively,	it	is	possible	that	these	proposed	endocytic	structures	are	normaly	
present	in	Toxoplasma	but	are	too	smal	to	be	noticed,	and	that	the	ingested	fatty	acids	in	large	
quantities	can	subsequently	modify	the	properties	of	the	PM,	e.g.	fluidity	or	curvature,	which	
leads	to	the	formation	of	endocytic	structures	of	considerable	size	and	capacity.	Nevertheless,	
this	discovery	wil	open	new	prospects	in	the	study	of	the	endocytic	traficking	machinery	in	
Toxoplasma.	 	
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INFLUENCE	OF	EXCESS	MONO-UNSATURATED	FATTY	ACIDS			
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4.1.	ABSTRACT	
The	obligate	intravacuolar	Apicomplexan	parasite,	Toxoplasma	gondi,	develops	in	a	
parasitophorous	vacuole	from	where	it	scavenges	lipids	such	as	cholesterol,	ceramides,	
phospholipids	and	fatty	acids	from	the	host	cel.	Previous	studies	have	shown	that	high	amounts	
of	cholesterol	and	ceramides	added	to	the	culture	medium	stimulate	parasite	replication.	
Nothing	is	known	about	the	influence	of	excess	fatty	acids	on	Toxoplasma’s	growth.	Surprisingly,	
we	show	that	addition	of	the	monounsaturated	18:1	cis9	fatty	acid	oleic	acid	(OA)	at	harmless	
concentrations	for	the	mammalian	host	cel	(0.2	to	0.4	mM),	has	a	detrimental	efect	on	
Toxoplasma	development,	impairing	both	the	replication	and	egress	of	the	parasite.	We	
document	that	OA	does	not	hinder	the	parasite’s	ability	to	associate	with	host	organeles,	nor	
does	it	act	as	a	stressor	inducing	stage	conversion	to	the	parasite	cyst	form	or	bradyzoite.	
Increased	autophagic	activities	in	the	host	mediated	by	excess	OA	do	not	seem	to	harm	the	
parasite.	We	hypothesize	that	the	cause	of	the	developmental	defect	of	intravacuolar	
Toxoplasma	is	likely	due	to	a	particularly	high	sensitivity	of	the	parasite	to	OA,	leading	to	
lipotoxic	damage.	At	the	morphological	level,	we	observed	numerous	lipid	deposits	including	
excess,	large	lipid	droplets	that	filed	the	parasite	cytoplasm	and	a	variety	of	lamelar	lipid	
structures	accumulated	within	the	PV.	This	reflects	a	dysregulation	in	lipid	metabolism	and	
intracelular	traficking	due	to	ectopic	overaccumulation	of	lipids	in	intravacuolar	parasites.	
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4.2.	BACKGROUND	
This	section	includes	a	brief	synopsis	of	Chapter	3	plus	general	background	information	on	the	
intracelular	development	of	Toxoplasma	and	fatty	acid	metabolism	that	is	relevant	for	the	
studies	in	this	chapter	on	the	influence	of	host	fatty	acid	on	Toxoplasma	infectivity.	
	
4.2.1.	Synopsis	of	Chapter	3	
The	focus	of	chapter	3	was	to	determine	whether	the	Apicomplexan	Toxoplasma	gondi	could	
manipulate	host	cel	LD	and	scavenge	neutral	lipids	(NL)	from	them	as	previously	observed	for	
other	lipid-filed	organeles.	Previous	studies	have	reported	the	scavenging	of	many	diferent	
lipid	species	by	the	parasite	including	cholesterol,	ceramides,	phospholipids,	sphingolipids	and	
fatty	acids	(Coppens	et	al,	2006;	Romano	et	al,	2013;	Quittnat	et	al,	2004;	Nishikawa	et	al,	2005;	
Charron	and	Sibley,	2002;	Tomavo	et	al,	1989).	Neutral	lipids	(NL),	e.g.	triacylglycerols	(TAG)	or	
sterol	esters	(SE)	are	the	primary	lipids	for	energy	storage	across	the	tree	of	life.	TAG	consists	of	
3	fatty	acids	(FA)	and	a	glycerol	molecule,	and	SE	consists	of	a	steryl	conjugated	to	a	FA.	Addition	
of	the	fatty	acid	oleic	acid	(OA)	at	a	concentration	of	0.2	mM	to	cels	leads	to	a	dramatic	
accumulation	of	LD	(Listenberger	et	al,	2003;	Fujimoto	et	al,	2006;	Mei	et	al,	2011;	Thörn	and	
Bergsten,	2010;	Ahn	et	al,	2013),	and	is	therefore	a	useful	technical	tool	to	track	host	LD	and	
monitor	NL	uptake	by	the	parasite.		
Our	previous	data	suggests	that	Toxoplasma	attracts	host	LD	to	its	PV,	has	access	to	the	
host’s	NL	reserves	and	stores	the	NL	in	its	own	LD.	This	salvage	process	may	involve	the	
internalization	of	host	LD	into	the	PV	as	observed	by	electron	microscopy,	and	by	visualizing	the	
distribution	of	Rab	proteins	associated	with	LD	inside	the	PV	by	fluorescence	microcopy.	
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Interestingly,	the	results	from	chapter	3	highlight	that	Toxoplasma	is	unable	to	regulate	its	
uptake	of	OA	by	feedback	mechanisms,	making	it	potentialy	vulnerable	to	lipotoxic	damage.	
Moreover,	the	work	from	chapter	3	has	also	hypotheticaly	identified	novel	endocytic	events	
and	vesicles	in	the	parasite	under	the	conditions	of	lipid	gavage.		
With	the	knowledge	that	excess	OA	leads	to	LD	accumulations	in	the	parasite,	at	least	
partialy	via	NL	uptake	from	host	LD,	our	focus	was	shifted	to	the	potential	benefit	of	this	
process	for	the	parasite.	In	fact,	the	addition	of	other	lipid	species	such	as	excess	cholesterol	or	
ceramides	leads	to	a	boost	in	Toxoplasma	replication	(Coppens	et	al,	2000;	Nishikawa	et	al,	
2005;	Romano	et	al,	2013).	Therefore	we	hypothesize	that	excess	FA	may	also	be	beneficial	for	
parasite	replication.	
	
4.2.2.	Intracelular	development	of	Toxoplasma	
Toxoplasma	gondi	is	an	Apicomplexan	parasite	capable	of	infecting	any	mammalian	nucleated	
cel.	There	are	3	major	steps	involved	in	the	intracelular	development	of	Toxoplasma:	invasion,	
replication	and	egress	(reviewed	in	Blader	et	al,	2015).	
	 Active	invasion	of	a	cel	by	Toxoplasma	is	a	parasite-mediated	event,	as	opposed	to	a	
cel-induced	process	or	phagocytosis.	Folowing	host	cel	penetration,	the	parasite	is	surrounded	
by	a	parasitophorous	vacuolar	membrane	(PVM),	derived	from	lipids	from	the	plasma	
membrane	(PM)	of	the	cel	of	which	host	cel	PM	proteins	were	excluded.	The	PV	is	resistant	to	
fusion	with	host	cel	organeles	such	as	endolysosomes	and	evades	the	cytosolic	immune	
surveilance	pathways.	The	PV	therefore	serves	as	a	protective	compartment	for	Toxoplasma	in	
which	to	replicate.	The	PV	localizes	to	the	perinuclear	region	of	the	cel	and	associates	with	host	
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organeles	and	structures	such	as	mitochondria,	the	ER,	the	Golgi,	microtubules	and	the	
microtubule-organizing	center	(MTOC)	(reviewed	in	Romano	and	Coppens,	2013).	Very	shortly	
after	cel	invasion,	the	host	rough	ER	distribution	is	intensely	altered	by	Toxoplasma	(Sinai	et	al,	
1997).	Within	4	h	folowing	invasion,	the	PV	of	Toxoplasma	is	covered	with	host	ER	elements	
and	is	localized	to	the	perinuclear	region	of	the	cel,	a	process	mediated	by	the	anchoring	of	the	
PVM	to	the	ER	envelope	(Sinai	et	al,	1997;	Romano	et	al,	2008).	Similarly,	close	association	and	
concentration	of	host	mitochondria	around	the	PV	is	also	apparent	4	h	p.i.	(Sinai	et	al,	1997).	
The	recruitment	of	mitochondria	to	the	PV	is,	at	least	in	part,	mediated	by	a	secreted	parasite	
protein,	TgMAF1	(Pernas	et	al,	2014).	Association	of	the	PV	with	host	cel	organeles	is	
hypothesized	to	facilitate	nutrient	transfer	and	acquisition	by	the	parasite.	Nutrient	acquisition	
from	the	host	cel	is	imperative	to	ensure	optimal	growth	rates.	For	example,	Toxoplasma	
cannot	synthesize	cholesterol	de	novo,	and	must	scavenge	it	from	the	host	cels,	in	part	by	
endolysosome	uptake	to	the	PV	(Coppens	et	al,	2000;	Coppens	et	al,	2006).	
	 Within	the	PV,	Toxoplasma	replicates	every	6-8	h	in	vitro	by	a	process	termed	
endodyogeny	whereby	two	daughter	cels	are	formed	within	one	mother	cel.	The	smal	
remnants	of	the	mother	cels	are	colected	in	a	structure	caled	the	residual	body,	located	in	the	
center	of	the	PV,	whose	contents	are	expeled	into	the	PV	lumen	prior	to	degradation	by	an	
unknown	mechanism.	When	the	PV	is	ful	of	parasites	and	the	host	cel	can	no	longer	support	
the	growth	of	the	parasite,	egress	ensues.	This	is	a	parasite-mediated	event	dependent	on	
calcium	signaling,	leading	first	to	the	destruction	of	the	PVM,	then	the	host	cel	PM	and	finaly	
the	emergence	of	fresh	parasites	ready	to	invade	another	cel.		
	 	Further	details	on	the	intracelular	development	of	Toxoplasma	can	be	found	in	the	first	
chapter	of	this	thesis.	
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4.2.3.	Fatty	acids	overview	
Lipids	are	non-polar	organic	molecules	that	are	distinguished	by	their	high	solubility	in	non-polar	
solvents	and	insolubility	in	water	due	to	the	presence	of	long	hydrophobic	hydrocarbon	chains.	
These	chains	can	be	saturated	between	carbon	atoms	(al	single	bonds)	or	unsaturated	(double	
of	triple	covalent	bonds).	Lipids	are	a	diverse	group	of	compounds	including	oils,	waxes,	fats,	
sterols	and	phospholipids	and	are	amphipatic	molecules	as	they	have	both	hydrophobic	and	
hydrophilic	regions.		
The	functions	of	lipids	are	very	broad	but	their	three	primary	roles	are:	1)	membrane	
constituents,	2)	energy	storage,	and	3)	hormone	production.	Firstly,	lipids	are	found	in	al	cel	
membranes	of	al	prokaryotes	and	eukaryotes	organisms.	Membranes	are	the	defining	feature	
of	the	basic	unit	of	life,	the	cel,	and	also	form	al	the	subcelular	compartments	in	eukaryotes.	
Secondly,	lipids	tend	to	be	reduced	molecules	and	so	oxidation	of	these	compounds	releases	
vast	amounts	of	energy.	Thirdly,	lipids	are	the	building	blocks	of	hormones,	essential	for	many	
signal	transduction	events	in	the	body	and	between	cels.		
	
4.2.3.1.	Fatty	acids	
Among	lipids,	fatty	acids	(FA)	are	long	chain	hydrocarbon	molecules	with	a	carboxylic	moiety	at	
one	end	(Fig.	4-1).	FA	are	essential	for	life	as	they	perform	3	roles:	1)	they	are	the	building	
blocks	of	more	complex	membrane	and	non-membrane	lipids,	2)	they	can	be	stored	as	energy	in	
the	form	of	TAG,	and	3)	they	are	the	precursors	for	the	synthesis	of	bioactive	lipids	involved	in	
signaling.		
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Figure	4-1.	Chemical	formula	and	structure	of	the	most	common	fatty	acids	in	mammals.		
Diagram	from	Karacor	and	Cam,	2015.	
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FA	are	major	constituents	of	membranes,	usualy	bound	to	phospholipids	or	cholesterol	
esters	but	around	1-2%	of	lipids	in	membranes	are	free	FA	(FFA)	(Funari	et	al,	2003).	Of	al	the	
FFA	in	membranes,	the	most	abundant	in	fibroblasts	are	42%	OA,	22%	palmitic	acid	(PA),	13%	
stearic	acid	and	9%	palmitoleic	acid	(Maziere	et	al,	1980).	
	
4.2.3.2.	Endogenous	FA	synthesis	and	degradation	
The	synthesis	of	FA	occurs	in	the	cytosol,	whereas	their	degradation	occurs	primarily	in	the	
mitochondrial	matrix	(Berg	et	al,	2002).	The	synthesis	of	FA	involves	several	enzymes	colectively	
named	fatty	acid	synthases	(FAS)	that	perform	several	reactions.	The	first	committed	step	to	FA	
synthesis	is	acetyl-CoA	carboxylation	to	generate	malonyl-CoA.	Several	more	reactions	take	
place	in	the	cytosol	using	intermediates	linked	to	the	sulfhydryl	groups	of	an	acyl	carrier	protein	
(ACP),	and	eventualy	ending	with	the	16-carbon	palmitic	acid	(PA).	The	majority	of	the	acetyl-
CoA	for	the	initial	FA	synthesis	step	originates	from	pyruvate	by	the	enzyme	pyruvate	
dehydrogenase	(PDH)	within	the	glycolytic	cycle	in	the	mitochondrion.	Pyruvate	is	therefore	a	
critical	molecule	linking	the	conversion	of	carbohydrates	to	FA.	As	an	aside,	the	glycerol	
molecule	needed	for	TAG	generation	is	also	produced	in	the	glycolytic	pathway.	
FA	degradation	occurs	in	the	mitochondria	or	peroxisomes	by	β-oxidation.	This	involves	
the	activation	and	transport	of	FFA	bound	to	CoA	to	the	mitochondrion,	folowed	by	cleavage	of	
two	carbons	every	cycle,	generating	acetyl-CoA.	The	degradation	of	FA	is	not	simply	a	reversal	of	
FA	synthesis	since	the	acetyl-CoA	generated	cannot	re-enter	the	FA	synthesis	pathway	in	the	
cytosol,	and	instead	enters	the	citric	acid	cycle	in	the	mitochondrion.	Additionaly,	the	two	
processes	use	two	distinctive	sets	of	enzymes,	occur	in	distinct	celular	locations	and	are	
mutualy	inhibitory.		
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4.2.3.3.	Fatty	acid	uptake	by	mammalian	cels	
Most	of	the	FA	present	in	the	serum	is	esterified	but	2-5	%	of	FFA	are	bound	to	albumin	(Wang	
et	al,	2008).	FFA	in	the	serum	are	generated	via	the	hydrolysis	of	TAG-rich	lipoproteins	by	lipases	
within	the	endothelial	lumen,	and	subsequently	bound	to	albumin	(Doege	and	Stahl,	2006).	The	
mechanism	by	which	FFA	are	released	from	albumin	is	unknown	but	increased	albumin	levels	in	
the	serum	can	stimulate	FFA	release	(Richieri	and	Kleinfeld,	1995).	Transport	of	FFA	across	
plasma	membrane	can	occur	either	by	passive	difusion,	or	binding	to	protein	carriers	such	as	
fatty	acid	transport	protein	complexes	(FATP),	as	wel	as	binding	to	cel-surface	proteins	such	as	
CD36	which	deliver	the	FFA	to	the	FATP.	Folowing	the	binding	of	FA	to	proteins	in	the	PM,	
albumin	dissociates	from	the	FA	prior	to	cel	entry	(Doege	and	Stahl,	2006).	FFA	may	also	be	
incorporated	into	celular	PM,	which	also	necessitates	albumin	removal.	FFA	can	also	act	as	
signal	transducers	on	the	cel	surface	e.g.	by	binding	toll-like	receptors	(TLR)	in	the	innate	
immune	response,	or	binding	G-protein-coupled	receptors	in	the	PM.	
	
4.2.3.4.	Fatty	acid	destinations	in	mammalian	cels	
Upon	cel	entry,	fatty	acid	binding	proteins	(FABP)	help	remove	FFA	carriers	bound	to	FFA	such	
as	FATP	and	bind	FFA	themselves.	FABP	then	mediates	the	traficking	of	FFA	to	many	diferent	
celular	compartments	(Doege	and	Stahl,	2005)	(Fig.	4-2).	Alternatively,	FFA	may	be	activated	by	
CoA,	yielding	acyl-CoA	destined	for	oxidative	degradation.	The	coupling	of	FFA	to	CoA	is	
performed	by	long-chain	fatty	acyl-CoA	synthetases	in	the	cytosol.	Acyl-CoA	can	then	be	
transported	throughout	the	cel	by	acyl-CoA	binding	protein	(ACBP)	(Rustan	and	Drevon,	2005;	
Furuhashi	and	Hotamisligil,	2008).		
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Figure	4-2.	Celular	fatty	acid	traficking	by	fatty	acid	binding	proteins.	
Folowing	the	intracelular	uptake	of	fatty	acid	(FA),	fatty	acid	binding	proteins	(FABP)	bind	FA	for	
subsequent	traficking	throughout	the	cel.	Organelar	destinations	include	the	mitochondria	and	
peroxisomes	for	β-oxidation,	lipid	droplets	for	storage,	the	endoplasmic	reticulum	for	membrane	
synthesis	and	signaling,	and	the	nucleus	for	the	control	of	FA-mediated	transcriptional	programs.		
Image	from	Furuhashi	and	Hotamisligil,	2008.	
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FA,	such	as	OA,	can	be	traficked	to	the	LD,	ER,	mitochondria,	peroxisomes,	and	the	
nucleus.	The	fate	of	OA	upon	entering	the	cel	depends	on	whether	OA	binds	FABP	directly	or	is	
activated	by	CoA	first.	In	the	former	scenario,	OA	bound	to	FABP	is	shuttled	to	LD	for	its	
incorporation	within	these	confines,	particularly	in	order	to	prevent	lipotoxicity.	In	the	latter	
case,	OA-CoA	can	then	be	bound	by	either	FABP	or	ACBP,	both	of	which	can	transport	OA-CoA	
to	mitochondria	or	peroxisomes	for	β-oxidation,	or	the	endoplasmic	reticulum	(ER)	for	
esterification	to	phospholipids,	TAG	or	CE	(McArthur	et	al,	1999).	Alternatively	in	the	ER,	FA	such	
as	OA	may	be	incorporated	into	membranes	or	signaling	molecules	also	via	esterification	of	
DAG.	Finaly,	FA	can	be	converted	into	signaling	molecules	such	as	eicosanoids	within	LD	or	
transported	to	the	nucleus	for	the	modulation	of	transcription	factors	that	are	mediated	by	
lipids	through	nuclear	hormone	receptors	(Furuhashi	and	Hotamisligil,	2008).	
	
4.2.4.	Efects	of	excess	oleic	acid	on	mammalian	cels:	lipolysis	and	lipophagy	
4.2.4.1.	Efects	of	oleic	acid.	
Oleic	acid	(OA)	is	a	monounsaturated	18:1	cis9	fatty	acid	and	is	the	most	common	FA	in	human	
serum,	celular	membranes	and	adipose	tissue	(Baylin	et	al,	2002;	Hodson	and	Fielding	2013;	
Lopez	et	al,	2014).	The	kink	at	the	9th	carbon	of	OA	helps	organize	membranes	into	non-lamelar	
phase,	induces	negative	curvature	and	helps	govern	the	fluidity	of	the	membrane	matrix	
(Khandoker	et	al,	1997;	Funari	et	al,	2003;	Lopez	et	al,	2014).	The	influence	on	membrane	
fluidity	is	specific	to	monounsaturated	FA	such	as	OA	or	linoleic	acid	since	saturated	FA	like	PA	
are	not	kinked	and	therefore	tightly	pack	together	in	membranes	(Funari	et	al,	2003).	As	wel	as	
influencing	membranes	fluidity,	OA	can	act	directly	as	a	signaling	molecule	at	the	PM	or	the	
nuclear	envelope	through	G-protein-coupled	receptor	binding	which	may	lead	to	transcriptional	
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changes,	activation	of	ERK1/2,	PI3K	or	Akt,	or	increase	of	cytosolic	calcium	levels	(Funari	et	al,	
2003;	Hara	et	al,	2011).		
Addition	of	OA	to	the	medium	leads	to	the	accumulation	of	intracelular	TAG,	an	
increase	in	DGAT	activity	and	stimulation	of	LD	biogenesis	(Listenberger	et	al,	2003;	Fujimoto	et	
al,	2006;	Mei	et	al,	2011;	Thörn	and	Bergsten,	2010;	Ahn	et	al,	2013;	Dupont	et	al,	2014).	In	
addition	to	changes	in	lipid	metabolism,	treatment	of	cels	such	as	macrophages	or	epithelial	
cels	with	OA	increases	the	baseline	levels	of	this	FA	in	membranes	to	nearly	40%	of	al	FA	
(Nowak	et	al,	2011;	Jackson	et	al,	2009).	
	
4.2.4.2.	Lipolysis	and	lipophagy	
Lipids	stored	within	LD	can	be	metabolized	by	cytosolic	neutral	lipases,	such	as	ATGL,	by	a	
process	of	lipolysis	(reviewed	in	Chapter	1).	Another	process	that	leads	to	LD	depletion	from	the	
cel	is	lipophagy,	a	selective	form	of	autophagy	targeting	LD.	LD	containing	NL	and	FA	can	be	
engulfed	by	autophagosomes	and	delivered	to	lysosomes	for	degradation	by	hydrolases	(Liu	and	
Czaja,	2013).	The	FA	liberated	from	the	LD	can	then	be	used	for	mitochondrial	β-oxidation.	Thus,	
lipophagy	helps	regulate	energy	homeostasis	by	modifying	intracelular	lipids	supplies	and	FFA	
levels.	
Lipotoxicity	can	severely	damage	the	cel	through	the	generation	of	reactive	oxygen	
species	(ROS)	and	nitric	oxide	(NO),	leading	to	celular	and	mitochondrial	dysfunction,	and	cel	
death	by	apoptosis	(Shimabukuro	et	al,	1997;	Ostrander	et	al,	2001;	Listenberger	et	al,	2003;	
Ricchi	et	al,	2009;	Mei	et	al,	2011).	Lipophagy	has	also	been	implicated	as	a	critical	pathway	for	
the	prevention	of	lipotoxicity.	Diferent	FA	have	diferent	efects	on	cels	in	relation	to	LD	
metabolism	and	lipophagy.		
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Conflicting	reports	on	the	ability	of	OA	or	PA	to	induce	lipophagy	have	been	published,	
indicating	cel	type	specificity	in	the	ability	of	these	FFA	to	induce	lipophagy.	Addition	of	palmitic	
acid	to	various	cel	types	(fibroblasts,	hepatocytes)	inhibits	lipophagy	whereas	addition	of	OA	
stimulates	lipophagy	(Singh	et	al,	2009;	Las	et	al,	2011;	Mei	et	al,	2011;	Dupont	et	al,	2014).	
Another	study	described	lack	of	lipophagy	in	hepatocytes	treated	with	both	0.25	mM	OA	or	0.25	
mM	PA	(Koga	et	al,	2010).	Other	studies	have	shown	that	OA	does	not	stimulate	lipophagy	in	
pancreatic	β-cels	and	fibroblasts,	whereas	it	does	in	hepatocytes	(Choi	et	al,	2009;	Las	et	al,	
2011;	Tan	et	al,	2012;	Tu	et	al,	2014).	In	general	however,	the	induction	of	lipophagy	is	critical	
for	resistance	against	lipotoxicity	from	FFA.	Lipotoxicity	occurs	more	readily	with	PA	incubation	
as	cels	cannot	eficiently	sequester	excess	PA	into	LD	or	increase	TAG	biogenesis.	Indeed,	in	
hepatocytes	and	fibroblasts,	no	increase	in	LD	numbers	were	observed	when	incubated	with	PA,	
in	contrast	to	OA	(Singh	et	al,	2009;	Mei	et	al,	2011;	Tan	et	al,	2012).		
	
4.2.5.	Chapter	goals:	
In	this	chapter,	we	investigated	the	efects	of	excess	OA	on	the	intracelular	development	of	
Toxoplasma	in	mammalian	fibroblasts.	Toxoplasma	scavenges	from	the	host	cel	many	lipid	
species	such	as	cholesterol	and	ceramides.	When	these	lipids	are	introduced	in	excess	to	the	
host	cels,	the	replication	of	Toxoplasma	is	stimulated.	However,	in	response	to	excess	
cholesterol	in	the	medium,	the	parasite	needs	to	store	this	lipid	in	LD	(Nishikawa	et	al,	2005),	as	
a	safe	mechanism	to	prevent	damage	from	free	cholesterol	(Coppens	et	al,	2000;	Romano	et	al,	
2013).		
In	this	chapter,	the	folowing	questions	wil	be	addressed:	
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- Does	excess	OA	introduced	to	the	medium	impact	the	development	of	Toxoplasma,	e.g.,	
its	replication	rate	or	ability	to	egress?	
- Does	the	parasite	exhibit	signs	of	lipotoxicity	upon	incubation	with	excess	OA?	
- Is	Toxoplasma	stil	capable	of	recruiting	host	organeles,	e.g.,	ER,	mitochondria	and	Golgi	
to	its	PV,	despite	the	accumulation	of	host	LD	around	the	PV?	
- Does	increased	autophagy	in	the	host	cel	upon	excess	OA	afect	the	development	of	
Toxoplasma?	
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4.3.	MATERIALS	AND	METHODS	
4.3.1.	Reagents	and	antibodies	
Al	chemicals	were	obtained	from	Sigma	(St	Louis,	MO)	or	Fisher	(Waltham,	MA)	unless	
otherwise	stated.	4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacene	(BODIPY	
493/503)	was	purchased	from	Life	Technologies	(Carlsbad,	CA).	The	folowing	primary	antibodies	
were	used:	rabbit	polyclonal	anti-giantin	(Covance,	Emeryvile,	CA);	rabbit	polyclonal	anti-GRA7	
antibodies	(Coppens	et	al.,	2006);	mouse	anti-KDEL	(Stressgen,	Assay	Designs,	Farmingdale,	NY);	
rabbit	monoclonal	anti-TOM20	mouse	polyclonal	(Santa	Cruz,	CA).	Secondary	antibodies	used	
for	immunofluorescence	were	conjugated	to	Alexa488,	Alexa594	or	Alexa350	(Invitrogen,	Carlsbad,	
CA).	For	oleic	acid	(OA)	preparations,	sodium	oleate	was	dissolved	in	H2O	at	a	concentration	of	
100	mM,	then	thoroughly	mixed	by	vortexing	(3	minutes)	with	5%	Fatty	Acid	Free	BSA	for	a	final	
concentration	of	10mM	to	ensure	BSA-OA	complexes	formation	and	stored	in	the	dark	at	4°C.	
For	palmitic	acid	(PA)	preparations,	sodium	palmitate	was	dissolved	in	50%	ethanol	at	a	
concentration	of	100	mM	and	prepared	subsequently	identicaly	as	OA.	Cels	were	incubated	in	
medium	with	various	final	OA	or	PA	concentrations.	
	
4.3.2.	Cel	lines	and	culture	conditions	
Human	foreskin	fibroblasts	(HFF)	and	HeLa	cels	were	obtained	from	the	American	Type	Culture	
Colection	(Manassas,	VA).	GFP-ADRP	HeLa	cels	were	kindly	provided	by	Raphael	Valdivia	(Duke	
University,	North	Carolina,	USA;	originaly	made	by	P.	Targett-Adams	and	J.	McLauchlan,	
Glasgow,	UK).	Al	cel	lines	were	grown	as	monolayers	and	cultivated	in	α-minimum	essential	
medium	(MEM)	supplemented	with	10%	fetal	bovine	serum	(FBS),	2	mM	glutamine	and	
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penicilin/streptomycin	(100	units/ml	per	100	µg/ml),	and	maintained	at	37oC	in	5%	CO2	unless	
specified	otherwise.		
	
4.3.3.	Parasite	cultivation	
	The	tachyzoites	from	the	RH	strain	(Type	I	lineage)	were	used	throughout	this	study.	In	one	set	
of	experiments,	the	Prugniaud	(Type	I	lineage)	strain	of	Toxoplasma	gondi	was	used	(kindly	
provided	by	David	Roos,	University	of	Pennsylvania,	PA).	Toxoplasma	stably	expressing	RFP	was	
generously	provided	by	Florence	Dzierszinski	(McGil	University,	Montreal,	Canada).	The	
parasites	were	propagated	in	vitro	by	serial	passage	in	monolayers	of	HFF	(Roos	et	al.,	1994).	
	
4.3.4.	Mammalian	cel	transfection	with	LC3	constructs	
The	GFP-LC3	construct	was	a	gift	from	Jennifer	Lippincott-Schwartz,	NIH,	Rockvile,	MD.	HFF	
were	transfected	using	the	Amaxa	nucleofector	kit	V	according	to	the	manufacturer’s	protocol	
(Lonza,	Basel,	Switzerland)	with	2.5	μg	of	plasmid	DNA,	and	16	h	later	infected	with	Toxoplasma	
for	30	minutes	at	37°C,	washed	with	PBS	to	remove	extracelular	parasites,	and	incubated	for	24	
h	at	37°C.	
	
4.3.5.	Parasite	assays	
4.3.5.1.	Development	
For	plaque	assays,	HFF	were	grown	until	confluence	in	a	6-wel	plate,	infected	with	one	hundred	
Toxoplasma	RH	parasites	per	wel	and	the	plates	were	incubated	at	37°C	for	5	days,	with	0.2	
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mM	OA,	0.4	mM	OA	or	0.2	mM	palmitic	acid,	or	in	the	absence	of	FA	as	a	control.	The	cels	were	
fixed	and	stained	as	described	previously	(Striepen	and	Soldati-Favre,	2013).	The	plates	were	
scanned	(ScanWizard	5,	Microtek).	The	average	area	of	the	plaques	was	calculated	using	
Volocity	software	and	graphed	in	Excel	(Microsoft).	
	
4.3.5.2.	Replication	
Coverslips	with	confluent	HFF	were	infected	with	RFP-expressing	Toxoplasma	RH	for	30	minutes,	
thoroughly	washed	with	PBS	to	remove	extracelular	parasites,	and	incubated	without	OA	
(control),	0.1	mM,	0.2	mM,	0.3	mM,	0.4	mM	or	0.5	mM	OA	for	24	h.	Coverslips	were	fixed	with	
4%	formaldehyde	plus	0.02%	glutaraldehyde	in	PBS	for	15	minutes	and	viewed	with	a	Nikon	
Eclipse	90i	equipped	with	an	oil-immersion	plan	Apo	100x	NA	1.4	objective	and	a	Hamamatsu	
GRCA-ER	camera	(Hamamatsu	Photonics,	Hamamatsu,	Japan).	The	number	of	parasites	was	
recorded	for	at	least	1000	PVs	on	the	coverslip	for	each	OA	condition.	The	means	of	means	for	
each	condition	is	graphed	as	a	percentage	of	al	PVs	recorded	with	standard	deviations	using	
Excel	(Microsoft).		
	
4.3.5.3.	Egress	
For	natural	egress	assays,	HFF	were	grown	until	confluence	in	a	6	wel	plate	and	5x106	parasites	
per	wel	were	alowed	to	invade	cels	for	1	h.	Non-invading	parasites	were	then	washed	away	
and	infected	cels	were	incubated	up	to	76	h	in	the	presence	of	0.2	mM	or	0.4mM	OA.	Cels	
were	fixed	and	observed	using	an	inverted	Microscope	(Nikon,	TE200)	using	a	DIC	filter.	Images	
were	taken	using	Spot	Advanced	Software	(Diagnostic	Instruments,	Inc)	and	processed	using	
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iMovie	(Apple).	For	induced	egress	assays,	HFF	were	grown	until	confluence	in	a	6	wel	plate	and	
5x106	parasites	per	wel	were	alowed	to	invade	cels	for	1	h,	washed	and	incubated	with	0.2	
mM,	0.4	mM	OA	or	without	OA	for	24	h.	Egress	was	induced	by	adding	the	Calcium	ionophore	
A23187	and	time	taken	to	egress	was	recorded	by	live	image	capture	using	an	inverted	
microscope	(Nikon,	TE200).	The	time	(in	seconds)	taken	for	individual	PVs	to	egress	from	their	
host	cels	was	recorded	using	Spot	Advanced	Software,	and	graphed	as	a	ratio	to	control	
conditions	(no	OA)	in	Excel	using	the	means	of	means	and	standard	deviations.	
	
4.3.5.4.	Diferentiation	
To	monitor	tachyzoite-bradyzoite	stage	conversion,	coverslips	with	confluent	HFF	were	infected	
with	Toxoplasma	RH	or	Toxoplasma	Prugniaud	strain	for	24	h	with	or	without	0.2	mM	OA	at	5%	
CO2,	or	in	the	absence	of	CO2	as	a	condition	control	for	diferentiation	induction.	Coverslips	
were	fixed	and	stained	for	lectin	with	TRITC-conjugated	lectin	from	Dolichos	biflorus,	4-,6-
diamidino-2-phenylindole	(DAPI)	(Boothroyd	et	al,	1997,	Prandovszky	et	al,	2011)	and	for	the	PV	
with	antibodies	against	GRA7.	
	
4.3.6.	Fluorescence	microscopy	
Immunofluorescence	assays	(IFA)	on	HFF	were	performed	as	described	previously	(Karsten	et	al,	
2004)	with	a	5	minute	permeabilization	step	with	0.3%	TritonX-100	in	PBS	folowing	fixation	
with	4%	formaldehyde	(Polysciences,	Warrington,	PA)	plus	0.02%	glutaraldehyde	in	PBS	for	15	
minutes.	Specific	IFA	with	BODIPY	493/503	labeling	was	performed	after	the	secondary	
incubation	step	for	30	minutes	at	1:100	dilution	in	PBS,	folowed	by	three	5	minute	PBS	washes	
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prior	to	staining	with	4-,6-diamidino-2-phenylindole	(DAPI).	Coverslips	were	mounted	using	
ProLong	Diamond	Antifade	Mountant	(Life	Technologies)	to	minimize	bleaching	during	
microscopy.	Cels	were	viewed	with	a	Nikon	Eclipse	90i	equipped	with	an	oil-immersion	plan	
Apo	100x	NA	1.4	objective	and	a	Hamamatsu	GRCA-ER	camera	(Hamamatsu	Photonics,	
Hamamatsu,	Japan).	Optical	z-sections	with	0.2	µm	spacing	were	acquired	using	Volocity	
software	(PerkinElmer,	Waltham,	MA).	The	images	were	deconvolved	using	an	iterative	
restoration	algorithm	and	the	registry	was	corrected	using	Volocity	software.	Volocity	and	
Photoshop	(Adobe)	were	used	to	adjust	brightness	levels,	cropping	and	resizing	of	the	images	
obtained.	To	quantify	host	organele-PV	interaction,	we	used	the	quantitative	image	analysis	
software	MetaScopics	using	the	“Intensity	by	Distance”	algorithm	or	the	“Centroid	to	Surface	
Distance”	algorithm	as	described	(Nolan	et	al,	2015).	
	
4.3.7.	Electron	microscopy	
For	transmission	EM,	HFF	cels	infected	with	T.	gondi	for	24	h	or	72	h	were	fixed	in	2.5%	
glutaraldehyde	(EM	grade;	Electron	Microscopy	Sciences,	Hatfield,	PA)	in	0.1	M	sodium	
cacodylate	bufer	(pH	7.4)	for	1	h	at	room	temperature,	and	processed	as	described	(Fölsch	et	
al.,	2001)	before	examination	with	a	Philips	CM120	Electron	Microscope	(Eindhoven,	the	
Netherlands)	under	80	kV.		
	
2.3.8.	Uracil	incorporation	assay	
HFF,	Hela	or	ADRP-GFP	HeLa	cels	were	grown	until	confluent	in	24-wel	plates	before	infection	
with	5x104	parasites	for	4	h	at	37°C,	washed	with	PBS	and	incubated	for	21	h	in	MEM	medium	
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containing	0.1,	0.2	or	0.4	mM	OA	or	PA.	Cels	were	then	incubated	with	1	µCi	of	[3H]uracil	for	2	h	
at	37°C	and	the	samples	were	processed	as	described	previously	(Roos	et	al,	1994).	
	
4.3.9.	Statistical	methods	
Data	were	displayed	in	box	plots	using	Kaleidagraph	software	(Synergy	Software)	or	graphed	in	
Excel	(Microsoft).	Means	and	standard	deviations	were	calculated	from	three	independent	
experiments	using	Excel	(Microsoft).	P-values	were	calculated	using	student’s	t-test	in	Excel.	
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4.4.	RESULTS	
4.4.1.	Excess	oleic	acid	impairs	the	intracelular	development	of	Toxoplasma	
Although	Toxoplasma	gondi	can	synthesize	de	novo	many	of	the	lipids	required	for	its	
intracelular	growth,	it	must	also	scavenge	others	from	the	host	cel.	The	latter	include	lipids	
that	the	parasite	is	unable	to	synthesize	as	wel	as	lipids	that,	despite	being	produced	de	novo	by	
the	parasite,	are	not	synthesized	in	large	enough	amounts	to	satisfy	the	parasite’s	needs	
(Charron	and	Sibley,	2002;	Quittnat	et	al,	2004;	Coppens	et	al,	2006;	Sampels	et	al,	2012;	
Romano	et	al,	2013).	This	is	emphasized	by	the	fact	that	the	addition	of	large	amounts	of	lipids	
such	as	ceramides	and	cholesterol	to	the	medium	of	infected	cels	has	been	shown	to	boost	the	
replication	of	Toxoplasma	in	vitro	(Coppens	et	al,	2000;	Romano	et	al,	2013),	presumably	by	
favoring	membrane	biogenesis	for	replication.	In	fact,	Toxoplasma	takes	up	various	fatty	acids	
from	the	medium	for	incorporation	into	lipids	and	proteins	(Tomavo	et	al,	1989;	Charron	and	
Sibley,	2002;	Nishikawa	et	al,	2005;	Romano	et	al,	2013;	Chapter	3).	In	this	study,	we	
investigated	the	efects	of	exposure	of	the	parasite	to	20-times	excess	oleic	acid	(OA),	
exogenously	added	to	the	medium,	on	parasite	growth.	We	hypothesize	that	such	a	large	supply	
of	FA	would	be	beneficial	for	the	parasite		
The	development	of	Toxoplasma	was	first	examined	by	plaque	assays	in	the	presence	of	
0.2	and	0.4	mM	OA	over	5	days	alowing	for	several	cycles	of	invasion,	growth	and	egress	of	the	
parasite	(Fig.	4-3.A).	The	presence	of	OA	in	the	medium	led	to	significantly	smaler	plaques,	
correlating	to	OA	concentration,	as	we	observed	a	50	%	and	65	%	reduction	in	average	plaques	
sizes	folowing	incubation	with	0.2	mM	and	0.4	mM	OA,	respectively	(Fig.	4-3.B).	These	data	
demonstrated	that	there	is	a	global	impairment	of	parasite	development	with	OA	incubation.	To	
assess	if	this	detrimental	efect	of	excess	OA	on	parasite	development	is	specific	for	this	FA,	we	
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performed	the	same	assay	with	0.2	mM	palmitic	acid	(PA)	added	to	the	medium.	There	was	no	
change	in	parasite	development	with	excess	PA,	as	the	average	plaque	size	was	not	significantly	
altered	as	compared	to	treatment	without	excess	FA.	Only	plaque	size,	not	the	number	of	
plaques,	were	altered	with	OA	incubation,	suggesting	that	invasion	is	not	afected	by	this	FA.	
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Figure	4-3.	Toxoplasma	development	with	incubation	of	fatty	acids.	
A.	Plaque	assays	comparing	the	development	of	Toxoplasma	grown	with	oleic	acid	(OA)	or	palmitic	acid	
(PA).	Cel	monolayers	of	HFF	were	infected	with	100	parasites	and	alowed	to	grow	for	5	days	at	the	
indicated	concentrations	of	fatty	acids	(no	FA	supplement;	0.2	and	0.4	mM	OA;	0.2	mM	PA).	
Representative	images	of	each	condition	are	shown.	B.	Histogram	of	the	mean	area	of	plaques	(in	μm
2
)	
from	the	assays	in	(A).	Means	±	SD	of	4	independent	experiments.	Indicated	statistical	diferences	are	
between	control	(no	OA)	and	0.2	mM	OA	and	0.4	mM	OA-treated	HFF.	p*	<0.002,	Student’s	t	test.	
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4.4.2.	Toxoplasma	replication	is	hindered	with	excess	OA	introduced	into	the	
medium	
To	distinguish	at	which	individual	step	OA	afects	the	development	of	the	parasite,	the	efect	of	
OA	on	Toxoplasma	replication	and	egress	in	vitro	were	investigated	separately.	We	evaluated	if	
the	parasite’s	ability	to	replicate	was	influenced	by	the	presence	of	excess	OA	in	the	medium.	
Infected	HFF	were	incubated	with	control	medium	(no	added	FA),	0.1	mM,	0.2	mM	or	0.4	mM	
OA	for	24	h	and	parasite	multiplication	was	measured	by	radioactive	uracil	incorporation	(Fig.	4-
4.A,	panel	a).	Addition	of	OA	resulted	in	a	significant	reduction	of	uracil	incorporation	into	the	
parasites	in	a	concentration-dependent	manner	(0.2	mM	vs	0.4	mM),	as	compared	to	control	
parasites	i.e.	0.4	mM	OA	led	to	35	%	less	uracil	incorporation	as	compared	to	control	(Fig.	4-4.A,	
panel	a).	This	replication	defect	was	specific	to	OA,	since	incubation	with	PA	at	identical	
concentrations	did	not	result	in	significant	variations	of	uracil	incorporation	into	the	parasites	
(Fig.	4-4.A,	panel	b).	The	same	replication	deficiency	was	observed	in	infected	HeLa	cels	
incubated	with	0.2	mM	OA	(29	%	decreased	uracil	incorporation)	indicating	that	this	efect	is	not	
cel	type	specific	(Fig.	4-4.B).	Interestingly,	Toxoplasma	replication	in	ADRP-GFP-expressing	HeLa	
cels	without	any	OA	addition	to	the	medium	was	also	impaired,	suggestive	of	a	role	of	increased	
LD	numbers	on	Toxoplasma	development	(Fig.	4-4.B).	The	addition	of	0.2	mM	OA	to	ADRP-GFP	
HeLa	cels	did	not	lead	to	significant	diference	as	compared	to	without	OA	in	these	cels.	In	
paralel,	we	counted	the	number	of	parasites	per	PV	to	investigate	whether	the	lower	levels	of	
uracil	incorporation	coincided	with	the	presence	of	fewer	parasites	in	the	PV	knowing	that	
Toxoplasma	has	a	doubling	time	of	6-8	h	in	vitro.	We	infected	HFF	with	RFP-expressing	
Toxoplasma	for	24	h	with	concentrations	of	OA	ranging	from	0	to	0.5	mM	in	0.1	mM	increments	
(Fig.	4-4.C).	A	gradual	shift	towards	smaler	PV	sizes	was	detected	as	OA	concentrations	
increased.	At	0.4	mM	and	0.5	mM	OA,	most	of	the	PVs	contained	1,	2	or	4	parasites.		 	
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Figure	4-4.	Influence	of	FA	on	Toxoplasma	replication.	
A-B.	Influence	of	OA	or	PA	addition	on	Toxoplasma	replication.	Uracil	incorporation	by	Toxoplasma	at	24	
h	p.i.	in:	(A)	HFF	incubated	with	0.1	mM,	0.2	mM	or	0.4	mM	OA	(panel	a)	or	PA	(panel	b);	(B)	HeLa	and	
GFP-ADRP	HeLa	cels	±	0.2	mM	OA	and.	Data	are	percentages	±	SD	relative	to	control	(No	OA;	set	as	100%)	
of	experimental	triplicates.	p*	<0.05,	Student’s	t	test.	C.	Toxoplasma	replication	assessed	by	PV	size	at	24	
h	p.i.	grown	with	OA	concentrations	ranging	from	0	to	0.5	mM,	in	0.1	mM	increments.	The	number	of	
parasites	per	PV	in	Toxoplasma-infected	HFF	24	h	p.i.	with	various	OA	concentration	are	displayed	as	
percentages	of	al	PVs.	At	low	or	no	OA,	the	majority	of	PVs	contain	8	or	16	individual	parasites.	At	higher	
[OA],	most	PVs	contain	1,	2	or	4	parasites.	Data	show	means	±	SD	from	at	least	1000	randomly	selected	
vacuoles	from	3	independent	experiments.	
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4.4.3.	Egress	of	Toxoplasma	from	the	host	cel	is	delayed	upon	incubation	with	
excess	OA	
We	next	determined	the	efect	of	excess	OA	on	Toxoplasma	egress.	In	HFF	with	a	MOI	of	2,	
egress	usualy	occurs	around	40-44	h	p.i.	We	performed	microscopy	studies	76	h	p.i.	in	HFF	
incubated	with	0.4	mM	OA	and	noticed	that	the	PV	eventualy	grew	excessively	large	and	the	
parasites	were	stil	retained	in	their	PV	(Fig.	4-5.A,	panel	a-b).	Based	on	data	from	Fig.	4-4.C,	at	
24	h	p.i.,	there	are	mainly	8-16	parasites	per	PV,	indicating	3	or	4	replication	events,	consistent	
with	the	doubling	time	of	6-8	h	in	vitro.	In	0.4	mM	treated	cels,	there	are	mainly	4	parasites	in	
the	PV	(2	replications),	indicating	a	doubling	time	of	10-12	h.	At	76	h	p.i.	in	untreated	cels,	we	
therefore	calculate	that	there	would	be	in	theory	512-1024	parasites	whereas	in	0.4	mM	treated	
cels,	there	would	be	64-256	parasites	per	PV.	This	latter	number	is	consistent	with	our	
observations.	Egress	in	untreated	cel	usualy	occurs	when	the	PV	reaches	64-128	parasites.	
Electron	microscopy	(EM)	of	infected	cels	incubated	with	0.4	mM	OA	showed	parasites	
sequestered	into	the	host	cels,	apparently	unable	to	breach	the	host	plasma	membrane	(PM)	
(Fig.	4-5.B).	Further	evidence	of	an	egress	defect	in	parasites	exposed	to	excess	OA	was	
demonstrated	by	their	delay	in	escaping	host	cels	even	upon	chemical	induction	with	the	
calcium	ionophore,	A23817	(Endo	et	al,	1982)	as	compared	to	control	parasites.	Indeed,	
folowing	the	addition	of	this	ionophore,	egress	occurred	by	30	seconds	in	normal	medium	while	
parasites	exposed	to	0.2	mM	and	0.4	mM	OA,	the	time	to	egress	increased	1.6	fold	and	2.2	fold,	
respectively.		
To	further	investigate	this	delayed	egress	phenotype,	we	conducted	additional	EM	
studies	on	parasites	incubated	with	0.4	mM	OA	for	72	h.	Diferent	stages	in	the	process	of	
egress	could	be	observed	(Fig.	4-6).	The	rosette	structure	characteristic	of	replicating	parasites	
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(Fig.	4-6,	panel	a)	started	to	disassemble,	a	sign	of	parasite	motility	within	the	PV	(Fig	4-6,	panels	
b	and	c).	Despite	host	cel	depletion	of	organeles	and	therefore	nutrients,	many	parasites	were	
observed	stil	encased	in	their	PV	(Fig.	4-6,	panel	e).	The	next	step	involves	the	rupture	of	the	
PVM,	leaving	the	parasites	free	in	the	host	cytosol	(Fig.	4-6,	panel	e).		
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Figure	4-5.	Influence	of	OA	on	Toxoplasma	egress	from	the	host	cel.	
A.	Live	DIC	phase	microscopy	of	HFF	infected	with	Toxoplasma	without	OA	at	30	h	p.i.	(a)	and	with	0.4	
mM	OA	at	76	h	p.i.	(b).	Scale	bars,	10	μm.	B.	EM	of	Toxoplasma-infected	HFF	with	0.4	mM	OA	for	76	h	p.i.	
The	parasites	appear	unable	to	breach	the	HFF	plasma	membrane.	Scale	bars,	7	μm.	C.	Histogram	of	the	
quantification	of	the	capability	of	Toxoplasma	to	egress	folowing	growth	with	OA	in	the	medium.	At	24	h	
p.i.	in	HFF,	egress	was	induced	with	an	ionophore	as	described	in	the	Materials	and	Methods.	Incubation	
with	0.2	or	0.4	mM	OA	during	infection	time	caused	a	delay	in	Toxoplasma	egress	upon	ionophore-
stimulated	egress.	Time-taken	to	egress	was	recorded	in	seconds	and	the	ratio	to	the	control	was	
calculated	and	plotted	as	means	±	SD	of	three	independent	experiments.	Indicated	statistical	diferences	
are	between	control	(no	OA)	and	0.2	mM	OA	and	0.4	mM	OA-treated	HFF.	p*	<0.05,	Student’s	t	test.	
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Figure	4-6.	Retention	of	Toxoplasma	within	their	host	cels	with	excess	OA.		
EM	of	parasites	in	HFF	incubated	with	0.4	mM	OA	for	72	h.	Panels	a	through	e	show	diferent	stages	of	
egress:	panel	a	shows	a	normal	rosette	which	begins	to	lose	structure	(b,	c),	followed	by	depletion	of	host	
cel	organeles	(c,	d,	e),	a	dwindling	of	the	PVM	(d)	and	eventual	loss	of	the	PVM	(e).	Scale	bar,	7	μm.	
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4.4.4.	The	slow	growth	of	Toxoplasma	in	the	presence	of	excess	OA	is	not	due	
to	parasite	diferentiation	into	the	latent	cyst	form		
We	next	investigated	whether	OA	may	act	as	a	stressor	on	the	parasite,	causing	the	
diferentiation	of	Toxoplasma	to	the	latent,	cyst	form.	The	conversion	of	the	Toxoplasma	
tachyzoite	(highly	proliferative)	to	bradyzoite	(slow	growing	cyst)	form	can	spontaneously	occur	
in	vitro	in	some	cel	types	(Ferreira-da-Silva	et	al,	2009),	but	can	also	be	induced	in	response	to	
stressors	such	as	changes	in	temperature,	alkaline	pH,	amino	acid	deprivation	and	lower	CO2	
levels	(Dzierszinski	et	al,	2004;	Skariah	et	al,	2010).	The	bradyzoite	phenotype	is	characterized	
by	slower	growth	and	the	incorporation	of	carbohydrates	into	the	PVM,	which	develops	into	a	
thick	cyst	wal	(Boothroyd	et	al,	1997).	As	excess	OA	in	the	medium	leads	to	a	decrease	in	
parasite	replication	(Fig.	4-4),	we	investigated	whether	OA	could	be	a	trigger	of	parasite	stress,	
resulting	in	tachyzoite	to	bradyzoite	conversion.	We	evaluated	the	ability	of	OA	to	induce	stage	
diferentiation	by	incubating	infected	HFF	with	0.2	mM	OA	for	24	h	and	monitoring,	using	TRITC	
labeled	lectin,	the	formation	of	the	cyst	wal	(Fig.	4-7).	No	fluorescent	staining	was	observed	on	
the	PVM	of	parasites	grown	with	OA	(Fig.	4-7,	panel	c,	blue	arrow).	As	a	positive	control,	we	
incubated	infected	cels	in	the	absence	of	CO2,	and	a	TRITC	lectin	signal	was	clearly	apparent	on	
the	PVM	(Fig.	4-7,	panel	b,	yelow	arrow).	The	Prugniaud	strain	is	cystogenic	and	therefore	more	
sensitive	to	external	stressors	(Skariah	et	al,	2010;	Asgari	et	al,	2013).	When	cels	were	infected	
with	Prugniaud	parasites	with	excess	OA	and	stained	with	TRITC	lectin,	no	fluorescence	was	
detected	on	the	PVM,	in	contrast	to	CO2-deprived	conditions	in	which	Prugniaud	parasites	
exhibited	a	very	strong	fluorescent	signal	as	a	sign	of	cyst	wal	formation	and	bradyzoite	
conversion.	These	results	indicate	that	parasite	growth	impairment	folowing	incubation	with	
excess	OA	in	the	medium	is	not	attributable	to	a	shift	in	the	developmental	program	of	the	
parasite	from	tachyzoite	to	bradyzoite	forms.	 	
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Figure	4-7.	No	detection	of	parasite	stage	diferentiation	induced	by	OA.	
Fluorescence	microscopy	of	HFF	infected	with	Toxoplasma	RH	(type	1	strain)	or	Prugniaud	(type	2	strain)	
with	0.2	mM	OA.	HFF	were	infected	with	Toxoplasma	RH	or	Prugniaud	for	24	h	with	α-MEM	medium	(a),	
without	CO2	(b)	or	with	0.2	mM	OA	in	the	medium	(c).	Coverslips	were	fixed	and	stained	with	4-,6-
diamidino-2-phenylindole	(DAPI;	nucleus,	blue),	TRITC-lectin	(red)	and	antibody	for	GRA7	(parasite	PVM	
and	PV	lumen,	green).	Upon	stage	conversion	of	tachyzoite	to	bradyzoite,	TRITC-lectin	stains	the	cyst	wal	
(yelow	arrows	in	panel	b)	instead	of	the	parasite’s	Golgi	apparatus	(blue	arrows	in	panels	a	and	c).	Scale	
bars,	10	μm.	
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4.4.5.	Upon	excess	OA	incubation,	Toxoplasma	accumulates	large	deposits	of	
lipids	in	the	PV	and	organeles	
To	gain	further	insight	into	the	impairment	of	parasite	development	with	OA	incubation,	we	
examined	the	parasites	at	the	EM	level.	Upon	treatment	with	0.2	mM	OA,	we	observed	the	
presence	of	large	osmiophilic	(electron-dense)	materials	in	the	PV	lumen,	squeezed	between	
individual	parasites	and	along	the	PVM,	seemingly	in	random	locations	(Fig.	4-8.A,	panels	a	and	
b).	At	high	magnification	we	could	resolve	multilamelar	stuctures	with	a	striking	compaction	
and	circular	organization,	as	seen	in	the	cross-section,	reminiscent	of	the	close-packing	of	lipid	
membrane	sheaths	(Fig.	4-8.A,	panels	c	to	d).	This	suggests	there	is	an	overaccumulation	of	lipid	
materials	within	the	PV,	which	is	likely	a	result	of	the	massive	uptake	of	OA	by	the	parasite.	Lipid	
deposits	were	also	observed	within	the	parasite,	associated	and	within	several	structures	
including	membrane-bound	organeles	such	as	the	mitochondrion,	the	apicoplast	and	the	
vesicles	of	the	Golgi	apparatus	(Fig.	4-8.B,	panels	a	and	b).	
Previously,	we	showed	that	parasites	incubated	with	0.4	mM	OA	stimulated	LD	
biogenesis	to	store	the	excess	NL	(Fig.	3-7	through	3-9	in	Chapter	3).	Although	LD	represent	a	
safe	mechanism	to	avoid	cel	lipotoxicity,	their	high	number	and	large	size	could	also	
compromise	celular	functions	and	the	formation	of	Toxoplasma	progeny.	Indeed,	our	EM	
observations	reveal	many	parasites	with	severe	cytopathies,	including	defects	in	organele	
formation	and	endodyogeny,	when	exposed	to	0.4	mM	OA	for	24	h	(Fig.	4-9).	Endodyogeny	is	a	
form	of	replication	where	two	daughters	are	formed	within	the	confines	of	the	mother.	When	
the	daughters	emerge,	a	smal	residual	body	is	left	in	the	PV,	containing	the	remnants	of	the	
mother	(Anderson-White	et	al,	2012).	Dividing	parasites	were	observed	exporting	lipid-
overloaded	organeles	and	excess	LD	to	the	residual	body	of	the	mother	cel	for	evacuation	(Fig.	
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4-9.A,	and	B).	Under	normal	conditions,	the	residual	body	is	detached	from	the	two	newly	
formed	parasites	and	reabsorbed	within	the	PV.	However,	under	0.4	mM	OA	conditions	we	
observed,	by	EM,	some	enormous	residual	bodies	occupying	a	very	large	space	in	the	PV,	more	
than	likely	interfering	with	the	normal	process	of	Toxoplasma	division.	Additionaly,	in	many	
instances	smal	PVs	containing	only	a	single	parasite	were	observed,	supporting	our	previous	
observations	of	replication	defects	(Fig.	4-4).	These	parasites	occupying	smal	PVs	showed	signs	
of	lipotoxicity	due	to	the	presence	of	uncharacterized	cytoplasmic	structures,	such	as	lipid	
deposits	and	membrane	whorls.	Altogether	these	studies	highlight	that	parasites	are	capable	of	
relentlessly	salvaging	exogenous	OA.	This	FA	accumulates	in	the	PV	and	is	internalized	into	the	
parasite	and	its	organeles,	leading	to	membrane	defects	and	lipid	overload.	The	consequence	of	
this	is	likely	celular	dysfunction	and	death.	
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Figure	4-8.	Lipid	accumulation	in	Toxoplasma	PV	and	organeles	upon	OA	incubation.	
A-B.	EM	of	HFF	infected	with	Toxoplasma	for	24	h	with	0.2	mM	OA.	Large	deposits	of	osmiophilic	material	
(A,	panels	a,	b)	and	the	accumulation	of	multilamelar	structures	(A,	panels	c-f)	were	observed	in	the	PV	
lumen.	Within	individual	parasites,	lipid	deposits	were	observed	in	mitochondria	(mt),	Golgi	(go)	and	
apicoplast	(ap)	(B,	panels	a,	b).	
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Figure	4-9.	Cytopathies	of	Toxoplasma	incubated	with	0.4	mM	OA	
A-B.	EM	of	intravacuolar	parasites	exposed	to	0.4	mM	OA	for	24h.	Panels	a	and	b	in	A	each	show	a	large	
residual	body	(RB)	containing	lipid	material	and	stil	attached	to	the	daughter	cels	(Dc).	Panels	a	to	c	in	B	
ilustrate	dying	parasites	by	lipotoxicity	with	accumulated	lipid	deposits	(arrows).	Scale	bars,	1	μm.	
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4.4.6.	Perivacuolar	LD	accumulation	does	not	hinder	host	organele	association	
to	the	PV	of	Toxoplasma	
Our	data	showed	that	excess	OA	leads	to	the	dramatic	accumulation	of	host	LD	around	the	PV,	
which	may	result	in	impaired	association	to	the	PV	of	host	celular	organeles,	such	as	the	ER,	
Golgi	apparatus	and	mitochondria.	The	interaction	between	these	host	organeles	and	the	PV	is	
most	likely	important	for	Toxoplasma	growth	as	this	proximity	may	facilitate	the	delivery	of	
their	nutrient	content	to	the	parasite	(Sinai	et	al,	1997;	Quittnat	et	al,	2004;	Coppens	et	al,	2006;	
Walker	et	al,	2008;	Romano	et	al,	2008;	Wang	et	al,	2010;	Romano	et	al,	2013;	Pernas	et	al,	
2014).	Perturbation	of	host	organele-PV	recruitment	may	therefore	be	detrimental	for	parasite	
viability.		
To	determine	whether	excessive	host	LD	numbers	disturb	the	association	of	the	host	ER	
to	the	PV,	we	analyzed	in	infected	cels	treated	with	0.2	mM	OA	the	distribution	of	the	host	ER	
to	the	PV	by	fluorescence	microscopy	using	anti-KDEL	antibodies	and	by	electron	microscopy	
(Fig.	4-10.A	and	4-8.B).	Uninfected	and	infected	HFF	displayed	an	altered	ER	network,	likely	due	
to	the	numerous	LD	throughout	the	cytoplasm	(Fig.	4-10.A).	However,	despite	LD	gathering	
around	the	PV,	we	observed	ER	association	with	al	the	PV	to	the	same	extent	as	found	for	PV	in	
normal	medium	with	70%	of	the	PVM	covered	by	the	ER.	EM	observations	ilustrate	a	close	
physical	apposition	of	host	ER	elements	with	the	PVM,	with	ER-bound	ribosomes	facing	the	host	
cytoplasm	(Fig.	4-10.B)	as	previously	reported	(Sinai	et	al,	1997).	Upon	incubation	with	excess	
OA,	the	host	LD	were	located	behind	the	layer	of	host	ER	attached	to	the	PVM,	indicating	that	
the	parasite	could	recruit	and	form	intimate	associations	with	the	host	ER	independent	of	the	
presence	of	abundant	LD	in	the	host	cel.		 	
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Figure	4-10.	ER	recruitment	to	Toxoplasma	PV	upon	OA	incubation.	
A.	Fluorescence	microscopy	of	ER	in	HFF	infected	with	Toxoplasma	for	24	h	±	0.2	mM	OA.	HFF	were	
infected	with	Toxoplasma	for	24	h	without	OA	(a)	or	with	0.2	mM	OA	(b),	fixed	and	stained	with	4-,6-
diamidino-2-phenylindole	(DAPI;	nucleus,	blue),	and	antibodies	for	KDEL	(host	ER,	green)	and	GRA7	(PVM	
and	PV	lumen,	red).	Association	of	host	ER	with	Toxoplasma	PV	stil	occurs	in	the	presence	of	OA.	Scale	
bars,	7	μm.	B.	Ultrastructural	analysis	by	EM	of	host	ER	association	with	Toxoplasma	PV	with	0.2	mM	OA	
in	HFF.	The	host	cel’s	ER	(hER)	associates	with	the	PV	of	Toxoplasma	24	h	p.i.	when	incubated	in	medium	
with	0.2	mM.	Host	LD	(hLD)	are	observed	in	close	proximity	to	the	hER	and	PV.	Scale	bars,	1	μm.	
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	 We	next	investigated	whether	the	clustering	of	host	Golgi	ministacks	stil	occur	around	
the	PV	of	Toxoplasma	with	excess	OA.	Infection	of	fibroblasts	with	Toxoplasma	induces	dramatic	
alterations	in	the	morphology	and	distribution	of	the	host	Golgi	apparatus.	Early	during	
infection,	the	host	Golgi	surrounds	the	PV	of	Toxoplasma,	which	then	fragments	into	functional	
ministacks,	that	al	gather	around	the	PV	(Romano	et	al,	2013).	
To	assess	the	influence	of	LD	accumulation	on	Golgi	recruitment	to	the	Toxoplasma	PV,	
we	inspected	the	morphology	of	the	Golgi	by	IFA	using	anti-giantin	antibodies	in	infected	HFF	in	
the	presence	of	0.2	mM	OA.	(Fig.	4-11.A,	panels	a-b).	In	both	smal	and	large	PVs,	the	host	Golgi	
was	recruited.	We	used	MetaScopics	to	quantify	the	association	of	the	host	Golgi	to	the	
Toxoplasma	PV	at	diferent	developmental	timepoints	based	on	PV	size.	In	the	presence	of	0.2	
mM	OA,	the	centroid-to-surface	distance	of	the	host	Golgi	to	smal	PVs	(1,	2	and	4	parasites	in	
the	vacuole)	was	significantly	longer	than	observed	in	conditions	without	added	OA	(Fig.	4-11.B),	
suggesting	a	slightly	delayed	accumulation	of	host	Golgi	ministacks	around	the	PV.	This	does	not	
imply	that	there	is	no	Golgi	clustering	around	the	PV,	as	the	Golgi	is	observed	in	close	proximity	
to	the	PV	regardless	of	OA	presence.	Later	during	infection,	the	recruitment	of	the	Golgi	to	the	
PV	with	OA	incubation	matched	that	of	control	medium.	Despite	a	significant	delay	in	the	
surrounding	of	the	PV	byvhost	Golgi	elements	early	during	infection	with	OA	treatment,	
eventualy	clustering	did	occur,	suggesting	that	perivacuolar	LD	did	not	afect	the	accumulation	
of	Golgi	ministacks	to	the	PV.		 	
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Figure	4-11.	Golgi	accumulation	around	the	Toxoplasma	PV	upon	OA	incubation.	
A.	Fluorescence	microscopy	of	the	Golgi	apparatus	in	HFF	infected	with	Toxoplasma	for	24	h	±	0.2	mM	
OA.	HFF	were	infected	with	Toxoplasma	for	24	h	without	OA	(a)	or	with	0.2	mM	OA	(b),	fixed	and	stained	
with	4-,6-diamidino-2-phenylindole	(DAPI;	nucleus,	blue),	and	antibodies	for	Giantin	(Golgi,	green)	and	
GRA7	(PVM	and	PV	lumen,	red).	The	host	cel’s	Golgi	clusters	around	the	PV	of	Toxoplasma	in	both	
conditions	and	becomes	segmented	around	larger	PVs.	Scale	bars,	7	μm.	B.	Quantification	of	Golgi	
apparatus	recruitment	by	Toxoplasma	using	MetaScopics	with	0.2	mM	OA.	Boxplot	shows	the	average	
distance	from	the	host	Golgi	complex	centroid	to	the	nearest	PV	boundary.	In	smaler	PVs	(1,	2	or	4	
parasites	per	PV),	the	centroid	distance	to	the	PV	is	significantly	larger	when	grown	with	0.2	mM	OA	but	
by	8	parasites	per	PV,	there	is	no	diference	between	OA-treated	and	control	samples	(n	>30	per	
condition).	p*	<0.001;	p**	<0.03;	.	p***	<0.02,	Student’s	t	test.	
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Shortly	after	penetrating	the	cel,	Toxoplasma	induces	a	dramatic	change	in	the	spatial	
distribution	of	host	mitochondria.	We	wanted	to	determine	whether	large	numbers	of	host	LD	
hinder	the	association	of	mitochondria	to	the	PV.	In	infected	cels	incubated	with	0.2	mM	OA	
,we	probed	the	distribution	of	host	mitochondria	and	their	association	with	the	PVM	by	IFA	
using	antibodies	against	TOM20.	A	concentric	fluorescent	signal	was	detected	around	the	PV	
similar	to	that	observed	in	control	conditions	(Fig.	4-12.A).	We	used	MetaScopics	to	determine	
the	intensity-weighted	distances	of	host	mitochondria	to	the	PV	of	Toxoplasma	in	both	
conditions.	There	was	no	significant	diference	in	the	recruitment	of	this	organele	to	the	PV	
regardless	of	OA	presence,	as	calculated	within	an	arbitrary	delineated	area	of	7	μm	radiating	
from	the	PV	(Fig.	4-12.B).		
We	performed	ultrastructural	analysis	to	verify	the	association	of	host	mitochondria	
around	the	PV	in	infected	cels	treated	with	0.2	mM	OA.	We	confirmed	that	host	mitochondria	
were	closely	apposed	to	the	PVM.	However,	the	morphology	of	these	organeles	was	profoundly	
altered,	as	they	appeared	enlarged.	These	swolen	mitochondria	were	characterized	by	an	
increase	in	area,	a	rounded	shape,	a	loss	of	matrix	density,	and	a	distortion	of	cristae	(Fig.	4-
13.A).	The	mitochondria	in	infected	cels	not	associated	with	the	PV,	however,	showed	no	
morphological	abnormalities	suggesting	a	relationship	mediated	by	the	parasite	between	host	
mitochondria	and	excess	OA.		
	 Jointly	these	data	ilustrate	that,	despite	significant	LD	accumulation	around	the	PV,	
host	organeles	are	stil	recruited	to	the	PV	as	previously	reported.	In	the	case	of	ER	and	
mitochondria,	these	two	organeles	stil	form	intimate	association	with	the	PVM.	Nevertheless,	
the	abnormaly	enlarged	mitochondria	attached	to	the	PV	strongly	suggests	mitochondrial	
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dysfunction,	and	such	a	degeneration	may	also	account	for	a	reduction	in	parasite	growth	with	
excess	OA.	
	 To	ensure	that	the	abnormal	morphology	of	the	mitochondria	around	the	PV	is	specific	
to	OA	incubation	and	subsequent	LD	accumulation,	we	treated	cels	with	0.2	mM	PA.	Addition	
of	0.2mM	PA	to	infected	cels	does	not	afect	Toxoplasma	growth	(Fig.	4-4)	nor	lead	to	excessive	
LD	accumulation.	However,	it	is	known	that	PA	can	alter	mitochondrial	function;	at	0.1	mM,	PA	
induces	mitochondrial	ROS	generation,	mitochondrial	membrane	potential	loss	and	DNA	
damage	(Rachek	et	al,	2007;	Yuzefovych	et	al,	2010;	Cheon	and	Cho,	2014).	PA	can	also	modify	
the	shape	and	distribution	of	the	mitochondrial	network	in	uninfected	cels	as	shown	by	IFA	
using	anti-TOM	antibodies	(Fig.	4-14.A).	We	next	investigated	whether	host	mitochondria	could	
be	recruited	by	Toxoplasma	in	the	presence	of	0.2	mM	PA.	In	infected	HFF	grown	with	0.2	mM	
PA	and	stained	with	TOM20,	a	concentric	fluorescent	signal	was	detected	around	both	smal	and	
large	PV	(Fig.	4-14.B),	comparable	to	that	of	PV	incubated	with	0.2	mM	OA.	This	suggests	that	
the	parasite	is	stil	able	to	recruit	host	mitochondria	despite	their	altered	morphology.	Excess	PA	
leads	to	universal	morphological	changes	to	the	host	mitochondrial	network	while	excess	OA	
leads	to	morphological	changes	to	the	host	mitochondria	associated	with	the	PV.	 	
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Figure	4-12.	Mitochondria	morphology	around	Toxoplasma	PV	with	OA	incubation.	
A.	Fluorescence	microscopy	of	mitochondria	in	HFF	infected	with	Toxoplasma	for	24	h	±	0.2	mM	OA.	HFF	
were	infected	with	Toxoplasma	for	24	h	without	OA	or	with	0.2	mM	OA,	fixed	and	stained	with	4-,6-
diamidino-2-phenylindole	(DAPI;	nucleus,	blue),	and	antibodies	for	Tom20	(mitochondria,	green)	and	
GRA7	(PVM	and	PV	lumen,	red).	The	morphology	of	the	mitochondria	is	altered	when	treated	with	OA,	
especialy	those	directly	associated	with	the	PV	as	they	appear	more	swolen.	Scale	bars,	7	μm.	B.	
Quantification	of	host	mitochondria	association	to	Toxoplasma	PV	by	MetaScopics	analysis.	Boxplots	
show	the	average	distances,	weighted	by	intensity,	of	the	host	mitochondria	to	the	PV	boundary,	as	
calculated	for	host	mitochondrial	profiles	within	a	7	μm	radius	of	the	PV	(data	from	>40	infected	HFF	per	
condition	at	24	h	p.i.).	A	comparison	between	the	treatments	is	not	statisticaly	significant.	
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Figure	4-13.	Ultrastructure	of	PV-associated	mitochondria	incubated	with	0.2mM	OA.	
A-B.	Electron	micrographs	of	Toxoplasma-infected	HFF	for	24	h	with	0.2	mM,	focusing	on	the	host	
mitochondria	associated	to	the	PV.	Mitochondria	in	the	host	cel	associated	with	the	PV	membrane	
exhibited	distorted	cristae	(A,	panel	b),	were	misshapen	and	enlarged	(A-B,	al	panels),	and	lost	matrix	
density	(B).	Host	cel	mitochondria	unassociated	to	the	PV	appear	healthy	(double	blue	arrow	in	A).	
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Figure	4-14.	Mitochondria	morphology	around	Toxoplasma	PV	with	PA	incubation.	
Fluorescence	microscopy	of	mitochondria	in	uninfected	(A)	and	infected	HFF	(B),	both	incubated	with	0.2	
mM	PA.	HFF	were	infected	with	Toxoplasma	for	24	h	with	0.2	mM	PA.	Coverslips	were	fixed	antibodies	for	
Tom20	(host	mitochondria,	red)	(A-B)	and	stained	with	BODIPY	493/503	(lipid	droplets,	green)	(B).	
Incubation	with	PA	leads	to	abnormal	mitochondrial	morphology	in	the	host	cel	(A,	uninfected;	B,	
infected	with	smal	and	large	PVs).	There	is	association	of	mitochondria	to	the	PV	in	the	presence	of	PA.	
Scale	bars,	7	μm.	
	206	
4.4.7.	Increased	autophagy	in	cels	incubated	with	excess	OA	is	not	involved	in	
reducing	Toxoplasma	development		
Upon	incubation	with	excess	OA	(up	to	1	mM),	lipophagy	is	stimulated.	This	is	an	important	
process	for	regulating	lipid	metabolism	and	homeostasis	by	preventing	the	aggregation	of	toxic	
FA	and	LD	in	the	cytoplasm	(Singh	et	al,	2009).	In	cels	such	as	hepatocytes,	excess	OA	triggers	
autophagy	and	these	lipids	are	mobilized	to	generate	phagosomal	membranes	and	
autophagosomes.	We	therefore	wanted	to	investigate	the	role	of	lipophagy	in	hampering	
parasite	growth	as	parasites	in	cels	incubated	in	the	presence	of	0.2	mM	OA	may	be	exposed	to	
a	harmful	environment	characterized	by	elevated	autophagic	activities.	Degradation	of	the	PV	
via	autophagy	has	not	been	reported	for	Toxoplasma	Type	I	strains,	such	as	RH,	however	Type	I	
and	II	strains	are	susceptible	to	immune-mediated	autophagy	induction.	In	such	strains,	this	
celular	process	involves	the	ubiquitination	of	the	PVM,	LC3	deposition	around	the	PV,	as	wel	as	
the	formation	of	multiple	membranes	enclosing	the	PV	(Seleck	et	al,	2015).	
We	first	wanted	to	confirm	that	OA	could	induce	autophagy	in	fibroblasts.	HFF	
expressing	a	GFP-LC3	construct	were	incubated	with	0.2	mM	or	0.4	mM	OA	to	monitor,	by	
microscopy,	the	formation	of	LC3-containing	autophagic	structures.	Similarly	to	amino	acid	
depletion	(Wang	et	al,	2009),	our	data	show	that	excess	OA	induced	large	GFP-LC3	puncta	in	the	
cytosol,	in	contrast	to	control	medium	showing	difuse	LC3	staining	(Fig.	4-15.A).	These	assays	
were	repeated	in	infected	cels	transfected	with	GFP-LC3.	We	detected	the	accumulation	of	LC3-
GFP	puncta,	likely	corresponding	to	autophagic	profiles,	(Fig.	4-15.B)	surrounding	the	PV.	This	
gathering	of	autophagosomal	structures	around	the	PV	was	confirmed	by	EM	(Fig.	4-15.C).	
However,	fusion	events	of	LC3-positive	structures	with	the	PV	were	never	observed,	making	the	
destruction	of	the	PV	by	autophagy	unlikely,	even	in	host	cels	with	many	autophagosomes.	 	
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Figure	4-15.	Distribution	of	GFP-LC3	structures	around	Toxoplasma	PV.	
A-B.	Fluorescence	microscopy	of	uninfected	(A)	or	Toxoplasma-infected	(B)	HFF	expressing	GFP-LC3	
grown	without	OA	(a),	without	serum	(starvation	condition)	(b),	0.2	mM	OA	(c)	or	0.4	mM	OA	(d).	GFP-
LC3-transfected	HFF	were	infected	with	Toxoplasma	and	incubated	for	24	h	without	serum	in	the	medium	
or	with	0.2	mM	or	0.4	mM	OA.	Uninfected	fixed	cels	were	stained	with	4-,6-diamidino-2-phenylindole	
only	(DAPI;	nucleus,	blue)	(A)	whereas	infected	cels	were	stained	with	DAPI	(nucleus,	blue)	and	
antibodies	against	GRA7	(PVM	and	PV	lumen,	red).	The	distribution	of	GFP-LC3-positive	vesicles	(green)	is	
shown	in	these	extended-focus	images	in	both	uninfected	and	infected	cels.	Scale	bars,	7	μm.	C.	
Ultrastructural	analysis	of	a	host	autophagosome	with	hLD	in	the	process	of	digestion,	in	close	proximity	
to	Toxoplasma	PV.	HFF	were	infected	with	Toxoplasma	for	24	h	with	0.2	mM	OA	to	observe	the	
occurrence	of	autophagy.	Scale	bars,	0.5	μm.	
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4.5.	DISCUSSION	
The	intracelular	lifestyle	of	Toxoplasma	gondi	requires	lipids	either	synthesized	de	novo	by	the	
parasite	or	scavenged	from	the	host	cel.	The	exogenously	acquired	lipids	include	those	that	the	
parasites	cannot	synthesize	(e.g.,	cholesterol)	or	lipids	produced	by	the	parasite	but	in	
insuficient	amounts	to	accommodate	the	parasite’s	needs	for	fast	replication	(e.g.,	ceramides,	
phospholipids)	(Charron	and	Sibley,	2002;	Quittnat	et	al,	2004;	Gupta	et	al,	2005;	Coppens	et	al,	
2006;	Romano	et	al,	2013;	Hartmann	et	al,	2014).	The	concentration	in	the	medium	of	lipids	that	
Toxoplasma	needs	to	salvage	directly	influences	its	growth	rate.	For	example,	the	replication	of	
Toxoplasma	is	boosted	by	high	amounts	of	exogenous	cholesterol	or	ceramides	whereas	
removal	of	celular	cholesterol	sources	leads	to	a	severe	decline	in	parasite	replication	(Coppens	
et	al,	2000;	Nishikawa	et	al,	2005;	Ihara	and	Nishikawa,	2014).	In	this	study,	we	examined	the	
impact	of	the	fatty	acids	oleic	acid	(OA)	and	palmitic	acid	(PA),	added	in	excess	to	the	medium,	
on	Toxoplasma	development.	We	showed	that	the	development	of	the	parasite	is	impaired	in	
the	presence	of	excess	OA	while	PA	has	no	efect.	Our	investigations	into	the	cause	of	the	
parasite’s	developmental	defect	observed	with	excess	OA	reveal	impairment	in	both	the	
parasite’s	ability	to	replicate	and	to	egress.	These	failures	seem	likely	to	be	due	to	lipotoxicity	
from	excess	OA	as	we	observed	abnormaly	large	lipid	deposits	inside	the	PV	as	wel	as	inside	
the	parasite,	which	in	turn	could	afect	the	proper	functioning	of	the	parasite	at	many	levels.	
Additionaly,	we	noticed	major	morphological	abnormalities	in	the	host	mitochondria	associated	
with	the	PV,	which	may	also	interfere	with	proper	parasite	development.	 	
Unlike	excess	cholesterol	or	ceramides	that	are	beneficial	for	the	replication	of	
Toxoplasma,	excess	OA,	unexpectedly,	is	detrimental	for	its	growth.	This	defect	is	specific	to	OA	
since	incubation	at	the	same	concentrations	of	PA	did	not	impair	the	development	of	
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Toxoplasma.	The	replication	defect	with	excess	OA	was	also	surprising	in	light	of	studies	on	
Chlamydia	trachomatis	for	which	0.1	mM	OA	addition	to	the	medium	positively	afected	the	
growth	of	the	bacterium	whereas	deletion	of	host	LD	enzymatic	machinery	(i.e.	DGAT)	led	to	a	
dramatic	growth	reduction	(Hatch	and	McClarty,	1998;	Cocchiaro	et	al,	2008).	The	efect	of	
excess	OA	or	PA	(0.03	to	0.4	mM)	on	the	Apicomplexan	parasite	Plasmodium	falciparum	is	also	
favorable	as	a	3	to	5	fold	increase	in	growth	rate	was	observed	in	parasite	infected	hepatocytes	
and	erythrocytes	(Lombard	et	al,	1998;	Mi-Ichi	et	al,	2007).	As	a	matter	of	fact,	OA	is	absolutely	
essential	for	the	proper	development	of	P.	falciparum	in	erythrocytes	(Vielemeyer	et	al,	2004;	
Mi-Ichi	et	al,	2007).	
The	egress	defect	observed	for	Toxoplasma	exposed	to	excess	OA	may	be	due	to	
diferent	factors:	1)	impaired	calcium	signaling,	2)	changes	in	lipid	membrane	composition,	
and/or	3)	parasite	weakness	due	to	toxicity.	In	OA-overloaded	cels,	parasites	take	more	time	to	
escape	naturaly	from	their	host	cels	and	are	retained	in	the	host	cytosol	for	up	to	3	days.	
Toxoplasma	egress	is	a	calcium-dependent	event	as	incubation	with	calcium	ionophores	triggers	
the	rapid	exit	of	parasites	from	the	PV	and	its	host	cel	(Endo	et	al,	1982).	Cytoplasmic	levels	of	
calcium	in	mammalian	cels	are	afected	by	OA.	OA,	bound	to	albumin,	causes	a	celular	influx	of	
calcium	leading	to	cytoplasmic	calcium	accumulation	in	many	cel	types	(Zaloga	et	al,	1987;	
Katsura	et	al,	2005;	Katsuta	et	al,	2009;	Carrilo	et	al,	2016).	The	efect	of	OA	on	calcium	stores	
in	Toxoplasma	is	unknown	but	OA	may	also	afect	calcium	signaling	within	the	parasite,	thus	
impairing	egress.	The	egress	defect	may	also	be	due	to	changes	in	the	lipid	composition	of	the	
PVM	and/or	host	PM.	It	is	not	yet	known	whether	the	composition	of	lipids,	FA	or	FA-derived	
lipids,	in	the	PVM	or	host	PM	afects	Toxoplasma	egress,	but	excess	OA	leads	to	increased	
membrane	fluidity	folowing	incorporation	within	the	bilayer	(Lopez	et	al,	2014).	Finaly,	the	
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egress	defect	may	be	a	symptom	of	a	general	malfunction	related	to	the	inability	of	parasites	to	
regulate	OA	influx,	leading	to	massive	lipid	accumulation	in	the	PV	and	parasite.	
Risk	of	toxicity	from	elevated	FFA	levels	occurs	in	mammalian	cels,	with	repercussions	
at	the	organismal	level,	of	hypertension,	diabetes,	insulin	resistance	and	heart	failure	(Wende	
and	Abel,	2010;	Yang	and	Li,	2012;	Tuder	et	al,	2014;	Karpe	et	al,	2011).	Adipocytes	and	adipose	
tissue	are	wel	equipped	to	manage	excess	FFA	but	the	accumulation	of	elevated	levels	of	FFA	in	
al	other	cel	types	with	a	limited	capacity	to	store	surplus	lipids	tends	to	cause	severe	
lipotoxicity,	a	phenomenon	leading	to	celular	dysfunction	and	cel	death	by	apoptosis	
(Listenberger	et	al,	2003).	The	celular	consequences	of	lipotoxicity	vary	depending	on	cel	type	
but	generaly	include	the	generation	of	ceramide,	ROS	and	NO	(Shimabukuro	et	al,	1997).	
Caspase	activation,	along	with	altered	mitochondrial	structure	and	dysfunction	is	also	a	wel-
documented	consequence	of	excessive	FFA	levels	in	the	cel	(Ostrander	et	al,	2001;	Listenberger	
et	al,	2003;	Ricchi	et	al,	2009).	The	saturation	of	the	FA	correlates	with	the	degree	of	lipotoxicity,	
as	saturated	FA	such	as	palmitic	acid	(PA)	tend	to	more	readily	lead	to	lipotoxicity	than	
unsaturated	FA	such	as	oleic	acid	(OA)	(Ricchi	et	al,	2009),	presumably	because	unsaturated	FA	
like	OA	are	incorporated	to	TAG	more	eficiently	than	saturated	FA,	and	subsequently	
sequestered	in	LD,	thus	preventing	the	onset	of	lipotoxicity	(Listenberger	et	al,	2003;	Jackson	et	
al,	2009;	Mei	et	al,	2011;	Nowak	et	al,	2011;	Ibarguren	et	al,	2014;	Garcia-Ruiz	et	al,	2015).	
Lipotoxicity	from	saturated	FA	(PA)	can	be	partialy	rescued	by	supplementation	with	
unsaturated	FA	(OA).	The	mechanism	is	yet	unknown	but	is	thought	to	involve	better	channeling	
of	PA	towards	TAG	storage	in	the	presence	of	OA	(Listenberger	et	al,	2003).	In	our	hands,	HFF	
could	tolerate	OA	up	to	a	concentration	of	0.7	mM	as	0.8	mM	led	to	cel	death,	potentialy	by	
apoptosis.	Many	studies	on	the	efects	of	OA	in	mammalian	cels	are	performed	between	0.5	
mM	and	1.2	mM	OA	without	any	apparent	cytotoxicity	(Dwight	et	al,	1992;	Mei	et	al,	2011;	
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Thörn	and	Bergsten,	2010).	OA	is	a	poor	inducer	of	lipotoxicity	in	mammalian	cels	due	to	its	
ability	to	be	rapidly	and	eficiently	converted	to	TAG	and	stored	in	LD	(Mei	et	al,	2011),	
however,	Toxoplasma	seems	extremely	vulnerable	to	high	amounts	of	OA	present	in	its	
environment,	with	a	much	lower	threshold	for	OA	concentration.	Colossal	osmiophilic	deposits,	
unrelated	to	LD,	are	visible	by	electron	microscopy	in	the	PV	and	within	individual	parasites	
when	incubated	with	0.2	mM	OA.	Increasing	OA	concentrations	up	to	0.4	mM	led	to	intensified	
osmiophilic	deposits,	despite	the	parasite’s	ability	to	upregulate	enzymes	for	NL	synthesis	and	
storage	in	LD	in	response	to	excess	OA	(Chapter	3).	
One	consequence	of	incubating	mammalian	cels	with	OA	is	the	biogenesis	of	many	
cytoplasmic	LD	(Listenberger	et	al,	2003;	Fujimoto	et	al,	2006;	Thörn	and	Bergsten,	2010;	Mei	et	
al,	2011;	Ahn	et	al,	2013).	The	presence	of	numerous	host	LD	accumulated	in	the	host	cytosol	
upon	OA	treatment	may	negatively	afect	Toxoplasma‘s	growth	by	posing	a	physical	hindrance	
on	the	parasite’s	ability	to	recruit	host	organeles	(Coppens	et	al,	2006;	Sinai	et	al,	1997;	Walker	
et	al,	2008;	Romano	et	al,	2008;	Wang	et	al,	2010;	Romano	et	al,	2013b;	Pernas	et	al,	2014);	the	
intimate	association	between	the	PV	and	host	organeles	is	hypothesized	to	facilitate	nutrient	
uptake	to	the	PV	(Charron	and	Sibley,	2002;	Quittnat	et	al,	2004;	Coppens	et	al,	2006;	Sampels	
et	al,	2012;	Romano	et	al,	2013).	Even	though	the	ER	is	the	site	of	LD	biogenesis,	ER	function	is	
not	compromised	in	mammalian	cels	upon	incubation	with	excess	OA	at	0.5	mM.	In	fact,	in	OA-
incubated	cels,	the	ER	helps	prevent	lipotoxicity	by	increasing	LD	biogenesis	and	ER	stress	is	
avoided,	whereas	saturated	FA	like	PA	causes	both	of	these	detrimental	processes	
(Shimabukuro	et	al,	1997;	Ostrander	et	al,	2001;	Listenberger	et	al,	2003;	Ricchi	et	al,	2009;	Mei	
et	al,	2011).	However,	there	seems	to	be	a	threshold	for	OA,	as	incubation	with	1.2	mM	OA	for	
prolonged	periods	has	been	shown	to	induce	ER	stress	in	vitro	and	in	vivo	in	murine	hepatocytes	
(Ota	et	al,	2008).	In	our	hands,	the	host	ER	appears	unafected	by	0.2	mM	OA,	and	stil	
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associates	with	the	PV,	thus	likely	not	impacting	Toxoplasma’s	growth.	Another	organele	that	
clusters	around	the	PV	is	the	Golgi	apparatus.	With	OA	in	the	medium,	our	quantitative	studies	
reveal	a	slight	delay	in	the	clustering	of	the	host	Golgi	around	the	PV	at	the	onset	of	infection.	
Further	studies	investigating	the	normal	functionality	of	the	host	Golgi	upon	OA	incubation	(e.g.,	
monitoring	ceramide	transport	from	the	host	Golgi	to	the	parasite)	may	prove	useful.	Finaly,	we	
investigated	the	association	of	mitochondria	to	the	Toxoplasma	PV.	The	intimate	apposition	of	
host	mitochondria	to	the	PV	is	wel	documented	although	the	significance	of	this	association	is	
stil	unknown	(Sinai	et	al,	1997;	Pernas	et	al,	2014).	In	fact,	only	type	I	stains	of	Toxoplasma	
recruit	mitochondria	to	the	PV,	and	these	strains	tend	to	be	more	virulent	in	vivo.	Neospora	
caninum,	a	very	closely	related	Apicomplexan	is	less	virulent,	but	also	recruits	mitochondria	to	
its	PV,	but	in	a	much	diminished	capacity	(Nolan	et	al,	2015).	It	is	therefore	possible	that	
mitochondrial	recruitment	may	only	play	a	role	in	virulence	in	vivo.	Interestingly,	the	
morphology	of	mitochondria	associated	with	the	Toxoplasma	PV	is	altered	upon	incubation	with	
OA	while	mitochondria	in	the	rest	of	the	cel	appear	normal.	This	may	be	important	as	there	
must	be	something	about	the	mitochondria’s	attachment	to	the	PV	that	is	altered	with	OA	
treatment.	This	may	help	in	future	to	provide	insight	about	interactions	between	the	PV	and	
host	mitochondria.	Alterations	in	the	shape	and	ultrastructure	of	mitochondria	are	wel	
documented	in	lipid-related	diseases,	such	as	neurodegeneration,	aging,	and	celular	lipid	
overdose	(Su	et	al,	2009;	Reddy	and	Reddy,	2011;	Galoway	and	Yoon,	2013;	Galoway	and	Yoon,	
2015;	2013;	Yoon	et	al,	2011).	Since	mitochondria	must	import	FA	for	β-oxidation,	it	is	not	
surprising	that	excess	FA	may	alter	mitochondrial	functions	and	disrupt	mitochondrial	
membrane	integrity.	Incubation	with	low	concentrations	of	PA	(0.1	mM)	induces	mitochondrial	
ROS	generation,	mitochondrial	membrane	potential	loss	and	DNA	damage	in	hepatocytes	and	
skeletal	muscles	cels	(Rachek	et	al,	2007;	Yuzefovych	et	al,	2010;	Cheon	and	Cho,	2014).	In	
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contrast,	1	mM	OA	did	not	induce	these	efects	in	these	cels	(Yuzefovych	et	al,	2010).	
Furthermore,	apoptosis	is	not	induced	when	treated	with	1	mM	OA,	whereas	Caspase	3	
cleavage	occurs	with	just	0.1	mM	PA	incubation	leading	to	apoptosis,	as	wel	as	ROS	generation	
(Turpin	et	al,	2006;	Yuzefovych	et	al,	2010;	Egnatchik	et	al,	2014).	Interestingly,	despite	PA	
incubation	clearly	afecting	mitochondrial	morphology	and	its	network,	no	diference	in	
Toxoplasma	growth	is	detected.	We	cannot	discount	the	fact	that	the	alteration	of	host	
mitochondria	next	to	the	PV	in	OA	treated	cels	may	afect	parasite	growth.	However,	it	is	
possible	that	host	mitochondria	association	to	the	PV	may	not	be	critical	for	the	intracelular	
development	of	Toxoplasma	RH	in	vitro,	as	observed	with	type	I	and	II	strains.	
	 Host	autophagy	could	be	involved	in	the	decrease	in	growth	of	Toxoplasma	upon	OA	
incubation	as	excess	of	this	FA	triggers	autophagy.	Degradation	of	the	PV	via	autophagy	has	not	
been	reported	for	Type	I	strains	of	Toxoplasma,	such	as	RH,	however	Type	I	and	II	strains	are	
susceptible	to	immune-mediated	autophagy	induction.	This	process	involves	ubiquitination	of	
the	PVM,	accumulation	of	LC3	around	the	PV,	as	wel	as	enclosure	of	the	PV	by	multiple	
membranes	(Seleck	et	al,	2015).	This	complex	does	not	fuse	with	lysosomes	and	endosomes	
and,	as	such,	is	not	xenophagy,	a	form	of	autophagy	occurring	in	the	control	of	intracelular	
pathogens.	Canonical	autophagy	occurs	during	periods	of	limited	resources,	i.e.	starvation.	In	
vitro	studies	have	shown	that	incubation	of	fibroblasts	in	starvation	medium	leads	to	an	
increase	in	LD	numbers,	which	in	turn	associate	with	mitochondria.	This	action	enables	FA,	
released	from	LD	by	ATGL	lipolysis	to	enter	the	mitochondria	for	β-oxidation	(Rambold	et	al,	
2015).	The	opposite	scenario,	i.e.	treatment	with	excess	OA	(up	to	1	mM)	stimulates	lipophagy,	
the	catabolism	of	LD	by	autophagy.	This	is	an	important	process	for	the	regulation	of	lipid	
metabolism	to	prevent	toxic	LD	aggregation	in	the	cytoplasm	(Singh	et	al,	2009;	Liu	and	Czaja,	
2013).	In	mammalian	cels,	including	HeLa	cels	and	hepatocytes,	excess	OA	triggers	lipophagy	
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whereby	OA	and	LD	lipids	contribute	to	the	generation	of	the	phagosomal	membranes	and	
autophagosomes	via	ATGL-mediated	LD	lipolysis	(Dupont	et	al,	2014;	Shpilka	and	Elazar,	2015).	
Interestingly,	Toxoplasma	appears	to	disrupt	host	cel	lipid	metabolism	as	a	decrease	in	ATGL	
expression	is	observed,	even	with	OA	incubation	(Chapter	3),	which	further	suggests	that	
Toxoplasma	alters	the	host	cel’s	metabolic	activities	(Blader	et	al,	2001).	Previous	studies	have	
reported	that	Toxoplasma	induces	autophagy	in	HeLa	cels	and	HFF,	alowing	optimal	
proliferation	for	the	parasite	and	increased	nutrient	scavenging	(Wang	et	al,	2009;	Lee	et	al,	
2013;	Gao	et	al,	2014).	Despite	autophagic	activity	upon	OA	incubation,	the	increase	was	not	
dissimilar	to	that	seen	under	normal	Toxoplasma-infected	conditions	without	OA.	This	suggests	
that	autophagy	induction	by	OA	may	not	afect	Toxoplasma’s	development	in	our	cel	culture	
conditions.	Additionaly,	Toxoplasma	may	disrupt	the	host	cel’s	autophagic	capacity	by	altering	
lipolysis	enzymatic	activity	and	therefore	may	also	dampen	the	extent	of	global	celular	
autophagy.	Further	studies	investigating	the	extent	of	LC3-I	protein	accumulation	in	the	cytosol	
would	confirm	our	microscopy	results	that	autophagy	is	not	highly	induced	with	OA	treatment	in	
Toxoplasma-infected	cels.	
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FUTURE	DIRECTIONS	AND	PERSPECTIVES	
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5.1.	Exploitation	of	Apicomplexan	auxotrophies	as	a	potential	therapeutic	
approach	
The	large	Apicomplexa	phylum	comprises	unicelular	protozoa	and,	among	them,	obligate	
intracelular	parasites	that	cause	disease	worldwide	in	animals	and	humans	such	as	malaria,	
toxoplasmosis,	cryptosporidiosis,	babesiosis	and	neosporosis.	These	parasites	are	able	to	
synthesize	many	metabolites,	however,	they	also	rely	on	nutrients	they	salvage	from	the	host	
cel	to	support	their	development.		
Presently,	al	the	anti-Apicomplexa	drugs	target	biosynthetic	pathways	that	are	unique	
to	the	parasites	(e.g.,	fatty	acid	type	I	or	folate	synthesis)	but	these	drugs	such	as	chloroquines,	
macrolides,	pyrimethamine,	sulfadiazine,	and	artemisins,	are	not	without	their	shortcomings.	
These	drugs	tend	to	cause	many	side	efects,	afect	the	host	cel’s	physiology,	may	be	expensive,	
are	not	very	eficient	at	curing	the	proliferative	parasite	stages,	have	poor	potency	against	the	
chronic	parasite	stages	and	are	prone	to	drug	resistance	by	the	parasites.	One	promising	
direction	in	the	search	for	new	chemotherapeutics	may	be	the	development	of	drugs	targeting	
the	parasite’s	salvaging	activities	as	a	powerful	way	to	essentialy	“starve”	Apicomplexa.	The	
rationale	for	this	approach	is	based	on	the	folowing	arguments:	
1. As	obligate	intracelular	parasites,	Apicomplexa	have	lost	their	ability	to	live	
independently	from	their	host	organism	and	cannot	replicate	axenicaly;	they	require	
nutrients	from	their	host	cel	to	efectively	replicate.		
2. They	express	many	transporters	and	few	metabolic	enzymes,	implying	that	salvaging	is	
critical	for	survival.	
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3. Parasites	should	be	particularly	sensitive	to	inhibitors	of	transporters	or	enzymes	in	
their	salvage	pathways.		
4. Subversive	substrate	analogs	internalized	by	the	parasite	might	be	metabolized	into	
toxic	metabolites.	
5. As	there	is	a	large	phylogenetic	separation	between	Apicomplexa	and	their	mammalian	
hosts,	parasite	transporters	must	have	some	specificity	in	their	mechanism	of	action	and	
sensitivities	that	may	be	exploited.	
	
The	problem	of	redundancy	in	salvage,	recycling	and	biosynthetic	pathways	in	
Apicomplexa	may	limit	this	chemotherapeutic	approach.	Nevertheless,	perturbing	one	salvaging	
pathway	may	have	metabolic	consequences	despite	possible	redundancies	by	reducing	global	
celular	biosynthesis.	This	may,	in	turn,	result	in	parasite	attenuation	or	loss	of	virulence	in	vivo.	
As	such,	identifying	the	most	vulnerable	facets	of	the	parasite’s	scavenging	mechanisms	may	aid	
in	the	discovery	of	better	drug	targets.	Alternatively,	a	multiple	step	attack	using	a	combination	
of	drugs	directed	against	more	than	one	target	in	salvaging	pathways	may	be	beneficial	to	avoid	
the	development	of	a	single	drug	resistance.		
This	thesis	focuses	on	two	Apicomplexa:	Toxoplasma	gondi	and	Neospora	caninum,	
very	closely	related	parasites	residing	within	a	parasitophorous	vacuole	(PV)	in	mammalian	cels	
(Sibley,	2003).	Their	sequestration	in	a	PV	provides	them	with	a	protective	environment	in	which	
to	replicate	but	the	PV	membrane	also	isolates	them	from	the	nutrients	present	in	the	host	
cytosol	and	organeles.	However,	both	of	these	parasites	have	evolved	strategies	to	circumvent	
this	barrier	as	we	have	shown	in	chapter	2.	One	example	is	the	recruitment	and	clustering	of	
host	organeles,	like	the	Golgi	apparatus	or	endolysosomes,	around	the	PV	to	facilitate	nutrient	
scavenging	(Fig.	5-1)	(Coppens	et	al,	2006;	Romano	et	al,	2013;	Nolan	et	al,	2015).	
	218	
	
Figure	5-1.	Recruitment	of	host	organeles	and	structures	to	the	PV	of	Toxoplasma	and	N.	caninum	
Both	Toxoplasma	and	N.	caninum	recruit	host	cel	structures	and	organeles	to	their	PV,	such	as	the	
endoplasmic	reticulum	(ER),	Golgi	apparatus,	mitochondria,	lipid	droplets	(LD),	microtubule	organizing	
center	(MTOC),	microtubules	and	Rab	vesicles.	In	addition,	both	parasites	can	scavenge	ceramide	via	the	
translocation	of	Golgi-derived	Rab	vesicles,	loaded	with	ceramide.	Exogenously	added	cholesterol	is	
scavenged	by	Toxoplasma	via	the	translocation	of	LDL-loaded	lysosomes	to	its	PV.	Although	N.	caninum	
also	scavenges	cholesterol,	the	mechanism	is	unknown.	Excess	cholesterol	salvaged	by	both	parasites	is	
eventualy	visible	in	labeled	structures	within	the	parasites,	likely	LD.	
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Toxoplasma	has	increased	the	number	of	genes	that	promote	nutrient	scavenging	for	
auxotrophic	or	insuficiently	synthesized	metabolites,	such	as	cholesterol,	choline,	polyamines,	
amino	acids	(arginine,	tryptophan,	histidine,	methionine,	threonine,	leucine,	isoleucine,	valine),	
and	purines	(Fig	5-2,	for	complete	list	of	metabolites	scavenged)	(reviewed	in	Coppens,	2013).	
The	host	cytosol	and	organeles	represent	a	valuable	source	for	these	nutrients	and	Toxoplasma	
contains	a	variety	of	transporters	for	these	compounds.	e.g.	for	purines	and	folate,	which	wil	be	
discussed	in	greater	detail.	Many	transporters	have	been	either	hypothesized,	uncharacterized	
or	have	yet	to	be	identified	(e.g.	those	mediating	lipoate,	isoprenoid,	or	pyrimidine	salvaging).	
The	purine	salvaging	pathway	in	Toxoplasma	has	been	extensively	studied	as	the	parasite	is	
auxotrophic	for	this	metabolite.	Toxoplasma	contains	3	purine	transporters:	TgAT1	(high	afinity	
for	adenosine	and	inosine);	TgAT2	(purines	and	pyrimidines);	and	TgNBT1	(hypoxanthine,	
xanthine,	guanine).	Only	TgAT1	has	been	cloned	and	its	inactivation	is	not	lethal,	indicating	
redundancy	in	purine	uptake	(Chiang	et	al,	1999;	De	Koning	et	al,	2003).	The	addition	of	purine	
nucleoside	analogs	causes	toxicity	for	the	parasite	folowing	their	internalization	into	the	
parasite	via	the	TgAT2	transporter	(Ilzsch	et	al,	1995;	Kim	et	al,	2010b).	Drug	targeting	to	the	
purine	salvaging	pathway	is	feasible	since	enzymes	involved	in	purine	metabolism	in	
Toxoplasma	vary	suficiently	from	mammalian	enzymes	in	terms	of	substrate	specificity.	The	
drugs	would	have	to	target	multiple	transporters	or,	at	the	very	least,	not	TgAT1	alone	because	
inactivation	of	TgAT1	is	not	lethal.	In	addition	to	nucleosides,	the	parasite	contains	transporters	
for	polyamines	derived	from	arginine,	such	as	ornithine	and	putrescine,	although	they	have	yet	
to	be	fuly	described	(Cook	et	al,	2007).	The	cofactor,	folate,	is	important	for	DNA	synthesis	and	
methionine	metabolism	and	the	folate	pathway	is	the	target	of	current	Toxoplasma	drugs	such	
as	pyrimethamine	and	trimethoprim.	Both	of	these	drugs	target	de	novo	folate	metabolism	by	
inhibiting	dihydrofolate	reductase	(DHFR)	and	folate	recycling	in	the	parasite.	In	contrast	to	
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mammalian	cels,	Toxoplasma	can	synthesize	folate	de	novo	but	also	scavenges	it	from	the	host	
cel	using	transporters	similar	to	the	BT1	family	of	proteins	(Anderson	et	al,	2005;	Massimine	et	
al,	2005).	Many	other	transporters	are	known	to	exist	based	on	research	using	analogs	and	
inhibitors,	but	are	stil	largely	uncharacterized.	These	transporters	include,	but	are	not	limited	to	
those	mediating	the	uptake	of	amino	acids,	lipoate,	pyrimidines,	isoprenoids,	and	phospholipids	
(reviewed	in	Coppens,	2013).	Targeting	the	aforementioned	salvaging	pathways	may	be	
promising	in	the	search	for	novel	drugs,	however,	more	eforts	needs	to	be	deployed	to	better	
characterize	these	transporters	in	order	to	find	their	specificities	for	a	selective	intervention	
against	the	parasites.	
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Figure	5-2.	Diagram	highlighting	the	salvage	activities	mediated	by	intracelular	Toxoplasma	
Metabolites	and	substrates	that	must	be	scavenged	by	the	parasite	are	in	pink,	whereas	those	that	are	
synthesized	and	scavenged	by	Toxoplasma	are	in	blue.	Lipoate,	in	green,	is	synthesized	and	scavenged	by	
the	parasite	but	its	fate	depends	on	its	origin.	The	transport	of	lipoate	or	lipids	from	mitochondria	is	
hypothesized	but	not	yet	proven.	Abbreviations:	ER,	endoplasmic	reticulum;	LDL,	low-density	lipoprotein;	
AA,	amino	acids;	PA,	phosphatidic	acid.	Image	from	Coppens,	2013.	
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5.2.	Lipid	salvage	pathways	in	Toxoplasma	as	potential	drug	targets	
Toxoplasma	has	a	very	rapid	replication	rate.	To	this	end,	the	parasite	must	either	synthesize	or	
scavenge	large	amounts	of	lipids	for	membrane	generation.	Targeting	lipid	salvage	pathways	
may	thus	provide	an	efective	avenue	for	future	drug	generation.		
5.2.1.	Cholesterol	
Cholesterol	is	essential	for	organizing	signaling	lipids	and	proteins	in	membranes,	as	wel	as	
regulating	general	membrane	fluidity.	It	is	the	main	sterol	in	mammalian	membranes	and	the	
only	sterol	present	in	Toxoplasma’s	membranes	despite	the	parasite’s	inability	of	synthesizing	
cholesterol	de	novo	(Coppens	et	al,	2000).	Toxoplasma	acquires	this	lipid	from	host	endosomes	
containing	plasma	low-density	lipoproteins	(LDL)	(Coppens	et	al,	2006).	Interfering	with	the	
parasite’s	access	to	cholesterol	has	a	detrimental	efect	on	Toxoplasma,	as	its	growth	is	
impaired	and	stage	conversion	to	the	slow-growing	cyst	form	is	stimulated	(Nishikawa	et	al,	
2005;	Lige	et	al,	2010;	Ihara	and	Nishikawa,	2014).	
Our	laboratory	has	identified	several	transporters	involved	in	cholesterol	metabolism	in	
Toxoplasma	e.g.	ATP-binding	cassette	(ABC)	G	family	(ABCG),	Niemann-Pick	type	C1-related	
protein	(NPC1)	and	sterol	carrier	protein	2	(SCP2).	ABCG	transporters	have	been	identified	in	
Toxoplasma	and	are	located	in	the	PV	membrane,	the	parasite	membrane	and	on	vesicles	in	the	
PV	lumen	(Ehrenmann	et	al,	2010).	Out	of	the	six	identified,	five	of	these	are	upregulated	upon	
sterol	exposure	and	may	represent	a	fruitful	drug	target	particularly	as	one	ABCG	has	been	
classified	as	a	cholesterol	importer.	Another	transporter	involved	in	cholesterol	homeostasis	is	
the	Niemann-Pick	type	C1-related	protein	(NPC1).	This	protein	is	localizes	to	the	endolysosome	
membrane	in	mammalian	cels	and	modulates	the	export	of	sterols	and	sphingolipids	(Liscum	
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and	Sturley,	2004).	Toxoplasma	contains	a	homologue,	TgNCR1,	located	in	the	inner	membrane	
complex	(IMC)	that	plays	a	role	in	lipid	homeostasis	(Lige	et	al,	2010).	Parasites	lacking	TgNCR1	
contain	large	amounts	of	cholesteryl	esters	and	divide	rapidly,	indicating	a	role	in	lipid	uptake	
regulation.	This	further	suggests	that	it	is	possible	to	disrupt	lipid	metabolism	in	Toxoplasma.	
The	sterol	carrier	protein	2	(SCP2)	is	localized	to	the	peroxisome	membrane	in	mammalian	cels.	
This	protein	helps	in	the	transport	of	not	only	sterols,	but	fatty	acids,	fatty	acyl-CoA,	and	
phospholipids	between	membranes	(Galegos	et	al,	2001).	Toxoplasma	contains	a	D-bifunctional	
protein	containing	two	SCP2	domains	involved	in	the	traficking	of	phospholipids,	cholesterol	
and	fatty	acids	between	parasite	organeles	and	the	plasma	membrane	(Lige	et	al,	2009).	
Overexpression	of	this	protein	leads	to	increased	growth	and	enhanced	cholesterol	uptake,	
which	makes	this	protein	another	potential	target	for	disruption.	
Once	internalized	in	Toxoplasma,	cholesterol	can	be	esterified	into	cholesterol	esters	in	
lipid	droplets	using	two	acyl-CoA:cholesterol	acyltransferases,	TgACAT1	and	TgACAT2.	
Incubation	with	ACAT	inhibitors	arrests	Toxoplasma’s	growth	due	to	lipotoxicity	from	
cholesterol	accumulation	in	membranes	(Nishikawa	et	al,	2005;	Lige	et	al,	2013).	These	findings	
suggest	that	the	acquisition,	traficking	and	storage	of	cholesterol	is	essential	for	the	parasite’s	
physiology	and	as	such,	may	represent	fruitful	drug	targets.	Future	research	could	involve	
studying	the	virulence	in	vivo	of	TgACAT1	and	TgACAT2	knockout	Toxoplasma.	If	cholesterol	
storage	ability	has	an	efect	in	vivo,	perhaps	TgACAT	could	represent	a	potential	drug	target.	If	
successful,	drug	screens	wil	be	performed	to	help	identify	candidates,	folowed	by	in	vivo	
eficacy	testing.	
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5.2.3.	Sphingolipids	
Al	eukaryotic	cels	contain	sphingolipids	in	their	membranes	to	provide	a	stable	and	chemicaly	
resistant	outer	membrane	for	protection	again	harmful	environmental	factors.	Sphingolipids	
and	their	precursors	are	also	important	for	neighboring-cel	recognition	and	signaling,	as	wel	as	
signaling	cascades	during	celular	development	and	stress	response	(ceramides).		
Lipidomics	studies	reveal	that	Toxoplasma	contains	over	20	types	of	sphingolipids	(Welti	
et	al,	2007;	Lige	et	al,	2010).	Toxoplasma’s	growth	can	be	severely	impaired	by	molecules	
targeting	host	sphingolipid	synthesis	and	salvage	pathways.	For	example,	treatment	of	infected	
cels	with	the	sphingolipid	analogs	threo-phenyl-2-palmitoylamino-3-morpholino-1-propanol	
(PPMP)	and	L-cycloserin,	impairs	the	growth	of	Toxoplasma	(Azzouz	et	al,	2002).	Aureobasidin	A,	
a	inositol	phosphorylceramide	synthase	inhibitor,	also	blocks	Toxoplasma	growth	by	reducing	
complex	sphingolipid	synthesis	without	afecting	the	host	cel	although	no	gene	coding	for	
inositol	phosphorylceramide	synthase	has	been	identified	in	the	Toxoplasma	genome,	in	this	
case	the	mechanism	of	action	remains	puzzling	(Sonda	et	al,	2005).	Moreover,	evidence	of	de	
novo	synthesis	of	this	lipid	by	the	parasite,	based	on	pharmocological	inhibitors,	remains	
argumentative.	
The	parasite	also	salvages	sphingolipids	from	the	host	Golgi	(de	Melo	and	De	Souza,	
1996;	Pratt	et	al,	2013;	Romano	et	al,	2013).	We	have	previously	shown	that	Toxoplasma	and	N.	
caninum	scavenge	ceramides	via	the	internalization	of	ceramide-loaded	Golgi-associated	Rab	
vesicles	(Romano	et	al,	2013;	Nolan	et	al,	2015).	Examples	include	Rab14,	which	mediates	the	
traficking	between	the	trans-Golgi	network,	endosomes	and	the	plasma	membrane	and	Rab30,	
involved	in	Golgi	structure	maintenance	and	vesicular	traficking	(de	Leeuw	et	al,	1998;	Junutula	
et	al,	2004;	Proikas-Cezanne	et	al,	2006;	Kitt	et	al,	2008;	Sinka	et	al,	2008;	Thomas	et	al,	2009;	
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Kely	et	al,	2011).	This	is	mediated	by	the	selective	translocation	of	Rab-vesicles	into	the	PV.	This	
implies	that	host	Rab	proteins	are	either	recognized	by	Toxoplasma	prior	to	translocation	to	the	
PV,	or	are	present	on	structures/vesicles	that	the	PV	internalizes.	Identifying	potential	
candidates	involved	in	the	recognition	and	internalization	of	Rab	vesicles	via	genetic	screens	on	
temperature	sensitive	mutants	may	prove	fruitful	in	characterizing	the	Toxoplasma	machinery	
involved	in	Rab	vesicle	uptake.	Another	suitable	method	of	identifying	this	machinery	could	
involve	infecting	stable	cel	lines	expressing	BirA,	fused	with	specific	Rab	proteins.	Proteins	in	
close	proximity	to	host	Rab	proteins	would	be	biotinylated,	which	could	then	be	isolated	
folowed	by	mass	spectrometry	identification.	
	
5.2.3.	Fatty	acids	
Fatty	acids	(FA)	are	essential	for	al	life	as	they	are	the	building	blocks	of	membranes,	are	
important	for	energy	storage	in	lipid	droplets	and	have	physiological	roles	such	as	signaling	and	
post-translational	protein	modifications.	Toxoplasma	has	three	FA	synthase	(FAS)	pathways:	1)	a	
FAS	I	pathway	in	the	apicoplast	producing	lipoic,	myristic	and	palmitic	acid;	2)	FA	elongation	
pathway	in	the	ER	for	long-chain	monounsaturated	FA	synthesis;	3)	FAS	I	pathway,	similar	to	
that	found	in	mammalian	cels	(Waler	et	al,	1998;	Crawford	et	al	2003;	Seeber	et	al,	2003;	
Ramakrishnan	et	al,	2012).	Targeting	the	FAS	I	pathway	is	not	a	viable	approach	due	to	the	
homologous	enzymes	in	the	host	cel.	The	FAS	I	pathway,	found	primarily	in	prokaryotes,	has	
been	extensively	studied	and	involves	diferent	sets	of	enzymatic	reactions,	not	found	in	
eukaryotic	cels	(Goodman	and	McFadden,	2007).	The	apicoplast	is	a	relict,	nonphotosynthetic	
plastid	resulting	from	secondary	endosymbiosis.	As	such,	the	reactions	taking	place	are	
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prokaryotic	in	nature	and	are	ideal	drug	targets	as	the	host	cel	would	be	unafected	by	targeted	
disruptions	in	this	pathway.		
Toxoplasma	is	not	auxotrophic	for	FA	but	it	can	also	scavenge	FA	such	as	palmitic,	oleic,	
linoleic,	or	arachidonic	acids	from	the	host	cel	for	incorporation	into	more	complex	lipids	or	
neutral	lipids,	or	degradation	by	β-oxidation	in	the	parasite’s	mitochondrion	(Tomavo	et	al,	
1989;	Charron	and	Sibley;	2002;	Quittnat	et	al,	2004;	Polonais	and	Soldati-Favre;	2010;	
Nishikawa	et	al,	2005).	Deletion	of	FAS	I	synthase	in	the	parasite	impairs	growth,	a	phenotype	
that	can	be	reversed	with	exogenous	addition	of	FA	to	the	medium	(Ramakrishnan	et	al,	2012)	
signifying	FA	synthesis	and	uptake	can	be	ofset.	Due	to	the	dual	sources	of	FA	for	Toxoplasma,	
interference	with	FA	pathways	need	to	occur	at	multiple	points	in	order	to	afect	Toxoplasma	
development.	The	work	in	this	thesis	revealed	that	Toxoplasma	readily	scavenges	FA	such	as	
oleic	acid	from	the	host	cel.	FA	uptake	by	Toxoplasma	is	part	of	its	parasitism,	and	therefore	
should	be	studied	in	greater	depth.	Host	lipid	droplets	represent	a	prominent	source	of	FA	and	
neutral	lipids	for	the	parasite,	so	a	greater	understanding	of	their	interaction	with	Toxoplasma	
may	help	reveal	novel	points	of	disruption	in	the	parasite’s	FA	metabolism.	
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5.3.	Perturbation	of	lipid	salvaging	pathways	in	Toxoplasma	
As	previously	discussed,	the	optimal	growth	of	Toxoplasma	relies	on	salvaging	of	lipids	from	the	
host	cel.	This	is	evidenced	by	the	boost	in	growth	folowing	addition	of	ceramides	and	
cholesterol	to	the	medium	(Coppens	et	al,	2000;	Nishikawa	et	al,	2005;	Romano	et	al,	2013).	
Conversely,	depletion	of	these	lipids	from	the	medium	leads	to	Toxoplasma	growth	impairment	
(Nishikawa	et	al,	2005;	Ihara	and	Nishikawa,	2014).	In	this	thesis,	we	explored	the	efect	of	
excess	oleic	acid	(OA)	on	parasite	growth,	hypothesizing	that	it	would	be	beneficial	for	the	
parasite’s	infectivity.	Surprisingly,	there	appears	to	be	a	deluge	of	the	parasite’s	salvaging	
pathways	leading	to	cytotoxic	damage	in	the	parasite.	This	was	evidenced	by:	1)	a	reduction	in	
replication	rate;	2)	delayed	egress	from	the	host	cels;	3)	the	over-accumulation	of	large-sized	
lipid	droplets	in	the	parasite,	often	protruding	out	of	the	cytoplasm;	4)	the	presence	of	lipidic	
deposits	in	the	PV	lumen,	the	cytosol,	organeles	and	residual	bodies	of	the	parasite;	5)	
morphological	defects	in	host	mitochondria	associated	with	the	PVM	(Fig	5-3).	
Clarifying	why	the	parasite	is	afected	to	such	an	extent	at	OA	concentrations	in	the	
medium	that	are	subtoxic	for	mammalian	cels	is	essential	for	a	better	understanding	of	
Toxoplasma’s	physiology.	One	direction	we	could	take	is	performing	lipidomics	studies	wil	be	
relevant	in	order	to	examine	lipid	profiles	in	the	lipid-overloaded	parasites,	particularly	
analyzing	the	nature	of	the	NL	accumulated	in	the	large	LD.	In	paralel,	analyzing	the	enzymatic	
activities	of	TgACATs	and	TgDGAT	in	these	parasites	would	be	interesting	to	reveal	unique	
properties,	e.g.	in	their	kinetics,	velocity,	or	avidity.	Down	the	road,	this	may	help	designing	
specific	pharmacological	ligands	as	potential	drugs.	
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Figure	5-3.	Summary	of	findings	in	chapters	3	and	4:	Distribution	of	host	organeles	and	Toxoplasma	
development	with	0.2	mM	OA.	
Addition	of	oleic	acid	(OA)	to	the	medium	of	infected	cels	leads	to	lipid	droplet	(LD)	accumulation	in	the	
host	cytosol,	some	of	which	are	translocated	to	the	Toxoplasma	PV,	along	with	the	biogenesis	of	parasite	
LD.	The	Despite	the	amassing	of	host	LD	around	the	PV,	the	host	ER,	Golgi,	autophagic	structures	(AS)	and	
mitochondria	are	normaly	recruited	by	the	parasite	to	the	PV	or	associated	with	the	PV.	However,	PV-
associated	mitochondria	display	morphological	abnormalities.	Intact	host	LD	were	observed	in	the	PV	
lumen,	as	were	as	host-derived	LD-associated	Rab	vesicles.	Endocytic	pits	observed	near	the	apex	of	the	
parasite	are	apparent	with	incubation	with	0.2	mM	OA.	OA	concentrations	greater	than	0.2	mM	led	to	the	
massive	accumulation	of	lipid	deposits	in	the	PV	lumen,	the	parasite	cytosol	and	the	residual	body	(not	
shown).		
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Additionaly,	RNA-Seq	analysis	comparing	transcriptional	profiles	of	parasites	cultivated	
with	excess	OA	and	under	normal	conditions,	as	wel	as	Protein	DIGE	(Diference	Gel	
Electrophoresis)	would	provide	essential	information	in	identifying	the	molecular	components	
implicated	in	lipid	uptake	(at	0.2	mM	OA).	These	include	proteins	that	may	be	forming	the	coat	
of	the	endocytic	structures,	FA	binding	proteins	or	transporters	including	potentialy	a	PLIN	
homologue	despite	The	Toxoplasma	genome	not	containing	a	homologue	for	LD-associated	
proteins	like	such	as	PLIN2	(ADRP)	or	PLIN5.	The	LD	protein	PLIN5	helps	mediate	LD	association	
with	mitochondria,	has	recently	been	implicated	in	promoting	NL	lipid	storage	and	preventing	
lipotoxicity	(reviewed	in	Kimmel	and	Sztalryd,	2014).	Further	digging	into	identifying	proteins	
found	in	Toxoplasma	involved	in	LD	maturation,	expansion,	fusion/fission,	motility	and	contact	
with	organeles	would	also	be	essential	in	order	to	gain	a	better	understanding	of	lipid	
metabolism	in	the	parasite.	Furthermore,	it	wil	help	elucidate	the	mechanisms	behind	the	
lipotoxicity	observed	in	the	presence	of	>	0.2	mM	OA.	In	non-adipose	cels,	several	lipotoxic	
pathways	have	been	identified	including	omega-oxidation,	lipid	peroxidation	and,	oxidative	and	
ER	stress.	The	lipotoxic-response	elicited	by	Toxoplasma,	incapable	of	storing	and	utilizing	
excess	FA	would	likely	reveal	unique	mechanisms	by	which	the	parasite	channels	excess	FA	to	
alternate	fates	than	storage	in	LD.	The	consequence	of	which	leads	to	alterations	of	organele	
membrane	structure/function,	production	of	toxic	metabolites	and	parasite	death.	
The	gluttonous	nature	of	Toxoplasma	could	be	exploited	by	incubating	the	parasite	with	
FA	analogs,	not	toxic	for	the	mammalian	host.	Previous	studies	on	obesity	therapies	have	shown	
that	plant	phytosterol	treatment	can	reduce	the	pool	of	available	cholesterol	in	humans,	
thereby	lowering	LDL-cholesterol	(reviewed	in	Ostlund,	2004).	Addition	of	FA	analogs	may	trick	
the	parasite	into	using	these	FA,	potentialy	to	detrimental	efects.	The	synthetic	OA	analog,	2-
hydroxylated	OA	(2OHOA),	has	a	longer	half	life	than	OA	as	it	is	not	degraded	through	β-
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oxidation	but	by	the	α-oxidation	pathway	(Vögler	et	al,	2008).	Currently,	OA	is	being	extensively	
researched	by	the	cancer	community	as	it	appears	that	OA	possesses	natural	anti-proliferative	
activities.	Addition	of	2OHOA	enhances	these	activities	and	inhibits	growth	of	tumors	and	cancer	
cels	in	vitro	and	in	vivo	(Terés	et	al,	2012).	The	mechanism	is	unknown	but	may	be	related	to	
changes	in	membrane	lipid	composition	and	membrane	biophysical	properties	(Prades	et	al,	
2008;	reviewed	in	Ibarguren	et	al,	2014).	Considering	the	detrimental	efect	of	OA	on	the	
parasite,	2OHOA	may	also	prove	to	be	a	valuable	tool	to	study	OA	toxicity	in	Toxoplasma	and	
potentialy	open	up	new	drug	opportunities.	
A	naturaly	occurring	FA	analog	derived	from	plants,	jasmonic	acid,	may	prove	to	be	a	
useful	therapeutic	approach	for	Toxoplasma.	JA	originates	from	α-linoleic	acid	and	its	
production	is	induced	in	response	to	stressors	(UV	radiation,	osmotic	stress,	temperature,	
pathogens)	and	mediates	the	production	of	reactive	oxygen	species	(ROS)	and	downstream	
defense	responses	in	plants	(Sembdner	and	Parthier,	1993;	Vasyukova	et	al,	2009).	This	FA	has	
no	efect	on	normal,	dividing	mammalian	cels	(EPA,	2013)	but	is	toxic	for	many	diferent	human	
and	murine	cancer	cels	(e.g.	breast,	cervical,	colorectal,	gastric,	hepatoma,	lung,	lymphoma,	
melanoma,	leukemia,	prostate,	neuroblastoma	and	sarcoma)	(reviewed	in	Cesari	et	al,	2014).	JA	
has	been	shown	to	be	toxic	to	cancer	cels	by	inducing	ROS	generation,	MAP	kinase	signaling,	
cel	cycle	arrest,	decrease	in	mitochondrial	membrane	potential,	and	apoptosis.	The	cause	of	JA	
selective	toxicity	on	some	cancer	cels	is	stil	unknown	but	it	may	be	interesting	to	investigate	its	
efect	on	Toxoplasma.	
Finaly,	considering	the	evolutionary	closeness	of	Toxoplasma	with	N.	caninum,	it	may	
be	interesting	to	investigate	if	N.	caninum	is	afected	by	OA	to	the	same	extent	as	Toxoplasma.	
As	opposed	to	Toxoplasma	that	possesses	two	TgACAT	enzymes,	N.	caninum	only	has	one,	
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which	shares	71%	identity	with	TgACAT1.	N.	caninum	has	the	ability	to	form	lipid	droplets	but	it	
is	not	known	whether	only	possessing	NcACAT	may	be	even	more	detrimental	upon	OA	excess.	
No	NcDGAT	enzyme	has	yet	been	identified	in	N.	caninum,	but	bioinformatics	searches	reveal	a	
putative	NcDGAT	with	87%	identity	with	TgDGAT	(NCLIV_032680).	This	suggests	that	both	
parasites	have	similar	capabilities	for	triacylglycerol	(TAG)	generation	but	requires	further	
studies	to	elucidate	the	capacity	of	N.	caninum	to	form	TAG	upon	OA	excess.	Since	N.	caninum	
does	not	seem	to	cause	disease	in	humans,	any	biological	and	physiological	diferences	between	
the	two	parasites	may	highlight	diferences	in	infectivity.		
The	focus	of	this	thesis	was	to	examine	the	ability	of	the	Apicomplexa	Toxoplasma	and	
N.	caninum	to	recruit	host	organeles	(mitochondria,	lipid	droplets,	Golgi,	endolysosomes),	
potentialy	in	order	the	salvage	nutrients	for	their	intracelular	development.	The	more	we	learn	
about	the	parasite	pathways	involved	in	the	salvage	of	key	nutrients	and	the	metabolism	of	key	
factors,	the	better	equipped	we	wil	be	to	develop	efective	therapies.	Such	therapies	may	in	
future	combine	inhibitors	that	disrupt	both	the	salvage	and	biosynthetic	pathways,	at	multiple	
targets.	The	identification	of	weak	points	in	Toxoplasma,	such	as	excessive	OA	salvaging	may	
also	provide	novel	drug	identification	opportunities.	Moreover,	considering	the	similarities	
shared	between	Toxoplasma	and	N.	caninum,	it	is	feasible	that	intervention	eforts	could	also	
target	more	than	one	Apicomplexa	species.	There	is	therefore	a	need	for	extensive	eforts	in	the	
fundamental	research	on	Apicomplexa.	In	particular,	acquiring	more	detailed	knowledge	of	their	
nutritional	needs,	metabolic	deficiencies	and	nutrient	transport	system	may	help	in	the	
development	of	antiparasitic	therapies.	
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- AY	2014-2015:	President	–	Chairing	and	organizing	student	committees,	
interacting	with	faculty,	logistics,	conveying	information	between	students	and	
faculty,	organizing	and	chairing	meetings,	inviting	and	hosting	outside	speakers	
(Dr.	Feng	Zhang,	MIT;	Dr.	Wiliam	Fischer,	UNC),	organizing	events,	distributing	
meeting	reports	to	students,	working	with	faculty	to	update	the	curriculum.	
- AY	2013-2014:	Vice-president	and	treasurer	
- 2011	–	present:	Recruitment	committee	
• American	Society	for	Microbiology:	student	member	since	2011	
• American	Association	for	the	Advancement	of	Science:	student	member	since	2011	
• Golden	Key	International	Honour	Society:	member	since	2008	
	
Scholarships	&	Honors:	
• May	2013:	Hegner,	Cort,	Root	Memorial	Felowship	in	Immunology	and	Infectious	
Disease	
• May	2012:	Dr.	J.	Harold	Drudge	Scholarship	
• April	2009:	Helmlinge	Summer	Stipend	Grant	and	Research	Supply	Grant		
• Summer	2005:	Nufield	Summer	Stipend	Grant	
	
Languages:	
• English	and	French	spoken	and	written	bilingualy	
• Moderate	understanding	of	German	and	Spanish	
	
	
	
	
